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General introduction and thesis outline
General introduction
Hemodynamic instability is often encountered in critically ill patients. Both patients undergoing 
high-risk surgery in the operating room (OR) and patients admitted to the Intensive Care Unit 
(ICU) may become hemodynamically unstable as a consequence of hypovolemia or vasodilation. 
While the pathophysiology and the underlying cause of hemodynamic instability may diff er, 
both patients in the OR and the ICU have in common that hemodynamic instability leads to an 
increased risk of complications and mortality (1,2).
To improve the outcome of critically ill patients, caregivers aim to prevent hemodynamic instability. 
Hemodynamic instability results in insuffi  cient perfusion of tissues and leads to organ dysfunction 
introducing a cascade that involves further loss of intravascular volume, i.e., hypovolemia, and 
vascular tone, i.e., vasodilation. The ultimate goal is to ensure suffi  cient oxygenation of the tissues 
through oxygen delivery and perfusion pressure. Oxygen delivery is the product of the volume 
of blood being pumped by the heart, i.e., cardiac output, and the amount of oxygen available in 
this blood, i.e., arterial oxygen content. Perfusion pressure is the diff erence between the infl ow 
pressure, i.e., mean arterial pressure, and the outfl ow pressure of the tissues. In short, the delivery 
of oxygen to the tissues requires adequate fl ow and pressure in the blood vessels. An overview 
of the interaction of these hemodynamic variables, which can be used as a target to prevent 
hemodynamic instability or potential intervention target when instability occurs, is shown in 
Figure 1.
Figure 1. Interaction of hemodynamic variables that can be targeted to prevent and treat hemodynamic instability. 
The aim is to optimize perfusion pressure and oxygen delivery to ensure adequate oxygenation of the organs and 
tissues (3)
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The real-time measurement of these hemodynamic variables is called hemodynamic monitoring, 
and a device that performs these measurements is called a hemodynamic monitor. Various types 
of hemodynamic monitors are commercially available, and many more are being developed. 
Monitoring devices range from fully invasive, e.g., a pulmonary artery catheter to measure cardiac 
output, to non-invasive, e.g., an oscillometric blood pressure cuff placed on the upper arm to 
intermittently measure blood pressure. Each of these monitors is indicated in distinctive clinical 
scenarios in different settings. The clinical heterogeneity of studies makes a comparison of the 
feasibility and applicability of monitors and judging the benefit of interventions using these 
monitors to obtain high-quality evidence difficult.
Thesis outline
The process of preventing hemodynamic instability by optimizing hemodynamic variables, and 
using the correct hemodynamic monitor to achieve this purpose remains a problematic aspect 
of perioperative and critical care medicine. Many different monitors are available that measure 
specific variables differently, and each monitor has to be validated correctly before it can be 
implemented in clinical practice. Failure to correctly validate monitors according to scientific 
standards or misinterpret conclusions of conducted studies can lead to erroneous decisions and, 
thus, potentially dangerous patient care.
This thesis has two aims. First, we aim to extend the available evidence on the applicability of 
hemodynamic monitoring to prevent and treat hemodynamic instability during the perioperative 
period and during admission to the ICU. Second, we aim to gain knowledge on how to improve 
the conduct of studies in perioperative and critical care medicine.
Throughout the thesis, the reader should be aware that a difference exists between the absence 
of evidence for monitoring versus evidence for the absence of monitoring in critically ill patients. 
Although evidence might lack for monitoring blood pressure and heart rate during surgery or 
admission to the ICU, no-one would perform surgery without monitoring these hemodynamic 
variables or treat a patient in the ICU without being informed on the circulation. Therefore, 
recommendations will be made even if high-quality evidence is absent. The goal is to increase 
knowledge and become aware of available evidence and areas where additional information is 
necessary. Proposing something as complex as hemodynamic monitoring to be either beneficial 
for every patient and setting or redundant overall will never be the conclusion of a thesis, as 
almost nothing is absolute.
Hemodynamic monitoring in the operating room and the intensive care
Hemodynamic monitoring during the perioperative period differs from basic to very advanced. 
Depending on the patient and the intervention, monitoring can vary from intermittent 
measurements of blood pressure alone to continuous measurements of cardiac output and 
surrogates of organ perfusion. More advanced hemodynamic monitors in perioperative medicine 
Chapter 1
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are most often used when perioperative goal-directed therapy (PGDT) is applied. PGDT aims at 
optimizing global hemodynamics during the perioperative period by titrating interventions such 
as fl uids, vasopressors, and inotropes to predefi ned hemodynamic targets (4). Assessment of the 
triggers and targets for PGDT and the response to interventions needed to reach these targets 
require hemodynamic monitoring beyond blood pressure and heart rate. Even though a vast 
amount of research has been conducted in this fi eld, conclusions on the optimal monitor and 
the eff ect of applying to monitor combined with interventions on patient outcomes are currently 
inconsistent. Some authors of systematic reviews with meta-analysis state that using PGDT 
improves perioperative outcomes such as mortality or morbidity, other systematic reviews with 
meta-analysis conclude that there is no such benefi t (5–7). Specifi c types of surgery or specifi c 
hemodynamic monitoring devices are often incorporated in these reviews (8,9). In chapter 2, we 
present a systematic overview of all studies that evaluated PGDT interventions in perioperative 
medicine.
Based on the available evidence for PGDT, several national and international anesthesiology 
societies have written practice guidelines that support the use of PGDT as part of perioperative 
care (10–12). Despite the availability of practice guidelines, the adoption and implementation 
of PGDT have been slow and incomplete (13). In chapter 3, we present a narrative review of the 
evidence for PGDT, which helps explain the considerations regarding the application of the PGDT 
intervention. We suggest the current best practice approach to using PGDT and discuss several 
future directions of PGDT, which may help to evolve this research fi eld further.
Hemodynamic monitoring in the ICU is even more complicated than in the OR. First, patients 
with hemodynamic instability usually are admitted acutely. Second, hemodynamic instability 
evolves. It can be the presenting condition of a patient admitted to the ICU, but it can also 
develop early after admission or later after several days, depending on the underlying disease 
or complication. Third, several patient characteristics in patients with hemodynamic instability 
hamper hemodynamic monitoring with many monitors. For example, the presence of atrial 
fi brillation limits reliable assessments of the arterial pressure waveform which is done by several 
monitors.
Despite these diffi  culties, hemodynamic monitoring in the ICU is often used, especially in patients 
with persistent circulatory shock. Most often, to measure blood pressure, heart rate, and cardiac 
output, to diagnose the underlying cause or the volume state, and to optimize blood pressure 
and cardiac output using interventions. In the acute setting of circulatory shock, physicians 
mostly rely on clinical examination. Clinical examination of critically ill patients with circulatory 
shock is challenging. Patients may present with varying states of circulating blood volume, cardiac 
contractility, sympathetic nervous activity, vascular tone, and microcirculatory function depending 
on the type of shock. Assessment is even more diffi  cult if comorbidities are present (14), which is 
increasingly the case in all patients. Clinical examination is practiced daily for clinical care, although 
it is not based on high-quality evidence (15). This lack of evidence leads to clinical examination in 
patients with circulatory shock being considered ‘best practice’ in circulatory shock guidelines (1).
General introduction and thesis outline
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To help improve clinical examination for hemodynamic estimates, we need to understand the 
current clinical practice. Our research group has recently conducted a large prospective cohort 
study, the Simple Intensive Care Studies-I (SICS-I), where researchers performed a standardized 
clinical examination, and clinical, laboratory and hemodynamic variables were collected from 
all acutely admitted critically ill patients during the first 24 hours of admission (16,17). As part 
of this protocol, researchers were asked to estimate cardiac function (i.e., cardiac index) using 
the variables obtained with clinical examination. In chapter 4, we present a Bayesian network 
that maps the decision-making process underlying researchers’ estimates of cardiac function. This 
study was a predefined substudy of the SICS-I (16).
In patients with circulatory shock, it is recommended by guidelines to initially target mean 
arterial blood pressure of 65 mmHg (1). Invasive arterial blood pressure monitoring using 
an arterial catheter is considered the clinical reference method in critically ill patients. Non-
invasive oscillometric blood pressure measurement using an upper-arm cuff is a widely used 
alternative for invasive monitoring (18). It is not yet conclusive whether non-invasive blood 
pressure measurements show agreement with the invasive arterial clinical reference technique. 
While some argue that non-invasive measurements may safely replace invasive measurements 
(19), others show an unacceptable disagreement in critically ill patients with circulatory shock 
(20,21). In chapter 5, we compared blood pressure measurements obtained using upper-arm cuff 
oscillometry with arterial catheter-derived blood pressure measurements in a large prospective 
cohort of critically ill patients with and without receiving norepinephrine. To investigate the 
clinical relevance of the differences between both methods, the recently developed error-grid 
method was used (22).
Non-invasive echocardiography is considered the standard clinical method to first measure 
cardiac output and to evaluate the type of shock in patients with circulatory shock (1). Application 
of the ultrasonography technique in the ICU is called critical care ultrasonography (CCUS) and is 
performed by critical care personnel, as opposed to a certified sonographer or cardiologist. CCUS 
is focused on the clinical question at hand, e.g., a quick, reliable measurement of cardiac output, 
and does not require obtaining all acoustic views from the standard windows (23). It has become 
more popular over the last years with the increasing availability of ultrasonography devices, 
and various professional bodies now mandate competency in CCUS (24). Data on the feasibility 
of obtaining images in ICU patients, the quality of the images obtained, and the quality of the 
measurements performed, is sparse but of significant importance for the adaptation of CCUS (23). 
In chapter 6, we present data on the feasibility of having CCUS performed by medical students, 
as an example of non-experts, in the ICU. This study was a predefined substudy of the SICS-I (16).
More advanced monitoring devices may become indicated if there is a more complex shock state 
(25). Besides measuring absolute values of cardiac output, it is also important to monitor changing 
trends in response to interventions such as a fluid challenge. One method of more advanced 
hemodynamic monitoring is the uncalibrated pulse wave analysis method, which estimates 
cardiac output from the arterial pressure waveform of an indwelling arterial line. In general, the 
Chapter 1
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reliability of this method must be interpreted with caution in patients with extensive changes 
in vascular tone, which may occur in circulatory shock (25). Recently, in order to improve the 
measurement performance, a new algorithm to estimate cardiac output was developed for one 
of these devices. In chapter 7, we compare the agreement and trending ability of cardiac output 
measurements made with arterial pressure waveform analysis to cardiac output measurements 
made with echocardiography. This study was a predefi ned substudy of the Simple Intensive Care 
Studies-I (SICS-I) (16).
How to improve the methodology and conduct of studies?
The second aim of this thesis was to gain knowledge on how to improve the conduct of studies in 
perioperative and critical care medicine. In the available literature, as well as in our studies, we found 
limitations regarding methodology and study conduct. Therefore, the quality of evidence should 
be considered when appreciating published studies. Many reasons exist as to why the quality of 
evidence of studies may be decreased, such as limitations in the methods, the inconsistency of 
results, indirectness of evidence, imprecision, or publication bias (26). Several of these problems 
are correctable during the design and conduct of studies, and it is essential to do so as weaknesses 
in studies can produce misleading results, results that can be implemented in guidelines, results 
that even change daily practice and could lead to harm and waste valuable resources as well (27). 
Over the last decades, a number of initiatives have been proposed and implemented to improve 
study planning and conduct as well as reporting of studies, such as checklists for reporting studies 
(28,29), the Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
approach to appreciate quality of evidence (26), and guidance on the use of core outcome sets 
when developing trials (30). These measures have helped partially to improve the methodology 
and conduct of studies.
When studies are performed in multiple hospitals or when a systematic review pools the results 
of various studies, it is essential that the studied patient populations are comparable for each 
hospital. Illness severity models are used in the ICU to characterize disease severity and degree of 
organ dysfunction, and predict outcome in critically ill patients (31). Examples of these models, 
which also provide mortality prediction, include the Acute Physiology and Chronic Health 
Evaluation-IV (APACHE-IV) (32) and the Simplifi ed Acute Physiology Score-II (SAPS-II) (33). For 
research purposes, these models are used to compare diff erent study populations. Therefore, 
these models must be appropriately developed and validated for optimal use. Until now, no 
study has systematically assessed which models have been developed. In chapter 8, we present 
a scoping review of all available mortality prediction models for adult critically ill patients.
Even though several measures have been implemented to improve research, further 
improvements are still possible and needed. In chapter 9, we comment on a recently published 
randomized controlled trial that was stopped for futility and propose that full protocols of trials 
and other clinical studies are being published in peer-reviewed journals before initiation.
General introduction and thesis outline
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Perioperative goal-directed therapy aims to optimize haemodynamics by titrating fluids, 
vasopressors and/or inotropes to predefined hemodynamic targets. Perioperative goal-directed 
therapy is a complex intervention composed of several independent component interventions. 
Trials on perioperative goal-directed therapy show conflicting results. We aimed to conduct a 
systematic review and meta-analysis to investigate the benefits and harms of perioperative goal-
directed therapy.
Methods
PubMED, EMBASE, Web of Science and Cochrane Library were searched. Trials were included if 
they had a perioperative goal-directed therapy protocol. The primary outcome was all-cause 
mortality. The first secondary outcome was serious adverse events excluding mortality. Risk of 
bias was assessed, and GRADE was used to evaluate quality of evidence.
Results
One hundred and twelve randomized trials were included of which one trial (1%) had low 
risk of bias. Included trials varied in patients: types of surgery which was expected due to 
inclusion criteria; in intervention and comparison: timing of intervention, monitoring devices, 
hemodynamic variables, target values, use of fluids, vasopressors and/or inotropes as well as 
combinations of these within protocols; and in outcome: mortality was reported in 87 trials (78%). 
Due to substantial clinical heterogeneity also within the various types of surgery a meta-analysis 
of data, including subgroup analyses, as defined in our protocol was considered inappropriate.
Conclusion
Clinical heterogeneity in patients, interventions and outcomes in peri-operative goal-directed 
therapy trials is too large to perform meta-analysis on all trials. Future trials and meta-analyses 
highly depend on universally agreed definitions on aspects beyond type of surgery of the 
complex intervention and its evaluation.
Chapter 2
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Introduction
Perioperative goa-directed therapy refers to the hemodynamic optimization during perioperative 
care by titrating fl uids, vasopressors, and/or inotropes to predefi ned hemodynamic goals (1). The 
main purpose of perioperative goal-directed therapy is to maintain or restore suffi  cient oxygen 
delivery by providing adequate organ and tissue perfusion. However, both under-resuscitation 
with insuffi  cient organ perfusion and over-resuscitation may lead to adverse outcomes (2).
In 1988, Shoemaker was the fi rst to report lower mortality and morbidity rates associated with 
perioperative goa-directed therapy compared with standard care, followed by a plethora of 
other trials (3). Shoemaker used invasive pulmonary artery catheter (PAC) monitoring to guide 
his interventions. In the past, such catheters were the most widely used technique although a 
clear survival benefi t was never proven (4). More recently, less-invasive and even non-invasive 
monitoring devices are used to reduce the risks associated with more invasive techniques. The 
British National Institute for Health and Care Excellence (NICE) and a report commissioned by the 
Centers for Medicare and Medicaid Services in the USA recommended the use of oesophageal 
Doppler monitoring (ODM) for optimizing hemodynamics in patients undergoing major surgery 
(5,6).
While most literature on perioperative goal-directed therapy evaluated patients having major 
gastrointestinal surgery, the data expand to orthopedic, cardiothoracic and vascular surgery (7-9). 
Several meta-analyses have been published on the use of perioperative goal-directed therapy 
in various types of patients, but conclusions are inconsistent (10-13). Furthermore, perioperative 
goal-directed therapy is not widely implemented in clinical practice across Europe (14). 
Recently, reviews evaluated specifi c types of surgery or hemodynamic monitoring devices 
(13,15). To provide a more extensive overview of perioperative goal-directed therapy, the aim of 
this systematic review was to investigate the benefi ts and harms of perioperative goal-directed 
therapy in patients having all types of surgery regardless of the protocol used.
Methods
This systematic review was conducted following our protocol registered on the PROSPERO 
database (CRD42016035548) following the recommendations of The Cochrane Handbook 
for Systematic Reviews of Interventions and Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) (16,17). We reported this review according to the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Table S1) (18).
Eligibility criteria
All trials published in English, irrespective of blinding, publication status or sample size were 
considered for assessment of benefi ts and harms. Quasi-randomized trials where the method 
Perioperative goal-directed therapy: A systematic review without meta-analysis
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of allocating participants to a treatment was not strictly random and observational trials were 
excluded. All trials evaluating any type of perioperative goal-directed therapy were considered 
for inclusion, irrespective the type of surgery, the goal-directed therapy algorithm, the types of 
vasopressors and inotropes used, the hemodynamic variable and its value targeted. All trials were 
included irrespective of the control intervention.
Perioperative goal-directed therapy was defined by any hemodynamic monitoring along with 
interventions aimed at optimizing haemodynamics during the perioperative period to achieve 
a specified predetermined hemodynamic target value. Trials had to describe the interventions, 
including the hemodynamic monitoring device, the hemodynamic variable and target value and 
the types and amounts of fluids and/or inotropes used. Such a clear description was required for 
the intervention group, but not for the control group.
The primary outcome was all-cause mortality (at longest follow-up). The first secondary outcome 
was serious adverse events (SAE) excluding mortality (to avoid double counts). SAE is a composite 
outcome summarizing all serious events necessitating an intervention and/or operation and/or 
prolonged hospital stay excluding mortality according to ICH-GCP definitions.19 Other secondary 
outcomes were hospital and ICU length of stay. Finally, we also considered the surrogate outcome 
of the total amounts of fluids administered.
Search strategy
We searched The Cochrane Central Register of Controlled Trials (CENTRAL) of The Cochrane 
Library, PubMed/MEDLINE, Web of Science and EMBASE. Furthermore, references of identified 
trials and (systematic) reviews were cross-searched. In addition, Google Scholar (Google Inc.) was 
used for ‘cited reference search’ by backwards snowballing (Supplement S1). We used no time 
restrictions. The final search was performed on 2 May 2018.
Study selection and data extraction
Two authors (TK, RPC) independently selected trials for inclusion. Excluded trials based on full 
text are listed with reasons for exclusion (Figure 1). Two authors independently performed data 
extraction, including trial characteristics (lead author, publication year, numbers of patients 
enrolled), participant characteristics (baseline characteristics, inclusion and exclusion criteria 
and types of surgery), intervention characteristics (hemodynamic variable and its value targeted, 
monitoring devices, interventions used) and all outcomes.
Bias risk assessment
The risks of bias were assessed by two authors (TK, RPC), independently, without masking of 
trial names following The Cochrane Handbook for Systematic Reviews of Interventions (16). Any 
differences in opinion were resolved through discussion. The following risk of bias domains was 
assessed: sequence generation, allocation concealment, blinding of participants and personnel, 
blinding of outcome assessors, incomplete outcome data, selective outcome reporting and other 
biases such as vested interests. Trials classified as low risk of bias in all domains were considered 
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as trials with low overall risk of bias. Trials with one or more of these bias risk domains scored as 
unclear or high risk of bias were considered trials with high overall risk of bias (16).
Statistical analysis
We followed the instructions in The Cochrane Handbook for Systematic Reviews of Interventions 
(16) for the intended meta-analyses using Review Manager 5.3.5 (20). For the intended trial 
sequential analysis (TSA), we used TSA software (version 0.9.5.10 beta) (21). 
For dichotomous variables, the risk ratio (RR) with the TSA-adjusted confi dence interval (CI) was 
calculated if there were two or more trials for an outcome. For rare events (<5% in the control 
group), we calculated odds ratios (OR) or Peto’s OR in case of very rare events (<2% in the control 
group) with TSA-adjusted CI. The outcomes were reported as proportions for each group. For 
continuous outcomes, we reported mean diff erences (MD) or weighted mean diff erences (WMD) 
with TSA-adjusted CI. 
Both a fi xed-eff ect and a random-eff ects model were used for meta-analysis. In case of discrepancy 
between the two models, both results were reported. Considering the anticipated abundant 
clinical heterogeneity (in populations, alternative and control interventions, and settings) the 
random-eff ects model was emphasized except if one or two trials dominated the available 
evidence.
Statistical heterogeneity was explored by the chi-squared test with signifi cance set at P-value of 
0.10, and the quantity of heterogeneity was measured by I-squared (22). 
We planned on performing the following subgroup analyses: (a) trials with overall low risk of bias 
compared to trials with overall high risk of bias; (b) the intervention eff ect in the trials depending 
on the type of surgery. Only subgroup analyses showing statistical signifi cant test of interactions 
(P < 0.05) were considered to provide evidence of an intervention eff ect pending the subgroup. 
A funnel plot was used to explore small trial bias and to use asymmetry in funnel plot of trial size 
against treatment eff ect to assess this bias if data on more than 10 trials were available (16).
GRADE
We used the GRADE system to assess the quality of the body of evidence associated with each 
of the major outcomes in our review using GRADE software (17). The quality measure of a body 
of evidence considers within-trial risk of bias, indirectness, heterogeneity, imprecision and risk of 
publication bias.
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Results
Our search strategy identified 2852 unique citations. After removal of duplicates, 1836 remaining 
hits were screened based on title and abstract. In all, 258 full-text articles were assessed for 
eligibility. After exclusion of 146 hits, 112 trials were selected for inclusion in this systematic review, 
of which 15 trials were identified through cross-reference searching (snowballing; Figure 1).
Figure 1. Flowchart of study selection
Characteristics of the included trials
In total, 112 trials with 13 562 patients were included in this systematic review (3,4,7-9,23-129). 
The characteristics of the 112 included trials are listed in the supplements (Table S2A-E). Nine 
trials used a three-arm parallel group design; all other trials used a two-arm parallel group design.
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Risk of bias
Adequate sequence generation was used in 82 trials (73%), allocation concealment was used in 
58 trials (52%), blinding of participants and personnel was used in 23 trials (21%) and blinding of 
outcome assessors was used in 61 trials (64%). Complete outcome data were reported in 88 trials 
(79%). There was a low risk of bias regarding selective outcome reporting in 103 trials (92%), and 
72 trials (64%) had no other risks of bias. One trial (1%) had a low overall risk of bias and 111 trials 
(99%) had high overall risk of bias (Figure 2 and Figure S1).
Figure 2. Risk of bias graph. Review authors’ judgements about each risk of bias item presented as percentages 
across all included trials
Characteristics of the patients included in the trials
The types of surgery that the patients in the trials underwent included abdominal surgery (43 
trials; 38%), cardiothoracic surgery (16 trials; 14%), high-risk surgery (13 trials; 12%), orthopedic 
surgery (eight trials; 7%), vascular surgery (nine trials; 8%), liver surgery (six trials; 5%), plastic 
surgery (fi ve trials; 4%), neurosurgery (three trials; 3%), trauma surgery (three trials; 3%), thoracic 
surgery (two trials; 2%) and other surgery or left unspecifi ed in fi ve trials (4%).
Timing of the intervention
The timing of the conduct of the perioperative goal-directed therapy intervention varied between 
trials. The majority of 70 trials (63%) only intervened during surgery, one trial (1%) only intervened 
before surgery, 11 trials (10%) performed the intervention exclusively post-surgery and 30 trials 
(27%) used extended durations.
Hemodynamic target variable
We identifi ed a total of 30 diff erent variables used as targets in the trials to guide the interventions. 
These consisted of static variables such as heart rate (HR), mean arterial pressure (MAP), cardiac 
output (CO), systolic blood pressure (SBP), central venous pressure (CVP), pulmonary artery 
occlusion pressure (PAOP), extravascular lung water (EVLW), global end diastolic volume 
(GEDV), intrathoracic blood volume (ITBV), left ventricular stroke work (LVSW), right ventricular 
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stroke work (RVSW) and stroke volume (SV). Calculated variables based on above-mentioned 
variables such as oxygen delivery (DO2), oxygen extraction ratio (O2ER), pulmonary vascular 
resistance (PVR), stroke volume index (SVI), systemic vascular resistance index (SVRI) and oxygen 
consumption (VO2) were also used. The dynamic variables used included stroke volume variation 
(SVV), pulse pressure variation (PPV), systolic pressure variation (SPV), corrected flow time (FTc), 
plethysmography variability index (PVI). Other variables used included base deficit (BD), central 
venous oxygen saturation (ScvO2), hematocrit (Ht), hemoglobin (Hb), lactate, PaO2/FiO2-ratio (PF-
ratio) and urine production. Even when identical variables were used, we found different cut-off 
target values in trials.
Monitoring devices
In total, 18 different hemodynamic monitoring devices were used in the trials (Table S2B). The 
devices varied from the pulmonary artery catheter to several less-invasive methods such as a 
central venous catheter already in place or newly introduced for fibreoptic oxymetry (CeVOX), 
calibrated transpulmonary thermodilution (PiCCO, VolumeView/EV1000), lithium dilution (LiDCO), 
pulse contour analysis (FloTrac, ProAQT, LiDCOrapid, Datex Ohmeda monitor, IBPplus monitor), 
endotracheal bioimpedance (ECOM), ultrasound derived techniques (ODM) and non-invasive 
methods such as thoracic bioimpedance (IQ), bioreactance (NICOM/Cheetah), and non-invasive 
pulse contour analysis (CNAP, Nexfin, Pulse CO-Oximetry).
Fluids
All trials used some combination of fluids and vasoactive medications to achieve the targeted 
hemodynamic value. Regarding fluid interventions, 61 trials (54%) used only colloids, 10 trials (9%) 
used only crystalloids and 32 trials (29%) used combinations of both. A total of nine trials (8%) did 
not specify the types of fluids used.
Vasopressors and/or inotropes
Different vasopressors and/or inotropes were used in the trials: dobutamine (46 trials; 41%), 
norepinephrine (34 trials; 30%), ephedrine (27 trials; 24%), dopamine (19 trials; 17%), phenylephrine 
(16 trials; 14%), epinephrine (15 trials; 13%), dopexamine (five trials; 4%), metaraminol (two 
trials; 2%), milrinone (two trials; 2%), cafedrine (one trial; 1%), theodrenaline (one trial; 1%) and 
vasopressin (one trial; 1%). In 28 trials (25%), the types of vasopressors and/or inotropes used were 
either unspecified or were left at the discretion of the anesthesiologist.
Outcomes
We observed vast clinical heterogeneity included in the trials for type of surgery but also in all 
individual components of the complex intervention of perioperative goal-directed therapy, 
including the timing of the intervention, the type of monitoring device, the hemodynamic 
variables assessed, the hemodynamic value targeted, the types and amounts of fluids given, the 
types of vasopressors and/or inotropes used (Table 1). Due to such observed clinical heterogeneity, 
it was deemed inappropriate to pool any of the data into a pooled intervention effect estimate, 
and therefore, no meta-analysis was conducted following recommendations of The Cochrane 
Handbook for Systematic Reviews of Interventions (16).
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Primary outcome
Eighty-seven trials (78%) reported mortality, the timing of which varied from perioperative 
mortality up to 1-year mortality or was left unspecifi ed. Furthermore, causation of mortality in 
this outcome varied from all-cause to specifi c causes such as cardiac death. Mortality varied 
from 0% to 34% in the intervention groups and from 0% to 44% in the control groups (Figure 3). 
Statistical heterogeneity measured by I2 was 12%. A funnel plot suggested no arguments for bias 
(Figure 4). We also evaluated subgroups classifi ed according to type of surgery (Figure 5). We did 
not perform meta-analysis in these subgroups as there still was signifi cant clinical heterogeneity 
based on all other variables.
Secondary outcomes
The SAEs that were reported varied from one single-specifi c complication, such as postoperative 
ileus or kidney failure, to multiple predefi ned adverse outcomes in several organ systems (Table 
S2C). None of the trials reported SAE according to the ICH-GCP defi nitions. 
Hospital stay was reported in 78 trials (70%) and ICU stay was reported in 40 trials (36%). Hospital 
stay varied from 2 to 31 days and length of ICU stay varied from 0 to 15 days (Table S2E). 
The types of fl uids given in the intervention and control groups varied substantially (Table S2B). 
Details on total amounts of fl uids given were reported in 104 trials (93%). The amounts of fl uids 
given were either reported as total amounts given during the trial or as total amounts of each 
type of fl uid or as mL/kg/h. Total amounts of fl uids given ranged from no additional fl uid to nearly 
22 L of crystalloids in severe trauma patients (Table S2E).
GRADE
The quality of the evidence was assessed as very low for all outcomes based on risk of bias 
limitations, indirectness, inconsistency, imprecision and other considerations (Table 2).
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Table 1. Key characteristics of the included trials 
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Table 1. Key characteristics of the included trials  
Author Year Type of 
surgery 
Device Timing Prime 
goal 
Types of fluids Vasoactive 
medication 
Schultz 1985 Orthopedic PAC pre/intra/post CI 3.0-3.5 N/S N/S 
Shoemaker 1988 High risk PAC pre/intra/post CI >4.5 Crystalloids/Colloids Inotropes/Vasopressors 
Berlauk 1991 Vascular PAC pre/intra CI >2.8 Colloids Inotropes 
Fleming 1992 Trauma PAC pre/intra/post CI >4.52 Crystalloids/Colloids Inotropes 
Boyd 1993 High risk PAC pre/intra/post DO2 >600 Colloids Inotropes/Vasopressors 
Bishop 1995 Trauma PAC pre/intra/post CI >4.5 Crystalloids/Colloids Inotropes 
Mythen 1995 Cardiothoracic ODM intra Maximum 
SV 
Crystalloids Vasopressors 
Bender 1997 Vascular PAC pre/intra/post CI >2.8 Crystalloids Inotropes 
Sinclair  1997 Orthopedic ODM intra CFT <0.35 Crystalloids/Colloids N/S 
Ziegler 1997 Vascular PAC pre PAOP 
>12 
Crystalloids Inotropes 
Ueno 1998 Liver PAC post CI >4.5 Colloids Inotropes/Vasopressors 
Valentine 1998 Vascular PAC pre/intra/post CI >2.8 Crystalloids Inotropes 
Wilson 1999 High risk PAC pre/intra/post PAOP 
=12 
Crystalloids/Colloids Inotropes/Vasopressors 
Lobo 2000 High risk PAC intra/post DO2 >600 Crystalloids/Colloids Inotropes/Vasopressors 
Pölönön 2000 Cardiothoracic PAC post SvO2 >70 N/S Inotropes/Vasopressors 
Velmahos 2000 Trauma Bioimpedance pre/intra/post SBP >100 Crystalloids/Colloids Inotropes/Vasopressors 
Bonazzi 2002 Vascular PAC pre/intra/post CI >3.01 Crystalloids Inotropes 
Conway 2002 Abdominal ODM intra CFT <0.35 Colloids N/S 
Gan 2002 High risk ODM intra CFT <0.35 Crystalloids/Colloids N/S 




Sandham 2003 High risk PAC intra DO2 550-
600 
N/S N/S 
McKendry 2004 Cardiothoracic ODM post SVI >35 Colloids Inotropes/Vasopressors 
Pearse 2005 High risk LiDCO post SVV <10 Colloids Inotropes/Vasopressors 
Szakmany 2005 Abdominal PiCCO intra ITBVI 850-
950 
Colloids N/S 
Wakeling 2005 Abdominal ODM intra SVV <10 Colloids N/S 
Lobo 2006 High risk PAC intra/post DO2 >600 Crystalloids/Colloids Inotropes 
Noblett 2006 Abdominal ODM intra CFT <0.35 Colloids Vasopressors 
Donati 2007 Abdominal CVL intra/post O2ER <27 Colloids Inotropes 
Goepfert  2007 Cardiothoracic PiCCO intra/post GEDVI 
>640 
Colloids Vasopressors 
Lopes 2007 High risk IBPPlus intra PPV <10 Colloids Vasopressors 
Buettner  2008 High risk PiCCO intra SPV <10 Crystalloids/Colloids Vasopressors 
Harten  2008 Abdominal LiDCO intra PPV <10 Colloids Inotropes 
Kapoor 2008 Cardiothoracic FloTrac intra SVV <10 Colloids Inotropes 
Senagore 2009 Abdominal ODM intra SVV >10 Colloids N/S 
Smetkin 2009 Cardiothoracic PiCCO intra ITBVI 850-
1000 
Colloids Inotropes/Vasopressors 
Benes 2010 Abdominal FloTrac intra SVV <10 Colloids Inotropes/Vasopressors 
Forget 2010 Abdominal Masimo/PVI intra PVI <13 Crystalloids/Colloids Vasopressors 
Jammer 2010 Abdominal CVL intra ScvO2 >75 Colloids N/S 
Jhanji 2010 Abdominal LiDCO post SVV <10 Colloids Inotropes 
Mayer 2010 Abdominal FloTrac intra CI >2.5 Crystalloids/Colloids Inotropes/Vasopressors 
Van der 
Linden 
2010 Vascular FloTrac intra CI >2.5 Colloids Inotropes 
Wenkui 2010 Abdominal Serum lactate intra Lactate 
<1.6 
Colloids Vasopressors 
Cecconi 2011 Orthopedic FloTrac intra SVV <10 Crystalloids/Colloids Inotropes 
Pillai 2011 Abdominal ODM intra SVV <10 Colloids N/S 
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Brandstrup 2012 Abdominal ODM intra SVV <10 Colloids Vasopressors 
Challand 2012 Abdominal ODM intra SVV <10 Colloids N/S 
Jain 2012 Plastic LiDCO intra SVV <10 N/S N/S 








Zhang Jun 2012 Abdominal Datex intra PPV <11 Crystalloids/Colloids Vasopressors 
Bartha 2013 Orthopedic LiDCO pre/intra DO2 >600 Colloids Inotropes/Vasopressors 
Bisgaard 
AAA 
2013 Vascular LiDCO intra/post Sustained 





2013 Vascular LiDCO intra/post Sustained 
rise of SVI 
>10 
Colloids Inotropes/Vasopressors 





2013 Liver ODM intra/post CFT <0.35 Colloids N/S 
Figus  2013 Plastic ODM intra SV rise 
<10 
Colloids N/S 
Goepfert  2013 Cardiothoracic PiCCO intra/post SVV <10 Crystalloids/Colloids Vasopressors 
Jones 2013 Liver LiDCO post Maximum 
SV 
Colloids Inotropes 
McKenny 2013 Abdominal ODM intra SV rise 
<10 
Colloids N/S 
Ramsingh 2013 Abdominal FloTrac intra SVV <12 Crystalloids/Colloids N/S 
Salzwedel 2013 Abdominal ProAQT intra PPV <10 N/S Inotropes/Vasopressors 
Scheeren 2013 High risk FloTrac intra SVV <10 Colloids N/S 
Zakhaleva 2013 Abdominal ODM intra CFT <0.35 Colloids N/S 
Zhang 2013 Cardiothoracic FloTrac intra SVV <10 Colloids Inotropes/Vasopressors 
Zheng 2013 Abdominal FloTrac intra CI >2.5 Colloids Vasopressors 
Fayed 2014 Liver ODM intra CFT <0.35 Colloids Vasopressors 
Pearse 2014 Abdominal LiDCO intra/post Maximum 
SV 
Colloids Inotropes 
Peng 2014 Orthopedic FloTrac intra SVV <10 
or <14 
Colloids Vasopressors 
Pestana 2014 Abdominal NICOM intra/post CI >2.5; 
MAP >65 
Crystalloids/Colloids Inotropes/Vasopressors 
Phan 2014 Abdominal ODM intra CFT <0.35 Colloids N/S 
Pösö 2014 Abdominal TTE/FloTrac pre/intra SVV <12 Colloids Inotropes/Vasopressors 
Thomson 2014 Cardiothoracic LiDCO post SV rise 
<10 
Crystalloids/Colloids N/S 
Zeng 2014 Abdominal FloTrac intra SVV <13 Colloids Vasopressors 
Ackland 2015 High risk LiDCO post SV rise 
<10 
Colloids Inotropes/Vasopressors 
Benes  2015 Orthopedic CNAP intra PPV <13 Crystalloids/Colloids Vasopressors 
Colantonio 2015 Abdominal FloTrac intra CI >2.5 Colloids Inotropes 
Correa-
Gallego 
2015 Liver FloTrac intra SVV <2SD 
baseline 
Colloids N/S 
Fellahi 2015 Cardiothoracic ECOM intra SVV <11 Colloids Inotropes/Vasopressors 
Funk AAA 2015 Vascular FloTrac intra SVV <13 Colloids Vasopressors 
Funk FFR 2015 Plastic FloTrac intra/post SVV <13 Colloids Vasopressors 
Kumar  2015 High risk FloTrac intra CI >2.5 Crystalloids/Colloids Inotropes/Vasopressors 
Lai 2015 Abdominal LiDCO intra SVV <10 Colloids N/S 
Lee 2015 Cardiothoracic NICOM intra  Colloids Inotropes/Vasopressors 
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Abbreviations: CFT, corrected velocity time; CI, cardiac index; CVL, central venous line; CVP, central venous pressure; 
DO2, delivery of oxygen; GEDVI, global end diastolic volume index; intra, intraoperative; ITBVI, intra thoracic blood 
volume index; MAP, mean arterial pressure; N/S, not specified; O2ER, oxygen extraction ratio; ODM, oesophageal 
Doppler monitor; PAC, pulmonary artery catheter; PAOP, pulmonary artery occlusion pressure; post, postoperative; 
PPV, pulse pressure variation; pre, preoperative; PVI, pleth variability index; RVEDVI, right ventricular end diastolic 
volume index; ScvO2, central venous oxygen saturation; SV, stroke volume; SVI, stroke volume index; SVV, stroke 
volume variation; VCCI, vena cava collapsibility index
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Mikor 2015 Abdominal CeVOX intra ScvO2 
>75 
Colloids Vasopressors 
Moppett 2015 Orthopedic LiDCO intra SV rise 
<10 
Colloids N/S 
Parke 2015 Cardiothoracic FloTrac post SVV <13 N/S N/S 
Xiao 2015 Other LiDCO intra SV rise 
<10 
Crystalloids Vasopressors 
Yu 2015 Abdominal Masimo/PVI intra PVI <13 Crystalloids/Colloids Vasopressors 
Broch 2016 Abdominal Nexfin intra/post PPV <10 Crystalloids/Colloids Inotropes/Vasopressors 
Hand 2016 Plastic FloTrac intra MAP >75 N/S Inotropes/Vasopressors 




Kumar  2016 Abdominal FloTrac intra SVV <10% Crystalloids/Colloids Inotropes/Vasopressors 
Osawa 2016 Cardiothoracic LiDCO intra CI >3.0 Crystalloids Inotropes 
Pavlovic 2016 Other PiCCO intra PPV or 
SVV <12 
Crystalloids/Colloids Inotropes/Vasopressors 
Picard  2016 Neuro ODM intra CFT <0.33 Colloids Inotropes/Vasopressors 
Schmid 2016 Abdominal PiCCO intra/post GEDVI 
>640 
Crystalloids/Colloids Inotropes/Vasopressors 
Elgendy 2017 Abdominal FloTrac intra/post SVV >12% Colloids Inotropes/Vasopressors 
Gomez-
Izquierdo 
2017 Abdominal ODM intra SV rise 
<10% 
Colloids Vasopressors 
Kapoor 2017 Cardiothoracic FloTrac intra/post ScVO2 
>70% 
Crystalloids/Colloids Inotropes 
Kaufmann 2017 Thoracic ODM intra SVV <10% Crystalloids Vasopressors 
Li 2017 Not specified FloTrac intra VCCI 
<40% 
N/S N/S 
Liang 2017 Other FloTrac intra SVV 8-
13% 
Colloids Inotropes 
Luo 2017 Neuro FloTrac Intra SVV<15% Colloids Inotropes/Vasopressors 
Reisinger 2017 Abdominal ODM Intra/post SV rise 
<10% 
Colloids Vasopressors 
Sethi 2017 Abdominal CVL intra CVP 8-12 Crystalloids Vasopressors 
Stens 2017 Abdominal Nexfin intra PPV 
<12% 
Crystalloids/Colloids Inotropes/Vasopressors 
Wu 2017 Neuro FloTrac intra SVV <12% Colloids Inotropes/Vasopressors 
Xu 2017 Thoracic FloTrac Intra SVV <13% Colloids Inotropes/Vasopressors 
Calvo-
Vecino 
2018 Abdominal ODM intra SV rise 
<10% 
Crystalloids/Colloids N/S 
Demirel 2018 Abdominal Masimo/PVI intra PVI <14% Crystalloids/Colloids Vasopressors 
Kim 2018 Plastic FloTrac intra SVV <12% Colloids Inotropes/Vasopressors 
Liu 2018 Other FloTrac Intra/post CI >2.5 Crystalloids/Colloids Inotropes 
 
r i ti : , corrected velocity time; CI, cardiac index; CVL, central venous line; CVP, central venous 
pressure; DO2, delivery of oxygen; GEDVI, global end diastolic volume index; intra, intraoperative; ITBVI, intra 
thoracic blood volume index; MAP, mean arterial pressure; N/S, not specified; O2ER, oxygen extraction ratio; 
ODM, oesophageal Doppler monitor; PAC, pulmonary artery catheter; PAOP, pulmonary artery occlusion 
pressure; post, postoperative; PPV, pulse pressure variation; pre, preoperative; PVI, pleth variability index; 
RVEDVI, right ventricular end diastolic volume index; ScvO2, central venous oxygen saturation; SV, stroke 
l ; SVI, stroke volume index; SVV, stroke vol me variation; VCCI, vena cava collapsibility index 
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Figure 3. Forest plot of all-cause mortality at maximum follow-up. Subgroups were constructed and classifi ed 
according to high or low risk of bias. Due to clinical heterogeneity, meta-analysis was deemed inappropriate
Figure 4. Funnel plot of all-cause mortality at maximum follow-up
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Discussion
We conducted a systematic review of perioperative goal-directed therapy and found 112 
randomized trials. Only one trial (1%) had a low overall risk of bias. Perioperative goal-directed 
therapy was tested in patient groups of at least 10 different types of surgery. There was very large 
clinical heterogeneity, not only in the types of patients but even more in the complex intervention 
of perioperative goal-directed therapy including its component interventions and also in the 
outcomes evaluated. This includes variations in the five main components that compose the 
complex intervention of perioperative goal-directed therapy: the type of monitoring devices (n 
= 18), the hemodynamic variables (n = 30), the target value (n = 112), the types of fluids (n = 5), 
and the inotropes and vasopressors used (combined n = 13). Theoretically, various perioperative 
goal-directed therapy interventions can be composed when accounting for all possibilities 
of each component intervention (even when ignoring the variations in hemodynamic values 
targeted). Even though low statistical heterogeneity (I2 = 12%) was observed, pooling of data 
was clearly inappropriate considering such clinical heterogeneity, and thus, we refrained from 
any meta-analysis, including in subgroups, following recommendations of The Cochrane 
Handbook for Systematic Reviews of Interventions. Even when disregarding the type of surgery, 
the perioperative goal-directed therapy interventions show substantial heterogeneity in other 
domains. Final conclusions of any beneficial or harmful effect of perioperative goal-directed 
therapy in general therefore remain to be decided and homogeneity on either the type of surgery 
or the five main components of perioperative goal-directed therapy is needed to extrapolate the 
observations to clinical practice.
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Figure 5. Forest plot of all-cause mortality at maximum follow-up with subgroups classified according to type of 
surgery. Due to clinical heterogeneity, meta-analysis was deemed inappropriate
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Many meta-analyses have been conducted for evaluation of perioperative goal-directed 
therapy for specifi c patient categories (10-13). Others narrowed their research question to 
specifi c perioperative goal-directed therapy interventions, limiting clinical heterogeneity in 
the interventions used. For example, one systematic review only evaluated LidCO-based fl uid 
management during hip surgery (83). Such narrowing has advantages in terms of population and 
device defi nitions at the costs of reduced power and reduced generalizability of the perioperative 
goal-directed therapy intervention. However, even within one trial or within a focused systematic 
review, patients may diff er in several aspects. We chose to include trials irrespective of type of 
surgery because national guidelines recommend the use of perioperative goal-directed therapy 
in major surgery (5,6).
Experts recognize that evaluation of the perioperative goal-directed therapy intervention is 
impeded by large clinical heterogeneity, especially considering the changes over time (130,131). 
Earlier perioperative goal-directed therapy trials targeted supranormal hemodynamic values 
compared to a more restrictive fl uid regimen applied in more recent trials. Researchers have 
adopted lessons learnt from earlier trials into new trials so that the perioperative goal-directed 
therapy intervention might have evolved (132). Furthermore, general advancements in medicine 
might have reduced mortality both in the intervention group and in the control group over time. 
Therefore, merging data from earlier trials with data from more recent trials into one pooled 
intervention eff ect estimate may be inappropriate.
During this systematic review, we made several deviations from our published protocol. First, 
there were no data on the composite outcome SAEs, and we were therefore unable to report 
this. We recognize the diffi  culty associated with the defi nition and registration of SAEs and did 
not take into account that most of the included trials were published before SAE defi nitions by 
ICH-GCP were developed. Third, we also included trials if most of the perioperative goal-directed 
therapy protocol was described. Last, since the total amount of administered fl uids and length 
of hospital stay were reported inconsistently, we could not perform statistical analyses on both 
outcomes.
We aimed to present the extracted data for this systematic review as accessible as possible. 
However, we realize that, without meta-analyses, we ask the reader to analyze the data on their 
own using the supplementary table in order to fully appreciate this work (Table S2).
In general, randomized trials with low overall risk of bias are needed before the conclusion can 
be drawn that any intervention is benefi cial (133). The benefi cial eff ects of perioperative goal-
directed therapy need confi rmation by trials with low overall risks of bias (134). This systematic 
review, as in general, is obviously limited by the quality of the included trials (135): only one trial 
had low overall risks of bias (33).
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Future research on perioperative goal-directed therapy will most likely benefit from a consensus 
on definitions of the standard combination of components that form the complex composite 
intervention of perioperative goal-directed therapy as well as on its individual components. 
Furthermore, initiatives such as Core Outcome Measures in Effectiveness Trials (COMET) have 
agreed on standard sets of outcomes for a specific area of research (136) and researchers of 
perioperative goal-directed therapy may likewise benefit from such a standard set of outcomes 
(133).
Conclusion
Perioperative goal-directed therapy has been tested in many randomized trials. Meta-analysis of 
data was considered inappropriate due to the vast amount of clinical heterogeneity. Therefore, a 
uniform conclusion on the effect of perioperative goal-directed therapy, in general, on outcome 
remains to be elucidated.
Future research on perioperative goal-directed therapy probably will benefit from consensus 
definitions and reports should at least include all perioperative goal-directed therapy components. 
Any reported pooled intervention effect estimates on perioperative goal-directed therapy 
should be interpreted with great caution due to the current heterogeneity. Various multicenter 
randomized trials on perioperative goal-directed therapy are ongoing (www.clinicaltrials.gov), 
including the large Fluid Optimisation in Emergency LAparotomy (FLO-ELA) trial targeting 7646 
patients (www.floela.org) and the OPtimisation of Peri-operaTive Cardiovascular Management to 
Improve Surgical outcomE II (OPTIMISE II) trial targeting 2502 patients (www.optimiseii.org).
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Abstract
Perioperative goal-directed therapy aims at optimizing global hemodynamics during 
the perioperative period by titrating fluids, vasopressors, and/or inotropes to predefined 
hemodynamic goals. There is evidence on the benefit of perioperative goal-directed therapy, but 
its adoption into clinical practice is slow and incomprehensive. Current evidence indicates that 
treating patients according to perioperative goal-directed therapy protocols reduces morbidity 
and mortality, particularly in patients having high-risk surgery. Perioperative goal-directed 
therapy protocols need to be started early, should include vasoactive agents in addition to fluids, 
and should target blood flow related variables. Future promising developments in the field of 
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Introduction
Optimal hemodynamic management in patients undergoing surgery remains a challenge for 
anesthesiologists, and there is large variability in care between health care providers, even for the 
same type of surgery and within the same hospital (1,2). Insuffi  cient hemodynamic management 
may lead to tissue hypoperfusion or tissue edema formation, both resulting in inadequate oxygen 
delivery to the tissue associated with organ dysfunction and adverse postoperative patient 
outcome (3). To reduce the uncertainties regarding the optimal hemodynamic management, 
various protocols for perioperative goal-directed therapy (PGDT) have been proposed (4). PGDT 
aims at optimizing global hemodynamics during the perioperative period by titrating fl uids, 
vasopressors, and/or inotropes to predefi ned hemodynamic goals (5).
Since the fi rst concepts of PGDT were described in the 1980s, more than 100 randomized controlled 
trials (RCTs) have been published, followed by an ever-increasing number of systematic reviews 
with meta-analyses. The cumulative evidence that PGDT is capable of improving patient outcome 
has led to its adoption in clinical practice guidelines, e.g., in the United Kingdom (6), France (7), 
and by the European Society of Anaesthesiology (8). Despite this, the actual implementation and 
adoption of PGDT protocols in clinical practice has been rather slow and incomprehensive (9). One 
reason for the poor adoption rate might be that PGDT is a vague, poorly defi ned, and confusing 
term for physicians and researchers, as it is used in multiple diff erent clinical scenarios. In general, 
PGDT can involve optimization of cardiac preload, afterload, and contractility to achieve a balance 
between systematic oxygen delivery and oxygen demand.
In this review, we summarize the currently available evidence for PGDT. We discuss early trials 
employing a protocol guided by hemodynamic variables assessed with the pulmonary artery 
catheter (PAC) as well as trials using modern PGDT protocols with less invasive monitoring. In 
addition, we also critically discuss why studies on PGDT may have led to confl icting results. Finally, 
we consider future directions of PGDT, which may help to further evolve this research fi eld
Diff erent concepts of perioperative goal-directed therapy
Early concepts of perioperative goal-directed therapy
The invention of the fl ow-directed balloon-tipped PAC in the 1970s has led to an increase in the 
use of invasive hemodynamic monitoring in critically ill patients (10). However, it took some time 
for the fi rst prospective RCT to be performed, which analyzed improvement of clinical outcome 
when using interventions guided by hemodynamic variables assessed with the PAC.
One of the fi rst RCTs evaluated elderly patients undergoing hip fracture surgery, with the 
intervention group undergoing perioperative optimization of their hemodynamic status guided 
by PAC-derived variables (11). In these patients, certain hemodynamic variables were monitored 
and optimized both pre- and postoperatively (among others, a cardiac index (CI) between 3.0 
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and 3.5 L/min/m2 and oxygen consumption (VO2) between 110 mL/min/m
2 and 165 mL/min/
m2) (11). This was one of the first treatment protocols that can be called PGDT. Patients treated 
according to this PAC-based protocol showed markedly lower postoperative mortality rates 
than control patients (1 of 35 (2.9%) versus 10 of 35 (29%)). Another RCT studied patients having 
surgery for peripheral vascular disease, who are at high risk of cardiovascular complications (12). 
A preoperative optimization protocol was used targeting a pulmonary artery wedge pressure 
between 8 and 15 mmHg, a CI of more than 2.8 L/min/m2, and a systemic vascular resistance of 
less than 1100 dyne-sec/cm5 (12). Fluids, inotropes, and vasodilators could be used to achieve 
these goals, and in intervention group patients, the postoperative mortality was 1 of 68 (1.5%) 
compared to 1 of 21 (9.5%) in control group patients (12).
Supranormal oxygen delivery
Measurements of hemodynamic variables in survivors and nonsurvivors of shock after major 
trauma surgery suggested that higher – so-called supranormal – values of hemodynamic variables 
were associated with improved survival in these patients (13). It was hypothesized that the 
survival benefit might be the consequence of less shock-related complications and organ failure 
in patients having supranormal values, e.g., CI of more than 4.5 L/min/m2, oxygen delivery (DO2) of 
more than 600 mL/min/m2, and VO2 of more than 170 mL/min/m
2. These values, which are higher 
than normal resting hemodynamic values, were then used in prospective trials as target values for 
high-risk patients having major noncardiac surgery. The results of the first trial in high-risk patients 
showed a reduction in mortality, postoperative complications, and length of hospital stay after 
using a treatment protocol based on the supranormal target values (14). These results led to the 
hypothesis that high-risk patients having surgery should be hemodynamically optimized to these 
targets already before surgery, i.e., before the surgical trauma and the development of organ 
failure. In addition, it was suggested to maintain these target values throughout surgery and also 
for the first 24 h after surgery in the ICU. Several trials used similar protocols with varying results 
(11,15-21). These early trials were summarized in a systematic review with meta-analysis by the 
original author of the first trial, who concluded that preoperative initiation of the protocol was 
associated with a decrease in mortality (22). It was emphasized that PGDT protocols have to be 
initiated early and aggressively to be most effective (22).
Investigators in these initial studies on PGDT used the PAC to monitor patient hemodynamics 
and guide interventions (10). Consequently, the use of the PAC became widespread and the PAC-
derived hemodynamic data were used by physicians to guide hemodynamic therapy in the ICU 
and the operating room. At its peak, more than 40% of all critically ill patients received a PAC as 
part of their care in the ICU, but evidence regarding its benefit was never objectified (23). The 
invasiveness of the PAC also meant that placement was associated with complications such as 
catheter-related infections and thromboembolic events. In one of the largest trials comparing a 
PGDT protocol based on PAC-derived hemodynamic variables with standard care without the 
use of a PAC, no survival benefit was found for PAC-guided therapy in high-risk surgical patients 
(24). The results of this RCT and numerous other trials combined in a Cochrane review led to a 
decrease in the use of the PAC (25,26). Also, routine PAC placement is not recommended by the 
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European Society of Cardiology/European Society of Anaesthesiology in their current guidelines 
on the management of patients undergoing non-cardiac surgery (27). In addition, optimizing 
patients preoperatively with a PAC requires admission to an ICU, which consumes many resources 
and is therefore not applicable to patients undergoing most types of surgery. The decline of the 
use of the PAC was further facilitated by the emergence of minimally invasive and noninvasive 
monitoring techniques to estimate cardiac output (CO) and other hemodynamic variables.
Minimally invasive and noninvasive monitoring in PGDT protocols
Minimally invasive monitoring refers to devices that measure hemodynamic variables by only 
using an arterial catheter or esophageal Doppler (28). Several of these devices have been 
developed, and the most important ones are discussed here.
Pulse wave analysis
Pulse wave analysis (PWA) allows estimation of stroke volume (SV) or CO and of dynamic preload 
variables. The method is based on the principle that aortic pulse pressure is proportional and 
inversely proportional to aortic compliance. Although static variables are single snapshots taken 
at specifi c points in the cardiac cycle (e.g., CO measured by thermodilution or central venous 
pressure (CVP)), dynamic preload variables express rapid changes in the cardiovascular status and 
can be monitored continuously. In addition, an increase in CO induced by volume expansion can 
be predicted by dynamic preload variables before volume expansion is actually performed, which 
is helpful in PGDT algorithms and helps to avoid unnecessary fl uid administration. Examples 
of these dynamic preload variables include systolic pressure variation (SPV), pulse pressure 
variation (PPV), and stroke volume variation (SVV). These variables are induced by heart-lung 
interactions during a respiratory cycle in mechanically ventilated patients and are an indicator 
of the position on the Frank-Starling curve, which is proportional to the degree of preload 
dependency (29,30). Of these dynamic variables, PPV is considered to have the best predictive 
ability for fl uid responsiveness (31). A disadvantage of these dynamic preload variables is that 
they cannot be used in a number of concomitant conditions including cardiac arrhythmias 
and spontaneous breathing (32). Some PWA monitors can be calibrated with an independent 
measurement of CO done by transpulmonary thermodilution. This calibration is done similar 
to the PAC with injection of a small fl uid bolus. To do this, transpulmonary thermodilution 
monitors require both a central venous catheter and a femoral arterial catheter and are therefore 
considered invasive, not minimally invasive (28). Transpulmonary thermodilution monitors can 
also estimate extravascular lung water, which is a measure of pulmonary edema, and pulmonary 
vascular permeability, which is a measure of pulmonary capillary leakage. These variables can 
help to guide fl uid strategies, for example, as safety measures to avoid fl uid overload in patients 
with acute respiratory distress syndrome. Transpulmonary thermodilution monitors are therefore 
mainly used for complex patients in the ICU (33). Uncalibrated PWA monitors estimate the CO only 
from arterial pressure waveform characteristics and biometric data. A proprietary algorithm uses 
the mean, standard deviation, skewness, and kurtosis of arterial pressure and arterial compliance 
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estimated from sex, age, weight, and height (34). The waveform characteristics become less 
reliable in pathophysiological conditions with low vascular resistance such as liver disease, 
during liver surgery, or septic shock. In these conditions, use of uncalibrated PWA monitors is not 
recommended (35).
Oesophageal Doppler Monitor
The Oesophageal Doppler Monitor (ODM) probe is placed in the patient’s esophagus and uses 
Doppler ultrasound to measure the velocity of blood flow in the adjacent descending aorta. The 
blood flow in the descending aorta is correlated to CO, assuming a fixed proportion of blood flow 
going to the upper and lower part of the body. Estimation of CO using the ODM was originally 
thought to have agreement with invasive CO measurements using the PAC (36). However, results 
of a more recent systematic review with meta-analysis have shown that agreement between 
ODM and PAC derived CO measurements is moderate at best (37). Several PGDT protocols using 
ODM-derived hemodynamic variables have been developed and tested. The first trials evaluated 
a PGDT protocol using an ODM to titrate fluids in patients undergoing hip fracture surgery (38,39). 
Both studies concluded that intraoperative volume loading to optimize stroke volume using an 
ODM resulted in more rapid postoperative recovery and a reduced length of hospital stay. Use of 
ODM was not limited to hip fracture surgery patients but ODM was also used to titrate fluids and 
vasoactive medication in patients undergoing abdominal surgery (40). This was also associated 
with a reduction in length of hospital stay, but also in postoperative complications, number 
of patients requiring ICU admission, and time to return of bowel function (40). Eventually, use 
of PGDT protocols employing an ODM was implemented in national guidelines in the United 
Kingdom to enhance recovery after surgery (6). In general, a limitation of the ODM is that it can 
only be placed intraoperatively under general anesthesia due to patient convenience.
Perioperative goal-directed therapy – what is the evidence?
Summarizing the evidence on PGDT is challenging because many different protocols have been 
developed and studied over the years. Nevertheless, a multitude of meta-analyses has been 
conducted on this subject. Several meta-analyses have suggested a beneficial effect of PGDT 
in terms of reduction in postoperative complications and length of stay (41-43). However, the 
studies included in these meta-analyses were heterogeneous and varied with regard to not 
only types of surgery but also all individual components of the PGDT intervention, including the 
timing of the intervention; the type of monitoring device; the hemodynamic variables assessed; 
the hemodynamic values targeted; and the types and amounts of fluids, vasopressors, and/or 
inotropes used (44). This clinical heterogeneity needs to be considered when pooling results of 
individual RCTs (45).
We previously performed a systematic review on PGDT where the observed clinical heterogeneity 
made us conclude that it was inappropriate to pool all the data to estimate an intervention effect 
of the PGDT intervention (44). Therefore, we believe a definite conclusion on the effect of PGDT 
remains to be elucidated (44).
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Recently, a systematic review with meta-analysis was published with more rigorous methodological 
conditions (4). Benefi t for PGDT was analyzed in various predefi ned subgroups, such as timing 
of initiation of PGDT protocol or whether a CO monitoring device was used. Subgroup analysis 
can be a way of reducing clinical heterogeneity within a meta-analysis, particularly if diff erent 
patient populations, technologies, and interventions exist within the literature. This approach also 
takes into account that many aspects of the management of high-risk surgical patients and trial 
methodology may have changed over the last decades (46). The authors of this systematic review 
discuss a number of results. First, PGDT reduced the risk of mortality compared with standard 
care only in high-risk patients (OR 0.60 (95% CI 0.42-0.85)) but not in low-risk patients (OR 0.79 
(95% CI 0.50-1.24)) (4). High risk was defi ned as patients undergoing cardiac surgery, critically ill 
patients, or studies with >50% ASA III physical class patients. Second, PGDT reduced the risk of 
mortality compared with standard care only if PGDT was started intraoperatively (OR 0.65 (95% CI 
0.47-0.89)) and not when PGDT was started postoperatively (OR 0.72 (95% CI 0.38-1.33)) (4). Third, 
PGDT reduced mortality only if vasoactive agents were used per protocol in addition to fl uids (OR 
0.59 (95% CI 0.40-0.89)) and not if only a fl uid-based intervention was performed (OR 0.65 (95% CI 
0.41-1.05)) (4). Last, PGDT reduced mortality only if a CO monitor was used to guide therapy (OR 
0.68 (95% CI 0.49-0.95)) (4).
Based on the abovementioned evidence, we believe that PGDT should be employed in patients 
who will benefi t the most: high-risk patients undergoing high-risk surgery. The PGDT protocol 
should be started early during the perioperative period (47). In addition, an algorithm which 
mainly targets fl ow optimization (i.e., CO or SV) should be used, and dynamic preload variables 
might also be included to assess fl uid responsiveness.
Two large RCTs on PGDT are currently being conducted. The fi rst is the FLuid Optimisation in 
Emergency LAparotomy (FLO-ELA) trial (www.fl oela.org), which aims to include 7646 patients 
undergoing emergency bowel surgery using a PGDT protocol. The other trial is the OPtimisation 
of Peri-operaTive CardIovascular Management to Improve Surgical outcomE II (OPTIMISE II) trial 
(www.optimiseii.org), which aims to include 2502 patients undergoing elective major abdominal 
surgery. Currently, a third large multicenter trial is being analyzed, and results should soon be 
available (48).
Perioperative goal-directed therapy – future directions
Personalized hemodynamic management
The above-mentioned methods and PGDT protocols all use a general strategy of hemodynamic 
optimization employing predefi ned “normal” values as hemodynamic targets. However, it is now 
known that many hemodynamic variables have marked inter-individual variability and depend on 
biometric factors (49). For example, CO measured by transpulmonary thermodilution in critically 
ill patients was shown to be independently associated with age, height, and body weight (50). 
In addition, left ventricular volume and stroke volume varies by gender and decreases with age 
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(51,52). Consequently, the term personalized hemodynamic management has been suggested 
as a means to optimize cardiovascular dynamics based on the patient’s personal hemodynamic 
profile (49). For PGDT, this could be realized by implementing personalized concepts of 
hemodynamic management based on individual baseline values and functional assessment of 
fluid responsiveness in the operating room.
Closed-loop system management
Other developments such as closed-loop system management are suggested to further help 
implementing PGDT protocols in clinical practice. One of the largest trials on PGDT showed that 
there is a learning curve for clinicians and that compliance to PGDT protocols is suboptimal 
(53). A possible way of integrating the monitoring of the variables in one place and increasing 
the compliance to the protocols is by implementing a closed-loop system for hemodynamic 
management. A closed-loop system is a system where a controller monitors multiple variables 
and adjusts interventions using a feedback process (54). In the context of PGDT, a clinical example 
of a closed-loop system uses dynamic variables (e.g., PPV and SVV) collected from an uncalibrated 
PCA monitor to automatically titrate fluid application. This system has been tested in simulation 
(55,56), engineering studies (57), and animal studies (58). Clinical studies in patients undergoing 
moderate- and high-risk surgery have established feasibility of implementing these systems and 
show that patients consequently spent a great portion of time in a preload-independent state 
throughout surgery (59,60). At the moment, the feasibility of a closed-loop system for vasopressor 
infusion is being developed, with initial promising results in simulation and animal studies (61,62).
Summary
Perioperative goal-directed therapy aims at optimizing global hemodynamics during 
the perioperative period by titrating fluids, vasopressors, and/or inotropes to predefined 
hemodynamic goals. There is evidence on the benefit of perioperative goal-directed therapy, but 
its adoption into clinical practice is slow and incomprehensive. Current evidence indicates that 
treating patients according to perioperative goal-directed therapy protocols reduces morbidity 
and mortality, particularly in patients having high-risk surgery. Perioperative goal-directed 
therapy protocols need to be started early, should include vasoactive agents in addition to fluids, 
and should target blood flow related variables. Future promising developments in the field of 
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Practice points
Current evidence indicates that treating patients according to PGDT protocols reduces 
morbidity and mortality, particularly in patients undergoing high-risk surgery. The PGDT 
protocol needs to be started early (i.e., intraoperatively, not postoperatively), should include 
vasoactive agents in addition to fl uids, and should target blood fl ow related variables.
Clinical heterogeneity between diff erent studies makes drawing defi nite conclusions on the 
benefi t of PGDT on outcome diffi  cult so that multicenter trials on this topic are still needed.
Research agenda
Large multicenter trials (OPTIMISE-II and FLO-ELA) are ongoing to further elucidate the benefi t 
of PGDT protocols.
Future PGDT protocols will consider individual variability in optimal hemodynamic targets 
and move toward personalized hemodynamic management.
Further research on closed-loop systems to administer fl uids and vasoactive agents will help 
with improving protocol compliance.
Perioperative goal-directed therapy – What is the evidence?
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Hemodynamic assessment of critically ill patients is a challenging endeavor, and advanced 
monitoring techniques are often required to guide treatment choices. Given the technical 
complexity and occasional unavailability of these techniques, estimation of cardiac function 
based on clinical examination is valuable for critical care physicians to diagnose circulatory shock. 
Yet, the lack of knowledge on how to best conduct and teach the clinical examination to estimate 
cardiac function has reduced its accuracy to almost that of “flipping a coin.”
Objective
The aim of this study was to investigate the decision-making process underlying estimates of 
cardiac function of patients acutely admitted to the intensive care unit (ICU) based on current 
standardized clinical examination using Bayesian methods.
Methods
Patient data were collected as part of the Simple Intensive Care Studies-I (SICS-I) prospective 
cohort study. All adult patients consecutively admitted to the ICU with an expected stay longer 
than 24 hours were included, for whom clinical examination was conducted and cardiac function 
was estimated. Using these data, first, the probabilistic dependencies between the examiners’ 
estimates and the set of clinically measured variables upon which these rely were analyzed 
using a Bayesian network. Second, the accuracy of cardiac function estimates was assessed by 
comparison to the cardiac index values measured by critical care ultrasonography.
Results
A total of 1075 patients were included, of which 783 patients had validated cardiac index 
measurements. A Bayesian network analysis identified two clinical variables upon which cardiac 
function estimate is conditionally dependent, namely, noradrenaline administration and 
presence of delayed capillary refill time or mottling. When the patient received noradrenaline, the 
probability of cardiac function being estimated as reasonable or good P(ER,G) was lower, irrespective 
of whether the patient was mechanically ventilated (P[ER,G|ventilation, noradrenaline]=0.63, 
P[ER,G|ventilation, no noradrenaline]=0.91, P[ER,G|no ventilation, noradrenaline]=0.67, P[ER,G|no 
ventilation, no noradrenaline]=0.93). The same trend was found for capillary refill time or mottling. 
Sensitivity of estimating a low cardiac index was 26% and 39% and specificity was 83% and 74% 
for students and physicians, respectively. Positive and negative likelihood ratios were 1.53 (95% CI 
1.19-1.97) and 0.87 (95% CI 0.80-0.95), respectively, overall.
Conclusions
The conditional dependencies between clinical variables and the cardiac function estimates 
resulted in a network consistent with known physiological relations. Conditional probability 
queries allow for multiple clinical scenarios to be recreated, which provide insight into the possible 
thought process underlying the examiners’ cardiac function estimates. This information can help 
develop interactive digital training tools for students and physicians and contribute toward the 
goal of further improving the diagnostic accuracy of clinical examination in ICU patients.
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In hemodynamically unstable patients admitted to the intensive care unit (ICU) for circulatory 
shock, the diagnosis and treatment decisions initially rely on accurate assessment of clinical 
examination (1,2). Shock is the clinical expression of circulatory failure that results in inadequate 
cellular oxygen utilization and is often accompanied by systemic arterial hypotension, clinical 
signs of tissue hypoperfusion, and hyperlactatemia (3). About one-third of critically ill patients 
experience circulatory shock, which is associated with increased morbidity and mortality (4).
Hemodynamic assessment of critically ill patients is challenging; depending on the type of shock, 
patients present with highly variable states of circulating blood volume, cardiac contractility, 
sympathetic nervous activity, vascular tone, and microcirculatory dysfunction. In addition, 
assessment is even more diffi  cult if comorbidities are present (5). Currently, hemodynamic 
estimates based on clinical examination show poor association with cardiac index in both 
univariate and multivariate analyses, and these estimates are no better than fl ipping a coin (6). 
Due to this limited ability to assess a patient’s hemodynamic status using clinical examination, 
physicians often base changes in treatment primarily on information obtained through advanced 
monitoring techniques (7). However, advanced monitoring techniques are currently advised and 
desired when clinical examination does not lead to a clear diagnosis, or when a patient does 
not respond to initial therapy (2,8). Therefore, it is important to place emphasis on improving 
hemodynamic estimates made with clinical examination, to avoid inappropriate overuse of 
technological aid (9).
The fi rst step in developing improved clinical examination structures for hemodynamic estimates 
is to study the current clinical practice. To understand how students and physicians diagnosed 
low cardiac index, Bayesian networks can be used to gain insight into the thought process behind 
the educated guess on hemodynamic status.
Bayesian networks have been frequently used to model domain knowledge in the context of 
decision support in other fi elds of medicine, given their ability to be interpreted as causal networks 
when no confounders are present (10-13). By combining prior knowledge and the uncertainty in 
data, Bayesian networks allow for inference tasks to be performed, which establish conditional, 
possibly causal, dependencies between variables (14). Conditional probabilities queries are 
interesting tools to study clinical reasoning, which are seen as an additive thought process where, 
at every step, information is interpreted conditioned on previously acquired information.
Objectives
The aim of this study was to use Bayesian networks to investigate the decision-making process 
underlying estimates of cardiac function of patients acutely admitted to the ICU, based on current 
standardized clinical examination using Bayesian methods. Additionally, we aimed to determine 
the diagnostic accuracy of the current standardized clinical examination for estimating cardiac 
function in patients acutely admitted to the ICU.
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Methods
Design, Setting, and Participants
This study was a predefined substudy of the prospective observational cohort Simple Intensive 
Care Studies-I (SICS-I) (ClinicalTrial.gov trial registration: NCT02912624) (15). The study was 
approved by the local institutional review board (METc M15.168207). In SICS-I, all consecutive, 
acutely admitted adults expected to stay beyond 24 hours were included on their first day of 
admission to the ICU. Written informed consent was obtained from all patients or their relatives. 
This study is reported following the Standards for the Reporting of Diagnostic Accuracy Studies 
guidelines (16).
Aims
The primary aim was to determine the conditional probabilities relating the variables measured 
during clinical examination to the cardiac function estimate made by the examiners.
The secondary aim of this study was to assess the diagnostic accuracy of cardiac function 
estimates made by the examiners and compare them to the cardiac index measured by critical 
care ultrasonography (CCUS).
Bayesian Network Analysis
Bayesian networks are probabilistic models that represent the conditional (in)dependence 
relations between a set of variables in the form of a directed acyclic graph. In the graph, each 
variable is represented as a node and the directed edges (arcs) connecting the nodes represent the 
conditional dependency relations among the variables. Given the conditional (in)dependencies 
implied by the directed acyclic graph, the joint probability distribution of all variables can be 
factorized into a product of simpler local probability distributions.
From the initial set of variables registered during clinical examination, 14 clinical variables available 
from bedside monitors and patient record files, perfusors, physical examination, and the cardiac 
function estimate were included for modeling (Multimedia Appendix 1). All continuous variables 
were discretized according to the definitions provided in the study protocol. The correlation 
coefficients between variables after discretization were calculated with the Cramér V test for 
correlation strength.
The network structure was learned using the Max-Min Hill-Climbing algorithm with the Bayesian-
Dirichlet equivalent scoring metric, as implemented in the R package “bnlearn” (17). The Max-
Min Hill-Climbing algorithm searches for the best network structure (ie, the best directed acyclic 
graph) that maximizes the Bayesian-Dirichlet equivalent scoring metric. To this end, the algorithm 
starts with an initial directed acyclic graph and then improves the Bayesian-Dirichlet equivalent 
score by iteratively adding, deleting, and reversing individual edges until the Bayesian-Dirichlet 
equivalent score does not improve further (18).
Chapter 4
543244-L-bw-Kaufmann
Processed on: 14-5-2020 PDF page: 67
67  
A set of restrictions can be applied to enforce certain connections between arcs in the network, 
so that prior knowledge is implemented a priori (13). Arcs representing known dependencies 
can be whitelisted (ie, forced to appear in the directed acyclic graph), while arcs that represent 
impossible dependencies can be blacklisted (i.e., excluded from the directed acyclic graph). In 
this network, age and gender are not determined by any other variables, so all arcs from other 
variables to these two were blacklisted. Similarly, as estimate does not infl uence any clinical 
variable, any arc from estimate to other variables was also blacklisted.
After the restrictions are defi ned, to obtain a confi dence measure for the presence and directionality 
of the individual network edges, the bootstrap technique was applied. R=2000 bootstrap samples 
were generated from the original data, and the Max-Min Hill-Climbing algorithm was used to 
search for the best network for each bootstrap data set. This gives R=2000 best networks, and 
the confi dence on the presence of an edge ranges from 0 (learned from 0 bootstrap samples) 
to 1 (learned from all bootstrap samples) (13). To further increase the robustness of the fi nal or 
consensus network, we defi ned the minimum signifi cance threshold for arc strength as 0.700 if 
the calculated signifi cance threshold was lower and accepted the calculated threshold otherwise. 
Regarding directionality, arcs with a direction coeffi  cient below 0.666 after bootstrapping were 
considered undirected.
To determine the distributions of the variables and calculate the associated probabilities of 
the network, the adjacency matrix of the average bootstrapped directed acyclic graph was 
reproduced using the Bayesian network function, and belief propagation was carried out using 
the gRain package (13,19).
Belief propagation allows for inference tasks (probability queries) to be performed on the learned 
Bayesian networks, thereby providing a calculation of the distribution of values of a certain 
variable and the marginal and conditional probabilities of these values occurring based on the 
known value of an observed variable. Given a certain distribution, the marginal probability of a 
certain value occurring is calculated by integrating out all other variables, while the conditional 
probability is the probability of a value occurring for one variable, given a known, fi xed value for 
at least one other variable (20). These probability queries will allow for multiple relevant clinical 
scenarios to be recreated, based on the consensus network and the properties of the Markov 
blanket. When carrying out a query for estimate, if the values of its parent nodes are known, no 
other node can infl uence the conditional distribution of estimate (21). If only some of its parent 
nodes are known, however, then some of the ancestors upstream of the undefi ned parent nodes 
can still infl uence the conditional probability of estimate (21). To validate the structure learning 
process beyond the bootstrapping strategy used in learning a consensus network, two steps 
were taken. First, an ad hoc expert analysis was conducted to assess the plausibility and accuracy 
of the physiological relationships identifi ed in the network. Second, 10-fold cross-validation was 
used to determine its predictive accuracy. Using the consensus network, the accuracy of the 
cross-validated predictions was determined by dichotomizing the estimates as described below 
and by calculating the area under the receiver operating curve, specifi city, and sensitivity of the 
predictions made for patients, from which a validated cardiac index measurement was available.
Bayesian Network analysis to determine how clinicians estimate cardiac function
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Definitions and Bias
Patients underwent a protocolized and standardized clinical examination and subsequent 
CCUS, as described in the SICS-I protocol (15). The main variable of interest was cardiac function 
estimation made by the student or physician after clinical examination was performed but before 
CCUS was performed. Examiners could score cardiac function as “poor,” “moderate,” “reasonable,” 
or “good.” For diagnostic test analyses and the validation step of the network structure, the “poor” 
and “moderate” estimates were grouped as “low,” and the “reasonable” or “good” estimates were 
grouped as “high.” Quality of the CCUS images and measurements of cardiac index were validated 
by core laboratory technicians (Groningen Image Core Lab, Groningen, The Netherlands) who 
were blinded for the rest of the measurements. Cardiac index measurements were categorized in 
two groups: “low” for cardiac index≤2.2 L/min/m2 and “high” for cardiac index>2.2 L/min/m2 (22). 
All patients for whom a validated cardiac index measurement and estimate of cardiac function 
were available were included in the Bayesian network analysis. Patients for whom CCUS images 
were of insufficient quality or cardiac index measurements were not available, were excluded 
from the diagnostic accuracy analysis.
Statistical Analysis
Due to the observational nature of the study, a formal sample size calculation was not possible. 
Statistical analyses were performed in STATA 15.0 (StataCorp, College Station, Texas) and R 
version 3.5.1 (R Core Team, Vienna, Austria). Data are presented as mean with SD when normally 
distributed, or as median with interquartile range in case of skewed data. Dichotomous and 
categorical data are presented in proportions. Sensitivity and specificity for both the network’s and 
the examiners’ estimated guess were calculated by cross-tabulation of the respective predictions 
and the validated cardiac index measurements. Additionally, positive predictive values (PPV) and 
negative predictive values (NPV) and positive likelihood ratios (LR+) and negative likelihood ratios 
(LR-) were calculated with 95% CIs for the examiners’ estimates. For these, the overall accuracy 
was further expressed as a proportion of correctly classified cardiac index measurements (true 
negative and true positive measures) among all measures.
Results
Participants
A total of 1075 patients fulfilled our inclusion criteria, of which 1073 patients had available 
cardiac function estimates and were therefore included in the Bayesian network analysis. Of the 
included patients, 783 (73%) had validated cardiac index measurements and were included in the 
diagnostic accuracy tests. Further, 569 patients (73%) were included by students and 214 patients 
(27%) were included by physicians.
Descriptive Measures
Characteristics of included patients according to availability of cardiac index measurements are 
shown in Table 1. Body mass index and Simplified Acute Physiology Score (SAPS) II score were 
significantly different between patients (Table 1).
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Bayesian Network Analysis
The structure learned for the network identifi ed two clinical variables, namely, noradrenaline 
administration and the presence of delayed capillary refi ll time or mottling (dCRT-M), upon which 
the estimates of cardiac function are directly conditionally dependent (Table 2).
Table 1. Patient characteristics Variable
Abbreviations: SAPS, Simplifi ed Acute Physiology Score; APACHE, Acute Physiology And Chronic Health Evaluation
Table 1. Patient characteristics 
Variable 
 











62 ± 14 62 ± 15 62 ± 15 0.75 
Male gender 
 
188 (64%) 486 (62%) 674 (63%) 0.49 
Body mass index (kg/m2)  27.5 (5.4) 26.7 (5.6) 26.9 (5.5) 0.043 
Mean Arterial Pressure (mmHg)  78 ± 14 79 ± 14 78 ± 14 0.30 
Heart rate (bpm)  87 ± 22 88 ± 21 88 ± 21 0.35 
Irregular heart rhythm  28 (10%) 88 (11%) 116 (11%) 0.44 
Central venous pressure (mmHg)  9 (5, 12) 9 (5, 13) 9 (5, 13) 0.74 
Patients administered 
noradrenaline 
 142 (49%) 386 (49%) 528 (49%) 0.85 
Urine output (mL/kg/h)  0.6 (0.3, 1.2) 0.7 (0.4, 1.2) 0.6 (0.4, 1.2) 0.22 
Respiratory rate (bpm)  18 ± 5 18 ± 6 18 ± 6 0.50 
Mechanical ventilation  179 (61%) 452 (58%) 631 (59%) 0.29 
Positive End-Expiratory Pressure 
(cm H2O) 
 7 (5, 8) 7 (5, 8) 7 (5, 8) 0.41 
Central temperature (°C)  37.0 ± 0.9 36.9 ± 0.9 36.9 ± 0.9 0.84 
Difference between central 
temperature and temperature on 
the dorsum of the foot (°C) 
 7.7 ± 3.2 7.8 ± 3.2 7.8 ± 3.2 0.66 
  109 (37.6%) 289 (37.1%) 398 (37.2%) 0.88 
Capillary refill time knee (sec)  3.0 (2.0, 4.5) 3.0 (2.0, 4.5) 3.0 (2.0, 4.5) 0.48 
Capillary refill time sternum (sec)  2.8 (2.0, 3.0) 3.0 (2.0, 3.0) 3.0 (2.0, 3.0) 0.84 
Capillary refill time finger (sec)  3.0 (2.0, 4.0) 2.5 (2.0, 4.0) 2.5 (2.0, 4.0) 0.37 
Mottling rate None 157 (58.8%) 397 (56.8%) 554 (57.3%) 0.64 
 Mild 24 (9.0%) 79 (11.3%) 103 (10.7%)  
 Moderate 75 (28.1%) 201 (28.8%) 276 (28.6%)  
 Severe 11 (4.1%) 22 (3.1%) 33 (3.4%)  
Hemoglobin (mmol/L)  6.8 ± 1.5 6.8 ± 1.4 6.8 ± 1.4 0.90 
Lactate (mmol/L)  1.4 (0.9, 2.4) 1.4 (0.9, 2.2) 1.4 (0.9, 2.2) 0.79 
ICU Length of Stay (days)  3.5 (1.9, 6.9) 3.1 (1.9, 6.5) 3.2 (1.9, 6.6) 0.29 
SAPS II (points)  47 (37, 58) 44 (34, 56) 45 (35, 57) 0.037 
APACHE IV score (points)  77 (56, 92) 73 (55, 91) 74 (56, 92) 0.14 
90-day Mortality (n, %)  81 (27.7%) 217 (27.7%) 298 (27.7%) 0.99 
Cardiac function estimate Poor 8 (2.8%) 18 (2.3%) 26 (2.4%) 0.004 
 Moderate 46 (15.9%) 165 (21.1%) 211 (19.7%)  
 Reasonable 164 (56.6%) 349 (44.6%) 513 (47.8%)  
 Good 72 (24.8%) 251 (32.1%) 323 (30.1%)  
Abbreviations: SAPS, Simplified Acute Physiology Score; APACHE, Acute Physiology And Chronic Health 
Evaluation 
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Table 2. Strength and direction coefficients of the consensus directed acyclic graph
Abbreviations: dCRT-M, delayed capillary refill time or mottling; SBP, systolic blood pressure; MAP, mean arterial 
pressure; DBP, diastolic blood pressure
Figure 1. Consensus directed acyclic graph. Red lines represent direct conditional dependencies to estimate. Black 
lines represent direct conditional dependencies to other variables. Width of the line represents strength coefficient. 
The dotted line represents the weakest strength coefficient. DBP, diastolic blood pressure; SBP, systolic blood 
pressure; MAP, mean arterial pressure; CRT, capillary refill time.
Table 2. Strength and direction coefficients of the consensus directed acyclic graph. 
From To Strength Direction 
Age Irregular rhythm 0.983 1.00 
Mechanically ventilated High respiratory rate 0.994 0.504 
Mechanically ventilated dCRT-M 0.875 0.884 
Irregular rhythm Tachycardia 0.848 0.954 
Tachycardia High respiratory rate 0.999 0.931 
Tachycardia Low SBP 0.821 0.883 
Tachycardia Elevated lactate 0.832 0.821 
Low SBP Low MAP 1 1 
Low DBP Low MAP 1 1 
Elevated lactate Oliguria 0.728 0.803 
Elevated lactate Noradrenaline administration 1 1 
Noradrenaline administration Mechanically ventilated 1 0.957 
Noradrenaline administration Estimate 0.999 1 
dCRT-M Estimate 0.876 1 
Abbreviations: dCRT-M, delayed capillary refill time or mottling; SBP, systolic blood pressure; 















Prolonged CRT / Mottling
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As denoted in Figure 1 by the dotted line, the arc from elevated lactate to oliguria had the lowest 
strength coeffi  cient (0.728). The average directionality coeffi  cient was 0.909, indicating well-
defi ned directionality. Only one edge (between mechanical ventilation and high respiratory rate) 
did not meet the threshold for directionality and was thereby left undirected in the consensus 
directed acyclic graph (for querying, however, a direction from high respiratory rate to mechanical 
ventilation was defi ned based on expert knowledge to comply with the formal computational 
requirements) (15). Additionally, there was no diff erence in network structure when including 
only students (n=801) or only physicians (n=271) compared to the network obtained with all the 
participants’ estimates.
The probability queries conducted with the conditional probabilities for estimate are presented 
in a tree diagram in Figure 2. Each of the pathways in the diagram represents a scenario that 
could occur during clinical examination. Since one of the main focuses of SICS-I was the 
collection and interpretation of information available at bedside during physical examination, 
we expanded the conditional probability queries to also include respiratory rate and mechanical 
ventilation. Tachypnea virtually did not infl uence the probability of cardiac pump function being 
estimated as reasonable or good P(ER,G), whereas ventilation status did (P[ER,G|not ventilated, 
no tachypnea]=P[ER,G|not ventilated, tachypnea)=0.85; P[ER,G|ventilated, tachypnea]=0.69 and 
P[ER,G|ventilated, no tachypnea]=0.63). When the patient received noradrenaline, P(ER,G) was lower 
irrespective of whether they were mechanically ventilated (P[ER,G|ventilation, noradrenaline]=0.63, 
P[ER,G|ventilation, no noradrenaline]=0.91, P[ER,G|no ventilation, noradrenaline]=0.67, P[ER,G|no 
ventilation, no noradrenaline]=0.93). The same trend was found for dCRT-M, with reasonable or 
good estimates being more likely in the absence of dCRT-M.
Finally, an area under the receiver operating characteristic curve of 0.58 was obtained for the 
10-fold cross-validated predictions of cardiac function made by the consensus network, with a 
specifi city of 36% and a sensitivity of 79% (23).
Diagnostic Accuracy
Diagnostic accuracy tests for estimating of a low cardiac index showed a sensitivity of 26% and 
39%, a specifi city of 83% and 74%, PPV of 45% and 48%, NPV of 67% and 66%, LR+ of 1.52 and 
1.52, and LR- of 0.89 and 0.82 for students and physicians, respectively. The overall accuracy 
of cardiac index estimates was 63% and 61% for students and physicians, respectively. For all 
patients combined, sensitivity was 30%, specifi city was 80%, PPV was 46%, NPV was 67%, LR+ was 
1.53, LR- was 0.87, and the overall accuracy of diagnostic tests was 62% (Table 3).
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Table 3. Accuracy, sensitivity, specificity, predictive values, and likelihood ratios for students’ and physicians’ 
estimates
All values are presented with 95% confidence interval.
Figure 2. Tree diagram showing the conditional probabilities queries for estimate associated with multiple 
scenarios during clinical examination. At each step, only the variables above the split are known and as more 
information becomes available, the conditional probabilities change. P, Poor; M, Moderate; R, Reasonable; G, Good; 
CRT, capillary refill time








Sensitivity (%) 26 (20  33) 39 (28  50) 30 (25  36) 
Specificity (%) 83 (78 - 86) 74 (66  82) 80 (77  84) 
Positive predictive value (%) 45 (38 - 53) 48 (39  58) 46 (40  53) 
Negative predictive value (%) 67 (65 - 69) 66 (61  71) 67 (65  69) 
Positive likelihood ratio 1.52 (1.10  2.09) 1.52 (1.02  2.25) 1.53 (1.19  1.97) 
Negative likelihood ratio  0.89 (0.81  0.98) 0.82 (0.67  1.00) 0.87 (0.80  0.95) 
Overall accuracy (%) 63 (59  67) 61 (54  67) 62 (59  66) 








Clinical examination is used daily by physicians as an easy, cheap, and noninvasive way of 
gathering information to guide interventions and further diagnostic testing. Clinical signs such 
as oliguria; altered consciousness; and cold, clammy skin are known possible indicators of organ 
hypoperfusion and are used to diagnose shock in critically ill patients (2). However, the value 
of clinical examination has been questioned, and previous studies have shown physicians to 
perform poorly in diagnosing a low cardiac index based on physical signs alone (8,9). In this study, 
we confi rmed that the accuracy of these estimates remains low for both students and physicians. 
Surprisingly, we identifi ed noradrenaline administration and delayed CRT or mottling as seemingly 
the major factors infl uencing cardiac function estimates using Bayesian network analysis. These 
fi ndings may serve as the basis for improving the value of clinical examination (1) by identifying 
some of the biases clinicians may be subjected to, which causes them to overdiagnose compared 
to students, and (2) by clarifying some of the thought process behind the clinical examination. 
This allows the examiner to “think about how they think” when performing clinical examination 




Validation of the network structure was a crucial yet challenging step toward our goal of trying to 
obtain a plausible representation of the examiners’ knowledge network and thought process at 
bedside. We believe to have tackled this challenge in the best way possible by validating it in three 
diff erent ways: using the bootstrapping process to generate a consensus network; conducting 
expert validation of the plausibility of the arcs; and using the network as a predictor, as previously 
suggested (13). We believe that the similarity in accuracy, sensitivity, and specifi city between 
the network’s predictions and the examiners’ own estimates is further proof of the validity of its 
structure. It must be restated that the goal of this study was not to build and optimize a predictive 
model, in which case the predictive accuracy, sensitivity, and specifi city we obtained would be 
subpar. In fact, had the network been able to make the estimates with a substantially higher 
accuracy than the examiners’ estimates, we would be more reluctant to affi  rm that is parallel with 
the examiner’s thought process.
As any exploratory study, however, we faced several limitations. The fi rst was practical, as not all 
included patients had cardiac index measurements, since CCUS is not applicable for every ICU 
patient and views obtained by CCUS can be obstructed due to lines, wounds, or excess adiposity 
(24). This prevented us from using the complete cohort and likely accounted for the diff erence in 
SAPS-II score and body mass index in the patients with and without CCUS measurements. Second, 
the discretization required by the parametric assumptions of Bayesian network algorithms 
comes with the inherent risk of useful information being discarded in the process, which does 
Bayesian Network analysis to determine how clinicians estimate cardiac function
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not guarantee that the dependence relationships involving the original variables are preserved. 
Last, for causality to be derived from Bayesian networks, there must be no unobserved variables 
influencing the variables included in the network that may act as confounding factors. In SICS-I, 
the focus was on examining and improving students’ and physicians’ educated guess, resorting 
primarily to bedside information, such as vasopressor and fluid perfusors, vital signs, and physical 
examination. Therefore, to best replicate this scenario, we opted to include in the network only 
variables that are readily available during the protocolized examination. Although this increases 
the risk of introducing bias in the causal network, the accuracy of the physiological dependencies 
identified gives us reason to believe that no substantial bias is present.
Do Probability Queries Help Explain the Modest Diagnostic Accuracy?
Previous studies on the diagnostic accuracy of clinical examination have found the performance 
of experienced physicians and students to be comparable (6). Expert physicians are more 
often affected by multiple cognitive biases, such as confirmatory bias and premature closure, 
compared to students, who remain more open to new hypotheses and persist in collecting data 
(25,26). Interestingly, while the diagnostic accuracy for individual physicians can be as low as 
62.5%, there is a visible increase as the number of physicians involved increases (up to 85.6% 
for groups of nine physicians) (27). Our results are in line with the literature, and we additionally 
showed that physicians had a higher sensitivity but lower specificity than students (39% and 
26%, and 74% and 83%, respectively). These differences in sensitivity and specificity represent 
a tendency of physicians to overdiagnose, which has previously been related to confirmatory 
bias and premature closure. Indeed, two other findings support the idea already given by the 
direct dependence of estimate solely on noradrenaline and dCRT-M that premature closure 
was a common phenomenon. First, in the probability queries, while machine ventilation does 
not directly influence the estimate, considerable changes in the probability of the estimate are 
still observable, depending on whether the patient is ventilated, before noradrenaline use and 
dCRT-M are known. This could be due to the fact that mechanical ventilation is almost inevitably 
the first variable to be noted when the examiner approaches bedside. Second, a comparison of 
the change in the probabilities of estimate based on varying clinical evidence with the likelihood 
ratios calculated in another SICS-I substudy shows that variables further upstream of estimate 
such as respiratory should be taken more into account (15). For example, while the positive 
and negative likelihood ratios of a high respiratory rate are as suggestive as those of a delayed 
CRT, the query shows that the probability of being estimated to have low cardiac function was 
considerably lower in those without dCRT-M (0.25) than in those with dCRT-M (0.46) and the 
probability of a patient with tachypnea being estimated to have low or high cardiac function was 
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Conclusion and Future Implications
This study confi rms that the accuracy of cardiac function estimates remains low for both students 
and physicians, and it identifi es noradrenaline administration and delayed CRT or mottling as 
seemingly the major factors infl uencing these estimates. Although it will remain challenging to 
try to replicate the thought process of the examiner, not only methodologically, but also because 
diff erent individuals have diff erent levels of knowledge and diff erent examination routines, 
Bayesian networks seem like a promising tool to help break down and better understand the 
educated guessing process. The insight gained in studies such as this one, can help teach 
students think about how they think and, on a clinical level, provide much-needed guidance for 
prioritization of variables during clinical examination. In fact, our team is currently compiling the 
knowledge acquired in the SICS-I substudies to build an interactive game for medical students, 
residents, and specialists. This electronic learning tool will ask the player to estimate cardiac 
function using the same scale and data from variables such as bedside monitor hemodynamic 
variables, ventilator and pump settings, and urine output.
Supplementary material
Supplements are available online: 
https://doi.org/10.2196/15358
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The aim was to compare non-invasive blood pressure measurements with invasive blood pressure 
measurements in critically ill patients.
Methods
Non-invasive blood pressure was measured via automated brachial cuff oscillometry, and 
simultaneously the radial arterial catheter-derived measurement was recorded as part of a 
prospective observational study. Measurements of systolic arterial pressure (SAP), diastolic arterial 
pressure (DAP), and mean arterial pressure (MAP) were compared using Bland-Altman and error 
grid analyses.
Results
Paired measurements of blood pressure were available for 736 patients. Observed mean 
difference (±SD, 95% limits of agreement) between oscillometrically and invasively measured 
blood pressure was 0.8 mmHg (±15.7 mmHg, -30.2 to 31.7 mmHg) for SAP, -2.9 mmHg (±11.0 
mmHg, -24.5 to 18.6 mmHg) for DAP, and -1.0 mmHg (±10.2 mmHg, -21.0 to 18.9 mmHg) for MAP. 
Error grid analysis showed that the proportions of measurements in risk zones A to E were 78.3%, 
20.7%, 1.0%, 0%, and 0.1% for MAP.
Conclusion
Non-invasive blood pressure measurements using brachial cuff oscillometry showed large limits 
of agreement compared to invasive measurements in critically ill patients. Error grid analysis 
showed that measurement differences between oscillometry and the arterial catheter would 
potentially have triggered at least low-risk treatment decisions in one in five patients.
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Non-invasive versus invasive blood pressure measurements in critically ill patients
Introduction
Blood pressure is one of the most frequently measured vital signs and can be measured non-
invasively or invasively (1). Measurements of blood pressure are commonly used as triggers 
and targets to guide hemodynamic interventions, especially in critically ill patients treated in 
the intensive care unit (ICU) (2). Circulatory shock is a common condition in critically ill patients, 
aff ecting about one-third of all admitted ICU patients (3). Systemic arterial hypotension is typically 
present in circulatory shock with associated tachycardia and signs of altered tissue perfusion (4). 
Guidelines on hemodynamic monitoring and circulatory shock advocate initially targeting a mean 
arterial pressure (MAP) above 65 mmHg (2). Therefore, clinicians need to have quick, reliable, and 
accurate measurements of blood pressure available at the bedside.
Invasive arterial blood pressure monitoring using an arterial catheter is considered the clinical 
reference method in critically ill patients. In situ arterial catheters also facilitate drawing blood 
for laboratory testing and blood gas analysis. Even though the guidelines recommend the 
placement of an arterial catheter for invasive monitoring in patients with suspected circulatory 
shock (2), non-invasive oscillometric blood pressure measurements using an upper-arm cuff  are a 
widely used alternative (5). This automated method allows for intermittent quick and convenient 
blood pressure measurements.
Several prospective studies showed an acceptable agreement of non-invasive oscillometric 
blood pressure measurements with invasive reference measurements in critically ill patients (6,7). 
Some say that intermittent non-invasive oscillometric blood pressure measurements may even 
safely replace invasive measurements (8). Other studies showed an unacceptable measurement 
performance of oscillometry in critically ill patients with circulatory shock, demonstrating a 
possible infl uence of the shock state and the use of vasoactive medication on the measurement 
performance (9,10).
This study aimed to compare blood pressure measurements obtained using upper-arm cuff  
oscillometry with arterial catheter-derived blood pressure measurements in a large prospective 
cohort of critically ill patients with and without receiving norepinephrine.
Material and Methods
Design and setting
This study was part of the Simple Intensive Care Studies-I (SICS-I), a prospective single-center 
observational cohort study designed to evaluate the diagnostic and prognostic value of 
combinations of clinical and hemodynamic variables in critically ill patients (11). We performed 
the study between 27 March 2015 and 22 July 2017. The local institutional review board approved 
the study (M15.168207).
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Participants and study size
In SICS-I, all acutely admitted patients of 18 years and older with an expected ICU stay of at least 
24 hours were eligible for inclusion. Exclusion criteria were planned admission, inability to acquire 
research data due to interference with clinical care, and absence of informed consent. Patients 
without either invasive blood pressure or non-invasive blood pressure measurement were 
excluded from this analysis.
Objectives
The primary objective of this study was to evaluate the agreement between blood pressure 
measurements obtained with non-invasive oscillometry (test method) and arterial catheter-
derived measurements (reference method) using Bland-Altman and error-grid analyses. 
The agreement between measurements was defined according to the Association for the 
Advancement of Medical Instrumentation (AAMI) standards for non-invasive arterial pressure 
measurement (12). The AAMI definition of an acceptable agreement in adults between the test 
and reference method is a mean of the differences of ≤5 mmHg with a SD of ≤8 mmHg (12).
The secondary objective was to analyze the differences between the two methods separately in 
patients with and without receiving norepinephrine.
Variables
For the SICS-I study, clinical and hemodynamic variables were collected during a one-time clinical 
examination in the first 24 hours of patient admission. Study procedures were only performed 
when there was no interference with clinical care. Complete data management was described in 
the design paper of the SICS-I (13). Reference blood pressure was measured invasively using an 
indwelling arterial catheter placed in the radial artery. Non-invasive oscillometric blood pressure 
measurements were performed using an upper-arm cuff placed on the arm contralateral to the 
arm with the arterial catheter. The correct cuff size was estimated for each patient by the nurse, 
and the arterial catheter transducer was zeroed and leveled. Blood pressure data were recorded 
simultaneously from the display of the bedside monitor IntelliVue MP70 (Philips, Eindhoven, The 
Netherlands). The dose of norepinephrine infusion was documented at the time of the blood 
pressure measurements.
Statistical analysis
Data are presented as means with standard deviations (SD), medians with 25th and 75th 
percentile, or absolute numbers (with percentages). Student’s T-test, Mann-Whitney U test, or the 
Chi-square tests were used as appropriate. Correlations between non-invasive and invasive blood 
pressure measurements are illustrated using scatter plots. The agreement was assessed using 
Bland-Altman plots, by plotting the mean of the two measurements against their difference and 
95% limits of agreement (LOA) (= mean difference ± 1.96 × SD of the difference) (14).
Error grid analysis was used to assess the clinical relevance of differences between the two 
methods (15). Error grid analysis assigns a specific risk level value to each pair of measured arterial 
Chapter 5
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pressures. Risk levels range from zones A to E with A representing no risk (i.e., no diff erence in 
clinical action between the reference and test method), B representing low-risk (i.e., test method 
values that deviate from the reference but would probably lead to benign or no treatment), C 
representing moderate risk (i.e., test method values that diff er from the reference and would 
eventually lead to unnecessary treatment with potential moderate non-life-threatening 
consequences for the patient), D representing signifi cant risk (i.e., test method values that 
deviate from the reference and would lead to unnecessary treatment with potential severe 
non-life-threatening consequences for the patient), and E representing dangerous risks (i.e., test 
method values deviate from the reference method and would lead to unnecessary treatment 
with potentially life-threatening consequences for the patient) (15). The clinical relevance of 
the diff erence between two methods is refl ected by the proportion of measurements in each 
risk level; i.e., higher proportions in the low-risk level indicate a lower clinical relevance of the 
diff erence. The risk levels were quantifi ed for systolic arterial pressure (SAP) and mean arterial 
pressure (MAP) by consensus among 25 international experts in anesthesiology and intensive 
care medicine (15). No consensus error grid for diastolic arterial pressure (DAP) was quantifi ed 
by experts due to its limited use in anesthesiology and critical care as an isolated value. The 
proportions of measurements in the fi ve risk levels were calculated and were visualized in a grid 
in which the consensus risk assessment is converted into a continuous risk level ranging from 0% 
to 100% (16). The Chi-square test was used to compare the proportions of measurements in risk 
zone A versus risk zone B-E between patients with and without norepinephrine.
For statistical analysis, Microsoft Offi  ce Excel 2010 (Microsoft Corp, Redmond, WA, USA) and 
Stata version 15 (StataCorp, College Station, TX, USA) were used. Continuous error grids were 
constructed using a computer program written for MATLAB version 2018b (The MathWorks Inc., 
Natick, MA, USA) (16).
Results
Overall, 1075 patients were included in the SICS-I study (11). Of these, 1052 patients (98%) had 
an invasive arterial pressure measurement, and 757 patients (70%) had a non-invasive arterial 
pressure measurement. Seven hundred thirty-six patients (68%) had paired blood pressure 
measurements, i.e., simultaneously measured using oscillometry and an arterial catheter (Figure 
1). Of 736 patients with a paired measurement, 352 patients (48%) received norepinephrine 
during the blood pressure measurements. Table 1 presents the characteristics of the 736 included 
patients, and the 339 excluded patients for this study based on the availability of paired blood 
pressure measurement.
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Figure 1. Flowchart showing patient inclusion in this study.
Patients without a paired measurement of invasive and non-invasive blood pressure had a higher 
body mass index (BMI), were more often admitted for a cardiovascular reason, and were more 
critically ill as refl ected by a higher APACHE-IV score at admission and increased 90-day mortality 
(Table 1).
The distribution and relation of arterial pressure data obtained non-invasively and invasively is 
illustrated in scatter plots (Supplementary Fig 1 in Supplementary Material).
Bland-Altman analysis of all paired measurements revealed a mean diff erence (±SD, 95% limits of 
agreement) of 0.8 mmHg (±15.7 mmHg, -30.2 to 31.7 mmHg) for SAP, -2.9 mmHg (±11.0 mmHg, 
-24.5 to 18.6 mmHg) for DAP, and -1.0 mmHg (±10.2 mmHg, -21.0 to 18.9 mmHg) for MAP (Table 
2; Figure 2).
Bland-Altman analysis of paired measurements in patients receiving norepinephrine and patients 
not receiving norepinephrine showed similar results. In patients receiving norepinephrine, Bland-
Altman analysis showed a mean diff erence (±SD, 95% LOA) of -1.1 mmHg (±16.1 mmHg, -32.8 to 
30.6 mmHg) for SAP, -1.9 mmHg (±10.0 mmHg, -21.5 to 17.7 mmHg) for DAP, and -1.0 mmHg (±9.9 
mmHg, -20.4 to 18.5 mmHg) for MAP (Table 2; Supplementary Fig 2 in Supplementary Material).
In patients not receiving norepinephrine, Bland-Altman analysis showed a mean diff erence (±SD, 
95% LOA) of 2.4 mmHg (±15.2 mmHg, -27.5 to 32.4 mmHg) for SAP, -3.9 mmHg (±11.8 mmHg, 
-27.0 to 19.3 mmHg) for DAP, and -1.1 mmHg (±10.4 mmHg, -21.5 to 19.4 mmHg) for MAP (Table 
2; Supplementary Fig 3 in Supplementary Material).
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In all patients with a paired measurement of blood pressure, error grid analysis showed that the 
proportions of measurements in risk zones A to E were 82.3%, 13.2%, 4.2%, 0.3%, and 0% for SAP 
and 78.3%, 20.7%, 1.0%, 0%, and 0.1% for MAP. Continuous error grids for SAP and MAP are shown 
in fi gure 3.
In patients receiving norepinephrine, error grid analysis showed that the proportions of 
measurements in risk zones A to E were 75.6%, 17.6%, 6.5%, 0.3%, and 0% for SAP and 74.7%, 
23.6%, 1.7%, 0%, and 0% for MAP (Supplementary Fig 4 in Supplementary Material).
In patients not receiving norepinephrine, error grid analysis showed that the proportions of 
measurements in risk zones A to E were 88.5%, 9.1%, 2.1%, 0.3%, and 0% for SAP and 81.5%, 18.0%, 
0.3%, 0%, and 0.3% for MAP (Supplementary Fig 5 in Supplementary Material).
Patients receiving norepinephrine had more paired measurements in risk zones B to E compared 
to patients not receiving norepinephrine (p < 0.001 for SAP, and p = 0.03 for MAP).
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Table 1. Patient characteristics.
+Multiple types of circulatory shock may be diagnosed in a patient. Abbreviations: SICS-I, Simple Intensive Care 
Studies-I; APACHE, Acute Physiology and Chronic Health Evaluation; SAPS, Simplified Acute Physiology Score-II.
Table 1. Patient characteristics. 
Variable Type 
SICS-I cohort 
N = 1075 
Without paired 
measurement 
N = 339 
With paired 
measurement 
N = 736 
P value 
Age (years)  62 (15) 62 (14) 62 (15) 0.30 
Male gender  674 (63%) 206 (61%) 468 (64%) 0.37 
Body Mass Index (kg/ 
m2) 
 26.9 (5.5) 27.4 (6.2) 26.7 (5.1) 0.038 
Mechanical ventilation  632 (59%) 195 (58%) 437 (59%) 0.57 
Sedation  430 (40%) 134 (40%) 296 (40%) 0.83 
Heart rate (bpm)  87.7 (21.2) 86.8 (21.8) 88.1 (21.0) 0.35 
Atrial fibrillation  78 (7%) 24 (7%) 54 (7%) 0.88 
Norepinephrine use  529 (49%) 177 (52%) 352 (48%) 0.18 
Norepinephrine dose 
(µg/kg/min) 
 0.13 [0.06, 0.27] 0.12 [0.07, 0.21] 0.14 [0.06, 0.29] 0.38 
Admission type Medical 713 (66%) 212 (63%) 501 (68%) 0.16 
 Acute surgery 316 (29%) 113 (33%) 203 (28%)  
 Planned surgery 46 (4%) 14 (4%) 32 (4%)  
Admission diagnosis 
by organ system 
Cardiovascular 318 (30%) 118 (35%) 200 (27%) 0.002 
 Gastrointestinal 167 (16%) 49 (14%) 118 (16%)  
 Genito-urinary 23 (2%) 11 (3%) 12 (2%)  
 Hematological 19 (2%) 8 (2%) 11 (1%)  
 Metabolic 22 (2%) 3 (1%) 19 (3%)  
 Musculoskeletal/skin 13 (1%) 5 (1%) 8 (1%)  
 Neurological 143 (13%) 31 (9%) 112 (15%)  
 Respiratory 229 (21%) 60 (18%) 169 (23%)  
 Transplant 58 (5%) 19 (6%) 39 (5%)  
 Trauma 82 (8%) 35 (10%) 47 (6%)  
Time to inclusion 
(hours) 
 15 [8, 20] 15 [8, 19] 15 [8, 20] 0.39 
Circulatory shock Total+ 540 (50%) 183 (54%) 357 (49%) 0.095 
 Cardiogenic 140 (13%) 52 (15%) 88 (12%)  
 Distributive 327 (30%) 107 (32%) 220 (30%)  
 Hypovolemic 120 (11%) 48 (14%) 72 (10%)  
 Obstructive 25 (2%) 12 (4%) 13 (2%)  
APACHE-IV score  76.1 (29.3) 79.1 (31.0) 74.7 (28.4) 0.031 
SAPS-II  46.4 (16.8) 47.3 (16.8) 46.0 (16.8) 0.22 
90-day mortality  297 (28%) 108 (32%) 189 (26%) 0.035 
+Multiple types of circulatory shock may be diagnosed in a patient. Abbreviations: SICS-I, Simple Intensive Care 
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Figure 3. 
A. Error-grid plot for mean arterial pressure. This figure illustrates the error grid for the test method (upper-arm cuff 
oscillometry) in comparison with the reference method (arterial catheter) for the 736 patients regarding mean 
arterial pressure. 
B. Error-grid plot for systolic arterial pressure. This figure illustrates the error grid for the test method (upper-arm cuff 
oscillometry) in comparison with the reference method (arterial catheter) for the 736 patients regarding systolic 
arterial pressure. In each plot, the background colors correspond to the risk level for each pair of measurements. 
The risk ranges from 0% to 100%, as shown below the plots. A risk level between 0% and 100% is assigned to each 
combination of measurement and true value (test device versus gold standard).
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Discussion
In this study, non-invasive blood pressure measurements using upper-arm cuff oscillometry 
showed a low mean difference but large limits of agreement compared to direct invasive 
measurements in critically ill patients. Precision and accuracy of non-invasive SAP, DAP, and MAP 
measurements determined by Bland-Altman analysis failed the AAMI standards for non-invasive 
arterial pressure measurement (12).
Estimations of precision and accuracy obtained by Bland-Altman analysis provide information 
about the overall statistical agreement but do not offer the clinical relevance of differences 
between paired measurements. Error grid analysis enables quantification and illustration of the 
clinical significance of observed differences between two blood pressure measurement methods 
(15). This novel method is based on expert opinion and has yet to be externally validated using 
outcome data. In this study, error grid analysis showed that for all included patients, the majority 
of measurements were situated in the no-risk zone A, i.e., 82% for SAP and 78% for MAP. However, 
in approximately one in five patients, i.e., 18% for SAP and 22% for MAP, the paired measurements 
were positioned in risk zones B to E, which implies a potential risk of at least low-risk treatment 
decisions if treatment was based on the test method. In patients receiving norepinephrine, there 
were more paired measurements, 24% for SAP and 25% for MAP, in the risk zones B to E compared 
to patients not receiving norepinephrine, which implies a higher potential risk of at least low-risk 
treatment differences. These results suggest that in approximately one in four patients receiving 
norepinephrine in this cohort, the measured difference could potentially have triggered at 
least low-risk treatment decisions if treatment was based on the test method. The distribution 
difference in the error grid risk zones for patients receiving norepinephrine may be explained by 
the reduced performance of the oscillometric blood pressure method with lower blood pressures 
(17).
Data used in this study were obtained as part of the SICS-I prospective observational cohort 
study, which evaluated clinical and hemodynamic variables obtained as a one-time clinical 
examination within the first 24 hours of ICU admission to diagnose a low cardiac index (11) and 
to build a prognostic model for 90-day mortality (18). Not all variables could be obtained in case 
of life-threatening disease, which could explain why patients without a paired measurement of 
blood pressure had a higher APACHE-IV score and increased mortality. Furthermore, the adequate 
size oscillometric cuff was not always directly available when study procedures were performed, 
which could explain why patients with a higher BMI had fewer paired measurements.
Our results on measurement agreement are in line with other studies comparing non-invasive 
oscillometric and invasive arterial blood pressure in critically ill patients. A poor statistical 
agreement was found in two retrospective observational studies of large ICU databases (17,19). 
Similar to our study, MAP measurements were less inaccurate than SAP and DAP measurements.
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Subgroup analysis according to the administration of norepinephrine showed similar results in 
both subgroups. Results we observed in patients treated with norepinephrine are comparable 
to results from previous studies. One study compared non-invasive oscillometric and invasive 
radial arterial blood pressure measurements in critically ill patients receiving norepinephrine (9). A 
comparison between measurements of MAP showed a mean diff erence of 6.6 mmHg (95% CI 5.3 
to 7.9) (9) in this study. In another study, non-invasive and invasive blood pressure measurements 
were prospectively compared in adult patients with septic shock in the ICU (10). Similar to our 
study, non-invasive blood pressure monitoring showed poor statistical agreement with invasive 
measurements (10).
Currently, the invasive blood pressure measurement using an arterial catheter remains the clinical 
reference method in critically ill patients. Despite the widespread use of arterial catheters, there 
is no evidence suggesting that the outcomes of critically ill patients improve with continuous 
invasive compared to intermittent non-invasive blood pressure monitoring. Arterial catheters 
are associated with rare but serious complications such as infections, bleeding, thrombosis, and 
pseudoaneurysm formation (20), and placement of the catheters may be diffi  cult and time-
consuming in some patients. One retrospective cohort study showed an association between the 
use of arterial catheters and an increase in mortality in critically ill patients receiving vasopressors 
for shock (21). Furthermore, invasive arterial pressure monitoring can be inaccurate because of 
underdamping and resonance phenomena (22). Finally, a diff erent blood pressure measurement 
may be obtained depending on the artery the catheter is placed in. Some evidence suggests 
that measurements obtained in the radial artery underestimates central blood pressure in septic 
shock patients receiving vasopressors and that femoral arterial pressure monitoring may be more 
appropriate in these patients (23).
Alternatively, frequent oscillometric cuff  infl ation is associated with patient discomfort and 
pressure bruises. Patient discomfort is increased if repeated percutaneous vascular punctures 
are needed for laboratory testing. Patient movement may also infl uence the performance of the 
oscillometric blood pressure method (24). In addition, clinically relevant hypotensive episodes 
might be missed or detected late by intermittent measurements. Multiple manufacturers have 
developed appropriate devices, and each makes use of proprietary algorithms that have not 
always been reliably validated against invasive direct blood pressure measurements with an arterial 
catheter (25). Although a structured method comparison study may better reveal the agreement 
between these two methods of blood pressure measurement, these data obtained as part of a 
prospective study may refl ect clinical practice and therefore our results potentially have better 
generalizability. It is recommended to be cautious in clinical practice on the interchangeability of 
blood pressure measurement methods as the presented analyses do not provide information on 
individual measurement diff erences and preferences may vary for individual patients.
There are several limitations to this study. First, this study was a post hoc analysis of a single-
center prospective observational study as this research question was not specifi ed a priori (11). 
Due to the study design there was no formal power calculation and the results are exploratory. 
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These findings have to be used with caution and have to be validated in other cohorts. Second, 
not all patients included in the cohort had a paired measurement of blood pressure. Acquiring 
an oscillometric blood pressure measurement was not a primary aim of the SICS-I study, and the 
measurement was not always performed, most often if this would have led to interference with 
clinical care. Third, we only performed a single paired measurement during the first 24 hours of 
patient admission. Fourth, we did not compare the non-invasive blood pressure measurements 
on both arms before performing a measurement.
Conclusions
Non-invasive blood pressure measurements using upper-arm cuff oscillometry showed a low mean 
difference but large limits of agreement compared to direct invasive measurements in critically 
ill patients. Error grid analysis showed that measurement differences between oscillometry and 
the arterial catheter would potentially have triggered at least low-risk treatment decisions in one 
in five critically ill patients, and in one in four patients on norepinephrine if treatment was based 
on oscillometry. It is recommended to be cautious in clinical practice on the interchangeability 
of blood pressure measurement methods as these analyses do not provide information on 
individual measurement differences and preferences may vary for individual patients.
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Supplements
eFigure 1. Scatter plots comparing invasive to non-invasive blood pressure measurements
eFigure 2. Bland-Altman plots for patients receiving norepinephrine 
eFigure 3. Bland-Altman plots for patients not receiving norepinephrine 
eFigure 4. Error grid plots for patients receiving norepinephrine
eFigure 5. Error grid plots for patients not receiving norepinephrine
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eFigure 2. Bland-Altman plots for patients receiving norepinephrine (n=352)
A. Bland-Altman plot for systolic arterial pressure for patients receiving norepinephrine. Comparison between 
measurements of non-invasive oscillometric cuff  (SAPNI) and invasive arterial catheter (SAPI) is illustrated.
B. Bland-Altman plot for diastolic arterial pressure for patients receiving norepinephrine. Comparison between 
measurements of non-invasive oscillometric cuff  (DAPNI) and invasive arterial catheter (DAPI) is illustrated.
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C. Bland-Altman plot for mean arterial pressure for patients receiving norepinephrine. Comparison between 
measurements of non-invasive oscillometric cuff  (MAPNI) and invasive arterial catheter (MAPI) is illustrated.
In each plot, the continuous horizontal line represents the mean diff erence, and the upper and lower dashed lines 
represent the 95% limits of agreement.
eFigure 3. Bland-Altman plots for patients not receiving norepinephrine (n=384)
A. Bland-Altman plot for systolic arterial pressure for patients not on norepinephrine. Comparison between 
measurements of non-invasive oscillometric cuff  (SAPNI) and invasive arterial catheter (SAPI) is illustrated.
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B. Bland-Altman plot for diastolic arterial pressure for patients not on norepinephrine. Comparison between 
measurements of non-invasive oscillometric cuff  (DAPNI) and invasive arterial catheter (DAPI) is illustrated.
C. Bland-Altman plot for mean arterial pressure for patients not on norepinephrine. Comparison between 
measurements of non-invasive oscillometric cuff  (MAPNI) and invasive arterial catheter (MAPI) is illustrated.
In each plot, the continuous horizontal line represents the mean diff erence, and the upper and lower dashed lines 
represent the 95% limits of agreement.
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eFigure 4. Error grid analyses for patients receiving norepinephrine (n=352)
A. Error-grid analysis for mean arterial pressure. This fi gure illustrates the error grid for the test method (upper-arm 
cuff  oscillometry) in comparison with the reference method (arterial catheter) for patients receiving norepinephrine 
regarding mean arterial pressure.
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B. Error-grid analysis for systolic arterial pressure. This fi gure illustrates the error grid for the test method (upper-arm 
cuff  oscillometry) in comparison with the reference method (arterial catheter) for patients receiving norepinephrine 
regarding systolic arterial pressure.
In each plot, the background colors correspond to the risk level for each pair of measurement. The risk ranges 
from 0% to 100%, as shown below the plots. A risk level between 0% and 100% is assigned to each combination of 
measurement and true value (test device versus gold standard).
Error grid analysis showed that the proportions of measurements in risk zones A to E were 75.6%, 17.6%, 6.5%, 0.3%, 
and 0% for systolic arterial pressure and 74.7%, 23.6%, 1.7%, 0%, and 0% for mean arterial pressure.
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eFigure 5. Error grid analyses for patients not receiving norepinephrine (n=384)
A. Error-grid analysis for mean arterial pressure. This fi gure illustrates the error grid for the test method (upper-
arm cuff  oscillometry) in comparison with the reference method (arterial catheter) for patients not receiving 
norepinephrine regarding mean arterial pressure.
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B. Error-grid analysis for systolic arterial pressure. This fi gure illustrates the error grid for the test method (upper-
arm cuff  oscillometry) in comparison with the reference method (arterial catheter) for patients not receiving 
norepinephrine regarding systolic arterial pressure.
In each plot, the background colors correspond to the risk level for each pair of measurement. The risk ranges 
from 0% to 100%, as shown below the plots. A risk level between 0% and 100% is assigned to each combination of 
measurement and true value (test device versus gold standard).
Error grid analysis showed that the proportions of measurements in risk zones A to E were 88.5%, 9.1%, 2.1%, 0.3%, 
and 0% for systolic arterial pressure and 81.5%, 18.0%, 0.3%, 0%, and 0.3% for mean arterial pressure.
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Critical care ultrasonography (CCUS) is increasingly applied also in the intensive care unit (ICU) 
and performed by non-experts, including even medical students. There is limited data on the 
training efforts necessary for novices to attain images of sufficient quality. There is no data on 
medical students performing CCUS for the measurement of cardiac output (CO), a hemodynamic 
variable of importance for daily critical care.
Objective
The aim of this study was to explore the agreement of cardiac output measurements as well 
as the quality of images obtained by medical students in critically ill patients compared to the 
measurements obtained by experts in these images.
Methods
In a prospective observational cohort study, all acutely admitted adults with an expected ICU stay 
over 24 hours were included. CCUS was performed by students within 24 hours of admission. 
CCUS included the images required to measure the CO, i.e., the left ventricular outflow tract (LVOT) 
diameter and the velocity time integral (VTI) in the LVOT. Echocardiography experts were involved 
in the evaluation of the quality of images obtained and the quality of the CO measurements.
Results
There was an opportunity for a CCUS attempt in 1155 of the 1212 eligible patients (95%) and 
1075 of the 1212 patients (89%) CCUS examination was performed by medical students. In 871 
out of 1075 patients (81%) medical students measured CO. Experts measured CO in 783 patients 
(73%). In 760 patients (71%) CO was measured by both which allowed for comparison; bias of CO 
was 0.0 L/min with limits of agreement of -2.6 L/min to 2.7 L/min. The percentage error was 50%, 
reflecting poor agreement of the CO measurement by students compared with the experts CO 
measurement.
Conclusions
Medical students seem capable of obtaining sufficient quality CCUS images for CO measurement 
in the majority of critically ill patients. Measurements of CO by medical students, however, 
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Background
Critical care ultrasonography (CCUS) is a deliberately focused examination, aimed at rapidly 
answering straightforward clinical questions (1). In the fi eld of emergency and critical care 
medicine, CCUS is increasingly used to guide interventions in critically ill patients in various 
settings by experts and novices (2–14). The training process required for users to attain 
competency in CCUS has varied widely between studies, refl ecting the diversity in CCUS training 
between centers. Similarly, there is variability among statements from stakeholders regarding the 
type of training, the required number of hours spent and examinations performed by the trainee 
to achieve competency in CCUS (15–17). However, besides these disparities, individual physicians 
struggle with barriers to its use, such as perceived diffi  culty in obtaining adequate technical skills 
(13), limitations in training, need (perceived and real), and costs (6, 14).
One valuable CCUS hemodynamic measurement is the determination of the cardiac output 
(CO), especially if the patient is in circulatory shock (18). Circulatory shock occurs in one-third 
of patients admitted to the ICU (19), so being able to perform CCUS and measure CO is of 
importance. However, CO measurement by CCUS is considered an advanced level CCUS skill (20, 
21). Whether trained novices (e.g., medical students or other less experienced physicians) are 
able to obtain reliable CO measurements has not yet been investigated. In a convenience sample 
of 100 adult patients in the emergency department (ED), two ultrasound-naive ED physicians 
were able to measure CO by ultrasonography accurately (22). Another study in the ED with a 
convenience sample of 80 patients, however, showed poor agreement in CO measurement by 
an emergency ultrasound fellow compared to an emergency cardiology fellow (23). At the start 
of our study there are were no data on medical students performing CO measurements by CCUS 
in critically ill patients, although medical students have been shown to be capable of performing 
CCUS after limited training (24). To our knowledge, only one small study investigated CCUS by 
medical students on a (cardiac) ICU, and CO was not measured (see supplements) (3).
The aim of this study was to explore the feasibility of a limited CCUS examination, consisting of CO 
measurements, performed by medical students in a protocolized manner, in critically ill patients. 
In addition, the quality of images required to calculate CO and the accuracy of CO measurements 
compared to those obtained by echocardiography experts were analyzed.
Methods
The Simple Intensive Care Studies (SICS)-I was a prospective, observational cohort study which 
followed a published protocol and statistical analysis plan (Clinicaltrials.gov; NCT02912624). The 
SICS-I was developed to unravel the diagnostic and prognostic value of a comprehensive selection 
of clinical, hemodynamic, and biochemical variables in critically ill patients, and details have been 
described elsewhere (25, 26). All acutely admitted adults with an expected ICU stay over 24 hours 
were included. Patients were excluded when admission was planned and if clinical care interfered 
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with acquiring research data (e.g., mechanical circulatory support). The local institutional review 
board approved the study (M15.168207).
Data collection and training
All patients underwent CCUS within 24 hours of ICU admission. Detailed information on the CCUS 
performed can be found in the supplements. Patients were enrolled by fourth-year to sixth-year 
medical students of a six-year medical school program. The training consisted of self-study on 
theoretical fundamentals and two practical sessions of at least two hours in total to learn how to 
operate the General Electric Vivid-S6 mobile ultrasonography machine using the cardiac phased-
array probe (see appendix in supplements for detailed information). The theoretical self-study 
on how to perform CCUS and measure the CO consisted of study of the protocol (supplements), 
a website on the principles of echocardiography (27), and international guidelines (28, 29). This 
information became available two weeks before participation of the medical students. During the 
practical sessions, medical students learned to obtain the parasternal long axis (PLAX), apical four-
chamber (AP4CH), and apical five-chamber (AP5CH) views, among others. The medical students 
alternated with obtaining the views and measurements of CO during the practical sessions. All 
medical students received at least two hours hands-on training from cardiologist-intensivists (GK 
and IVDH).
Views and images were obtained randomly during the respiratory cycle and/or phase of 
mechanical ventilation. In case of any arrhythmias, the average of multiple measurements over 
five heartbeats was taken.
The first 20 CCUS images and measurements of each medical student were supervised by medical 
students who had independently performed more than 50 CCUS examinations. After 20 scans, 
CCUS medical students were allowed to perform CCUS unsupervised, since previous studies 
showed acceptable capability for acquiring images beyond 20 exams (30).
Validation and definitions
For quality control, echocardiography technicians from an independent core laboratory 
(Groningen Image Core Lab, UMCG, Groningen, the Netherlands) assessed all CCUS images 
and measurements obtained by the medical students according to the study protocol. If the 
images were obtained according to guideline standards, the LVOTd and VTI were independently 
remeasured and CO recalculated (28, 29). Core laboratory technicians, which we refer to as 
experts throughout this report, were blinded to all other clinical measurements. The experts did 
not perform any CCUS examination.
Outcomes, index test and reference standard
The number of patients where CCUS could not be performed and reasons for unobtainable 
images by the medical students were reported. Patients were excluded from the analysis if, for 
research purposes, experts would also not be able to perform CCUS (i.e., drains, subcutaneous 
emphysema, surgical dressing/wounds). The number of patients in which CCUS images of PLAX 
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or AP5CH were obtained was analyzed (28, 29). Proportion of patients was reported wherein the 
CCUS images assessed by the experts was of insuffi  cient quality for CO measurement.
We also evaluated the accuracy of CO measurements by medical students (COstudent) compared to 
CO measurements by experts (COexpert). Moreover, the two components needed for CO calculation 
(i.e., LVOTd or VTI) were assessed to determine possible diff erences between medical students’ 
and experts’ measurements.
Sensitivity analyses were done with baseline characteristics to investigate reasons why experts 
could not measure a CO.
Sample size and missing data
Due to the observational nature of this study, no formal power calculation was performed. For the 
accuracy analysis on CO measurements, we only included patients if CO was measured by both 
medical students and experts.
Statistical analyis
Data were presented as mean with standard deviation (SD) when normally distributed or as 
median with interquartile ranges (IQR) in case of skewed data. Dichotomous and categorical data 
were presented in proportions. Intraclass correlation coeffi  cients (ICC) were calculated to assess 
the concordance between the measurements made by the medical students and the experts. 
Bland-Altman analysis was performed to assess agreement of medical student versus expert 
measurements by calculating mean and SD of the diff erences, the 95% limits of agreement 
(LOA) (= mean of the diff erence ± 1.96 × SD of the diff erence), and the percentage error (31). 
In method comparison studies, a percentage error of 30% is considered acceptable if the error 
of the test and the reference method is 20%, which is the case when using the thermodilution 
method to calculate CO (32). Since there is no reference for CCUS, and only one method was 
used with comparison between the observers, a percentage error of less than 20% was defi ned 
as clinically acceptable. This would mean that the CO diff erence between medical students and 
experts would be less than 0.5 L/min in the lower end of the CO spectrum (e.g., when the experts 
measured a CO of 2.5 L/min, a CO of 2.0 – 3.0 L/min by the medical student would be clinically 
acceptable). An alpha error of 0.05 was used to indicate statistical signifi cance. Statistical analyses 
were conducted using STATA version 15.0 (StataCorp, College Station, USA).
Results
CCUS acquisition and images
Between March 27th, 2015 and July 22nd, 2017, sixteen medical students were involved in the 
study and 1212 patients fulfi lled inclusion criteria. Of these, in a total of 1155 patients CCUS was 
performed, as in 40 patients there was interference with clinical care during the fi rst 24 hours 
of admission (e.g., the patient was in severe hemodynamic instability or an intervention was 
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being performed) and 17 patients had isolation restriction measures. Of these 1155 patients, 
in 80 patients, clinical conditions (i.e., thoracic drains, wounds, or subcutaneous emphysema) 
prohibited the image acquisition by CCUS, leaving 1075 patients with ultrasonography data 
(Figure 1).
The medical students deemed both LVOTd and VTI unmeasurable (i.e., images were of too low 
a quality and no or few structures could be identified) in 129 patients (12%), the LVOTd in 46 
patients (4.2%), and the VTI in 29 patients (2.6%). The parasternal short axis view did not provide 
any additional measurements when the LVOTd was unmeasurable in the PLAX view. Thus, 204 
patients (19%) out of 1075 had no CO measurement, leaving a total of 871 patients (81%) with a 
measured CO by medical students.
CCUS quality of images
The experts used the images obtained by the medical students and were unable to measure both 
the LVOTd and VTI in 152/1075 (14%), LVOTd in 76/1075 (7.1%), and VTI in 64/1075 (6.0%). While 
the experts deemed more measurements to be impossible in the obtained images compared to 
the medical students, the experts were also able to add 23 CO measurements in patients where 
medical students judged the images to be of too poor a quality and consequently did not perform 
the measurements. In total, the experts measured CO in 783 patients (73%). Comparisons of CO 
measurements by medical students and experts were possible in 760 (71%) out of 1075 patients 
in case of adequate image quality (Figure 1).
Differences in patient baseline characteristics were found between the group in which experts 
could measure a CO and the group in which experts could not measure a CO (Table 1). Patients 
without CO measured by experts were characterized by older age, greater illness severity 
(reflected in higher APACHE IV scores), higher heart rate, greater prevalence of chronic obstructive 
pulmonary disease (COPD), higher rates of mechanical ventilation, greater likelihood of being 
post-operative, and higher vasopressor dose
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Figure 1. Flow diagram of the Simple Intensive Care Studies-I (SICS-I). Abbreviations: CCUS, critical care 
ultrasonography; CO, cardiac output; LVOT, left ventricular outfl ow tract; VTI, velocity time interval
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Table 1. Patient characteristics 
Variable  Patients without CO 
measurement  
(N = 292) 
Patients with CO 
measurement  
(N = 783) 
p 
value 
Age (years)  64 ± 13 61 ± 15 0.004 
Male gender  190 (65%) 484 (62%) 0.33 
BMI (kg/m2)  26.9 ± 5.3 26.9 ± 5.6 0.96 
Respiratory rate (bpm)  18 ± 6 18 ± 6 0.88 
Mechanical ventilation  194 (66%) 438 (56%) 0.002 
PEEP (cm H2O)  7 (5, 8) 7 (5, 8) 0.83 
SBP (mmHg)  113 ± 25 120 ± 25 <0.001 
DBP (mmHg)  59 ± 12 60 ± 12 0.44 
MAP (mmHg)  76 ± 14 79 ± 14 0.014 
Heart rate (bpm)  91 ± 22 87 ± 21 0.002 
Atrial fibrillation  22 (8%) 56 (7%) 0.91 
Norepinephrine  168 (58%) 361 (46%) <0.001 
CVP (mmHg)  9 (4  12) 9 (5  13) 0.84 
Lactate (mmol/L)  1.5 (1.0  2.5) 1.3 (0.9  2.1) <0.001 
Consciousness Alert 75 (26%) 254 (32%) 0.018 
 reacting to Voice 49 (17%) 154 (20%)  
 reacting to Pain 22 (8%) 67 (9%)  
 Unresponsive 146 (49%) 308 (39%)  
COPD  54 (18%) 88 (11%) 0.002 
Acute surgery  108 (37%) 230 (29%) 0.017 
Post cardiothoracic 
surgery 
 40 (14%) 48 (6%) <0.001 
SAPS-II  49 ± 17 46 ± 17 0.004 
APACHE IV score  80 ± 30 75 ± 29 0.017 
90-day mortality  80 (27%) 217 (28%) 0.97 
Abbreviations: APACHE; acute physiology and chronic health evaluation, BMI; body mass index, bpm; beats per 
minute, CO; cardiac output, CVP; central venous pressure, DBP; diastolic blood pressure, MAP; mean arterial 
pressure, PEEP; positive end-expiratory pressure, SAPS; simple acute physiology score, SBP; systolic blood 
pressure. 
 
Table 1. Patient characteristics
Abbreviations: APACHE; acute physiology and chronic health evaluation, BMI; body mass index, bpm; beats 
per minute, CO; cardiac output, CVP; central venous pressure, DBP; diastolic blood pressure, MAP; mean arterial 
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Figure 2. Bland-Altman plot showing the comparison between cardiac output measured by medical students 
(COstudent) and core lab experts (COexpert). The mean bias between COexpert and COstudent and the upper and lower limits 
of agreement (LOA) are presented
Comparison of CO measurement by medical students and experts
The mean COstudent was 5.2 ± 2.0 L/min and COexpert was 5.2 ± 1.8 L/min (p=0.44). Bland-Altman 
analysis demonstrated a bias of 0.0 L/min (95% CI -0.06 – 0.13) with limits of agreement of -2.6 L/
min (95% CI -2.7 – -2.4) to 2.7 L/min (95% CI 2.5 – 2.8) (Figure 2). Plotting a regression line in the 
Bland-Altman plot showed a proportional bias of 2%. The percentage error was 50% (95% CI 47 – 
53). The ICC was 0.75 (95% CI 0.72 – 0.78).
Comparison of LVOTd and VTI measurements by medical students and experts
The medical students measured 900 LVOTd and the experts measured 847. There were 815 paired 
LVOTd measurements. Mean LVOTd by medical students (LVOTdstudent) was 2.06 ± 0.24 cm, whereas 
the mean of the LVOTd measured by experts (LVOTdexpert) was 2.09 ± 0.18 cm (p<0.001). Bland-
Altman analysis showed a bias of 0.0 cm (95% CI 0.0 – 0.0) with limits of agreement of -0.5 cm 
(95% CI -0.5 – -0.4) to 0.4 cm (95% CI 0.4 – 0.4) (see supplements). The percentage error was 21% 
(95% CI 20 – 23). There was a proportional bias of 20% (0.41 cm). The ICC was 0.43 (95% CI 0.37 – 
0.48).
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The medical students measured 917 VTI and the experts measured 859. There were 840 paired 
VTI measurements. Mean VTI by medical students (VTIstudent) was 19.0 ± 5.6 cm compared to 18.5 
± 5.4 cm of the experts (VTIexpert) (p<0.001). Bland-Altman analysis showed a bias of 0.5 cm (95% 
CI 0.4 – 0.7) with limits of agreement of -5.0 cm (95% CI -5.3 – -4.6) to 6.1 cm (95% CI 5.7 – 6.4) 
(see supplements). The percentage error was 30% (95% CI 28 – 31). The ICC was 0.86 (95% CI 0.84 
– 0.88).
Discussion
In this large prospective ICU cohort study with CCUS, we found that, after dedicated training, 
medical students were able to acquire a CO measurement in three out of every four patients (871 
of 1155 patients). This finding is of interest considering that the medical students were ultrasound 
naïve, the CO measurement is considered an advanced CCUS skill, and the ICU population is 
known for technical difficulties in acquiring ultrasound images. In a minority of ICU patients 
(80 of the 1155 patients) CCUS was not possible due to clinical conditions hampering image 
acquisition, leaving 1075 patients with ultrasonography data. The CCUS images obtained by 
medical students were assessed by experts and rated to be of adequate quality in 73%. Patients 
(292 of 1075 patients) in which no adequate image quality could be obtained were more often 
mechanically ventilated, admitted after cardiothoracic surgery or were more severely ill.
Although the students reached a reasonable percentage on image acquisition/quality, our data 
do not support CO measurements by medical students (after limited training), as comparison 
to CO measurements by experts showed poor agreement. CCUS concerns more than acquiring 
the required images and any operator should be aware of the potential errors that can be made 
with ultrasonography, especially in complex critically ill patients (33). It is important to note 
that education on ultrasonography should focus on specific training and quality control on all 
aspects of ultrasonography in order to achieve accurate measurements (17). Our results are in 
line with recommendations by the European Association of Cardiovascular Imaging (EACVI) on 
point-of-care, problem-oriented focus cardiac ultrasound examination (FoCUS), which state that 
supervision and quality control by experts are essential for proper and complete examination. 
Quality control in our study was performed by an accredited echocardiographic laboratory as is 
recommended in this viewpoint (15).
To be able to compare our results to those of other studies, it is of utmost importance that every 
step, from eligible patients to the number of patients in which a reliable CO measurement by 
CCUS is obtained, are presented. Currently these numbers are often lacking, and this leads to 
varying success rates on the feasibility of CCUS. If reported, results may vary based on differences in 
ultrasonography training and experience, which impedes a comparison of image acquisition and 
quality. We found four studies, on measuring CO in critically ill patients by non-experts to compare 
with our study (see supplements) (22, 23, 34, 35). In two out of the three studies the operators 
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had previous experience with ultrasonography, but training varied (23, 34). The setting, sampling, 
and exclusion criteria may explain the reported high success rate in one study over another (22). 
Whether images obtained are of suffi  cient quality should preferably be judged by independent 
experts, as two out of three studies did (22, 34). In one study independent investigators assessed 
the quality, however, it is not clear if these were experts or not (35). The percentage of adequate/
good-quality images in our study was comparable with Dinh et al. In the study of Betcher et al. 
and Villavicencio et al., image quality was generally (judged) overall lower. Duration of training or 
diff erences in baseline characteristics might explain part of these diff erences.
The fi nal step to obtain a reliable CO measurement is to measure LVOTd and VTI on images of 
suffi  cient quality. Dinh et al. and Lee et al. reported data on measurement quality, and, furthermore, 
Dinh et al. reported a low bias between sonographers and independent experts. These studies 
and ours showed lack in precision for CO measurement by novices. Villavicencio et al. compared 
ultrasonography derived CO with the transpulmonary thermodilution technique and concluded 
that there was an acceptable level of agreement between the techniques. Furthermore, they 
found a high inter- and intra-observer reliability.
Ultrasonography in the acute setting remains challenging, and data regarding novice-based 
CCUS are limited (see supplements). In our study we chose for medical students as novices (i.e., 
non-experts), since non-experts constitute the majority of ultrasound trained personnel in an IC 
and as students would not interfere with daily ICU care. Five studies reported on medical students 
performing CCUS in critically ill patients (3 in ED setting, 1 in operating theatre and 1 in ICU) (3, 
7–10). Four out of the fi ve studies showed that images could be acquired in a promising 82-
98% of cases. The studies reporting on image quality showed percentages of (at least) adequate 
imaging ranging from 89 to 98%, unfortunately by non-independent judging (3, 7). Furthermore, 
after training, medical students can adequately interpret images with a very simplifi ed or binary 
assessment (36). A number of previous studies employed training curricula for medical students 
on ultrasonography protocols (37–39). Four other studies used a point-of-care ultrasonography 
training program to determine diagnostic performance in various clinical scenarios (36, 40–42). All 
studies showed feasibility to train medical students to perform ultrasonography after a relatively 
short amount of training, which is comparable to the training medical students received in our 
study.
In previous manuscripts on SICS study data we reported a higher percentage of images judged 
to be of suffi  cient quality (25, 26). The current results showed the percentage of measurements of 
CO considered of suffi  cient quality by a core-laboratory and not images with a LVOT and VTI. The 
higher level of quality considered necessary is according to internal protocol and is independently 
monitored.
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Limitations
First, the proportion of patients with an acoustic window was based on the results of CCUS by 
medical students only. We did not check if more experienced sonographers were able to retrieve 
images in these cases, because the design of our study was to obtain images outside patient 
care. We believe image quality can only be assessed if the observers are blinded for all other 
study data and are not involved in the patient’s clinical care. Ideally, independent experts perform 
ultrasonography themselves and make a direct comparison with the medical student. The 
availability of time and staff outside clinical care in our center was limited, leading us to include all 
consecutive patients and allow trained medical students to run the study.
Second, we did not check for interindividual variation of skills and quality of CCUS in each medical 
student who participated in the study, mainly to limit the time of investigation at the bedside.
Third, CCUS of the heart was limited to 2D imaging of the LVOTd, 2D imaging of the AP5CH, and 
pulse wave Doppler imaging of the LVOT. Therefore, valvular disease could have been missed.
Conclusions
Medical students as novices were capable of performing CCUS with adequate image acquisition 
in the majority of an ICU population of acutely admitted critically ill patients. However, they 
cannot accurately measure a CCUS derived cardiac output after limited training. Cardiac output 
measurements with CCUS in research and daily care should be interpreted with caution if not 
validated by experts; this is in concordance with the viewpoint of the EACVI on CCUS.
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Cardiac output measurements may inform diagnosis and provide guidance of therapeutic 
interventions in patients with hemodynamic instability. The FloTracTM algorithm uses uncalibrated 
arterial pressure waveform analysis to estimate cardiac output. Recently, a new version of the 
algorithm has been developed. The aim was to assess the agreement between FloTracTM and 
routinely performed cardiac output measurements obtained by critical care ultrasonography in 
patients with circulatory shock.
Methods
A prospective observational study was performed in a tertiary hospital from June 2016 to January 
2017. Adult critically ill patients with circulatory shock were eligible for inclusion. Cardiac output 
was measured simultaneously using FloTracTM with a fourth-generation algorithm (COAP) and 
critical care ultrasonography (COCCUS). The strength of linear correlation of both methods was 
determined by the Pearson coefficient. Bland-Altman plot and four-quadrant plot were used to 
track agreement and trending ability.
Result
Eighty-nine paired cardiac output measurements were performed in 17 patients during their first 
24 h of admittance. COAP and COCCUS had strong positive linear correlation (r
2 = 0.60, p < 0.001). 
Bias of COAP and COCCUS was 0.2 L/min (95% CI − 0.2 to 0.6) with limits of agreement of − 3.6 L/min 
(95% CI − 4.3 to − 2.9) to 4.0 L/min (95% CI 3.3 to 4.7). The percentage error was 65.6% (95% CI 53.2 
to 77.3). Concordance rate was 64.4%.
Conclusions
In critically ill patients with circulatory shock, there was disagreement and clinically unacceptable 
trending ability between values of cardiac output obtained by uncalibrated arterial pressure 
waveform analysis and critical care ultrasonography.
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Background
Critically ill patients with circulatory shock have increased risks of multi-organ failure, long-term 
morbidity, and mortality (1). Advanced hemodynamic monitoring in these patients may inform 
diagnosis and simultaneously guide management by providing insight into cardiac function, 
cardiac preload, and afterload (2). Several methods for measuring cardiac output (CO) exist, 
varying from invasive (e.g., thermodilution by pulmonary artery catheter (PAC)) to minimally 
invasive (e.g., pulse contour analysis by FloTracTM (Edwards Lifesciences, Irvine, USA)) or even non-
invasive (e.g., transthoracic Doppler ultrasound by critical care ultrasonography (CCUS)). These 
methods all have their own merits, disadvantages and requirements (3).
One type of pulse contour analysis is the uncalibrated arterial pressure waveform analysis method 
to estimate CO (APCO). Reliability of APCO is questioned in patients with hemodynamic instability, 
and this occurs frequently in patients admitted to the ICU (4). Therefore, CO measurements 
obtained by APCO should be interpreted with caution in critically ill patients with circulatory 
shock (5,6).
The FloTracTM system using the APCO method calculates CO based on the principle that aortic 
pulse pressure is proportional to stroke volume (SV) and inversely related to aortic compliance 
using a proprietary algorithm. FloTracTM has been widely studied in more than 70 validation studies 
as of yet, mostly showing adequate performance in normo- and hypodynamic conditions, but not 
in patients with large changes in vascular tone which typically occur in patients with circulatory 
shock (7). However, these studies vary by the statistical methods and versions of the algorithm 
used. Recently, the fourth-generation algorithm was developed to improve performance.
Evaluation of the trending ability rather than the agreement of absolute values of CO monitoring 
devices is increasingly considered in validation studies for assessment of potential clinical 
usefulness (8). In addition to one single CO measurement for diagnosing circulatory shock, 
repeated measurements of CO informing the trending ability could be informative for monitoring 
and guidance of supportive treatments of patients with circulatory shock.
The aim of our study was to compare both agreements and trending ability for APCO measurements 
of CO (COAP) with CO routinely measured by CCUS (COCCUS) in critically ill patients with circulatory 
shock. CCUS was chosen as the reference standard since it is the preferred method for diagnosis, 
but not for monitoring, of circulatory shock in critically ill patients and is widely available (2, 9). 
Importantly, it should be noted that CCUS is not a gold standard reference technique for method 
comparison studies aiming to evaluate the validity of CO monitors (10).
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Methods
This study was a substudy of the Simple Intensive Care Studies-I (SICS-I), which was a single-centre, 
prospective, observational cohort study in which all consecutive acutely admitted adult patients 
expected to stay beyond 24 h were included (NCT02912624) (16, 17). The STROBE guidelines for 
reporting observational studies were used (Additional file 1) (11). The checklist for CO monitor 
method comparison studies was used (10). The local institutional review board (Medisch Ethische 
Toetsingscommissie, University Medical Center Groningen) approved the study (M15.168207 and 
M16.193856). Written informed consent was obtained from all patients.
Selection criteria
In this substudy, all consecutive acutely admitted adult patients with suspected circulatory shock 
and expected to stay beyond 48 h were included from June 2016 to January 2017. The circulatory 
shock was defined as the requirement of any dose of vasopressor to maintain a mean arterial 
pressure (MAP) of 60 mmHg or if the MAP remained below 70 mmHg despite fluid resuscitation 
(defined by at least 1000 mL of crystalloids). In addition, at least one other sign of organ or tissue 
hypoperfusion had to be present: altered state of mind (Alert-Voice-Pain-Unresponsive scale) (12), 
mottled skin (Mottling score ≥ 1 (13)), decreased urine output (≤ 0.3 mL/kg/h) or increased serum 
lactate level (≥2 mmol/L). Exclusion criteria were inability to obtain sufficient quality CCUS images; 
no arterial line; atrial fibrillation; and aortic valve or mitral valve diseases known to impair the 
arterial waveform. We included this group of patients because CO measurements are indicated 
to identify the type of shock, select necessary therapeutic interventions and evaluate patient’s 
response to therapy (2).
Objectives
The primary objective was to evaluate COAP measurements in terms of the agreement and 
trending ability against COCCUS as reference technique in patients with circulatory shock.
Definitions and bias
Patient characteristics including clinical, hemodynamic and laboratory variables as well as Acute 
Physiology and Chronic Health Evaluation (APACHE) IV and Simplified Acute Physiology Score 
(SAPS) II values were recorded (14,15). Measurements were performed following protocolized 
definitions and procedures (16, 17).
In short, COCCUS was measured by transthoracic echocardiography using the Vivid-S6 system 
(General Electric, Horton, Norway) with cardiac probe M3S or M4S, and with default cardiac 
imaging setting. The parasternal long axis was used to measure the left ventricular outflow tract 
diameter. In the apical five-chamber view, a pulse wave Doppler signal in the left ventricular 
outflow tract was used to measure the velocity time integral. COCCUS was calculated using an 
established formula (18). CCUS was performed after ICU admission within 6 h and repeated once 
every 24 h after admission provided there was no interference with clinical care. Researchers were 
trained in performing CCUS by experienced cardiologist-intensivists.
Chapter 7
543244-L-bw-Kaufmann
Processed on: 14-5-2020 PDF page: 125
125  
The FloTracTM sensor was connected to an indwelling radial artery catheter and an EV1000TM 
monitor (version 4.00; Edwards Lifesciences, Irvine, USA), which continuously displayed COAP 
values. The value of COAP displayed on the EV1000
TM monitor was registered simultaneously (i.e., 
‘beat-to-beat’) with each COCCUS measurement.
All measurements, including CCUS fi ndings, were kept blind for the caregivers. Quality of CCUS 
images and COCCUS measurements were validated by an independent specialized core laboratory 
(Groningen Image Core Lab) blinded for the COAP measurements.
Statistical analysis
No formal sample size calculation was performed due to lack of data on COAP variation in patients 
with circulatory shock. Therefore, this study has an exploratory nature.
Data were presented as means with standard deviations or medians with interquartile ranges 
depending on distributions. Normality of data was checked using the Shapiro-Wilk test. 
Dichotomous and categorical data were presented in proportions.
Correlations were assessed by scatter plot, and the strength of linear correlation was determined 
by calculating a Pearson (r) coeffi  cient. Bland-Altman analyses of repeated measurements in each 
patient were performed and means (bias) and SD of the diff erences, 95% limits of agreement 
(LOA) (=mean diff erence ± 1.96 × SD of the diff erence) as well as the percentage error of COAP 
versus COCCUS were calculated (19, 20). To evaluate the trending ability of COAP versus COCCUS a four-
quadrant plot was used and the concordance rate was calculated using an exclusion zone of 0.5 
L min−1 (21). For statistical analysis, we used STATA version 15.0 (StataCorp, College Station, USA).
Results
Participants
During the study period, 184 patients were diagnosed with circulatory shock, but only 24 patients 
appeared eligible for this study. One hundred patients who had circulatory shock were not 
included as they were expected to stay for less than 48 h, and 60 patients with circulatory shock 
were not included because CCUS was not possible or image quality was insuffi  cient to perform 
measurements. Six patients had to be excluded because study procedures interfered with clinical 
care, leaving 18 patients to be included. One patient was excluded afterwards for invalid COAP 
measurements due to improper use of a FloTracTM sensor. Thus, 17 patients were included in the 
fi nal analyses (Fig. 1).
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Figure 1. Patient fl owchart. Abbreviations: CCUS, critical care ultrasonography
Bias, precision and correlation
The characteristics of the 17 included patients are shown in Table 1 (and Additional fi le 2: Table 
S1). The mean COAP and COCCUS for 89 paired measurements were 5.9 ± 1.9 L/min and 5.7 ± 2.0 
L/min, respectively (p = 0.24). A signifi cant correlation was observed for all CO measurements 
(r2 = 0.60, p < 0.001) (Fig. 2). Bias was 0.2 L/min (95% CI − 0.2 to 0.6), with LOA of − 3.6 L/min (95% 
CI − 4.3 to − 2.9) to 4.0 L/min (95% CI 3.3 to 4.7) (Fig. 3). Plotting a regression line in the Bland-
Altman plot gave no arguments for proportional bias (line not shown). The overall percentage 
error was 65.6% (95% CI 53.2 to 77.3). Individual cardiac output measurements for each patient 
are provided in Additional fi le 3: Table S2.
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Table 1. Patient characteristics
Data are presented as the mean and standard deviation, median and interquartile ranges or as absolute 
frequencies with percentages as appropriate. Abbreviations: AVPU, alert, verbal pain, unresponsive; APACHE, Acute 
Physiology and Chronic Health Evaluation; SAPS, Simplifi ed Acute Physiology Score
Trending ability
For assessment of trending ability 72 paired measurements were analyzed. Trending of 
measurements was evaluated using a four-quadrant plot (Fig. 4). Forty-fi ve paired measurements 
showed a clinically relevant change, which was defi ned as larger than 0.5 L/min. The concordance 
rate was 64.4%.
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Figure 2. Scatter plot of cardiac output measured by FloTracTM and CCUS. Abbreviations: COAP, cardiac output 
measured using fourth-generation FloTracTM algorithm; COCCUS, cardiac output measured by critical care 
ultrasonography
Figure 3. Bland-Altman plot for repeated measurements showing the comparison between COAP and  COCCUS. 
The mean bias between COAP and COCCUS and the upper and lower limits of agreement (LOA) are presented. 
Abbreviations: COAP, cardiac output measured using fourth-generation FloTrac
TM algorithm;  COCCUS, cardiac output 
measured by critical care ultrasonography
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Figure 4. Four-quadrant plot showing the trend of COAP versus  COCCUS. Exclusion zone of 0.5 L/min (white area). 
Abbreviations: COAP, cardiac output measured using fourth-generation FloTrac
TM algorithm;  COCCUS, cardiac output 
measured by critical care ultrasonography
Discussion
In this prospective observational study, agreement and trending ability of COAP was compared 
with  COCCUS in critically ill patients with circulatory shock. COAP showed a low bias of 0.2 L/min 
but a large percentage error of 65.6% when compared with  COCCUS, indicating disagreement (20). 
Trending ability was poor with a concordance rate of 64.4%. The new FloTracTM algorithm should 
not be used for diagnosis or guidance of treatment in critically ill patients with circulatory shock.
Interpretation
There are no data on the reliability of CO measurements with the fourth-generation FloTracTM 
software algorithm in critically ill patients with shock as of yet. The main concern with the 
previous version(s) of the APCO algorithm was the lack of reliability in tracking CO changes after 
hemodynamic interventions or in patients with sepsis (7, 22).
The low bias and the high percentage error of CO measurements are in accordance with results 
from another study, which tested the fourth-generation algorithm for tracking CO measurements 
after administration of phenylephrine to increase vasomotor tone in patients prior to cardiac 
surgery (bias −0.7 L/min; percentage error 55.4%) (23). Concordance rate for trending ability 
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was 87% which was higher than in our study. In that study, the chosen reference technique for 
measuring CO was thermodilution.
In a more recent study in patients undergoing cardiac surgery, the new FloTracTM algorithm 
also showed lack of agreement and trending ability (bias −0.4 L/min; percentage error 37.1%; 
concordance rate 76%) (24). The reference technique was thermodilution and in that study, bias 
was influenced by systemic vascular resistance.
Another study tested the fourth-generation FloTracTM algorithm in patients undergoing abdominal 
aortic aneurysm surgery and also found a low bias and high percentage error (bias 0.4 L/min; 
percentage error 46.7%) of CO measurements (25). The concordance rate for trending ability was 
26.9% before and after aortic clamping and 47.3% before and after first unclamping of the iliac 
artery. The reference technique chosen in this study was transoesophageal echocardiography.
Advanced hemodynamic monitoring techniques are currently used to identify the type of 
shock, to guide choices of interventions and to evaluate the response to therapy. Less invasive 
hemodynamic monitoring techniques such as APCO are currently not recommended for use 
in patients with shock, especially when receiving vasopressors (2, 26). Our findings support this 
statement.
Implications and generalizability
Even though CO monitoring is considered a cornerstone in diagnosing and managing circulatory 
shock, the sequential evaluation of the hemodynamic state during shock is only a level 1 
recommendation based on low quality of evidence (2).
The abovementioned studies validating the new fourth-generation FloTracTM algorithm were 
performed in different target populations and contained different reference techniques, 
which limit comparability. There is a concern about the interchangeability of COCCUS and CO 
measurements by thermodilution, and tracking ability of the two methods has only been scarcely 
assessed and needs evaluation by larger studies (27)
Considerations and limitations
There are several considerations and limitations when interpreting the results of our study. First, 
since only parallel and no serial CO measurements were performed for each time point, the 
precision of individual measurements could not be assessed. While only few studies determined 
the precision of the CCUS and FloTracTM technologies, it is a given that both methods have 
some degree of variation which influences precision of agreement (28). This might influence—
and possibly overestimate—the observed bias and precision to an unknown extent, since the 
precision of the CCUS as reference method was not incorporated.
Second, a stepwise approach and checklist for the complete presentation of CO method 
comparison research have been published (10). This checklist includes a design study phase 
where it is encouraged that criteria for acceptable bias and LOA or percentage error are defined, 
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and a sample size calculation should be performed prior to the conduct of method comparison 
studies. In our study, we defi ned clinically acceptable limits based on available literature, but we 
did not specify a sample size in advance. The current study could serve as a pilot for a further 
validation study.
Third, during the study period, we included only 17 patients. Patients with circulatory shock were 
eligible only if they were expected to stay for longer than 48 h and if it was possible to perform 
CCUS. We chose this defi nition to ensure that a complete picture of shock treatment could be 
presented which allowed for the best comparison between the two methods. Last, CCUS was 
used as a reference technique in our study despite pulmonary or transpulmonary thermodilution 
being the gold standard for CO method comparison studies (10). Therefore, we cannot prove 
direct superiority of either method. In order to do this, a comparison with a thermodilution 
method will have to be performed. We chose CCUS as reference because it is currently the fi rst-
line evaluation modality in patients with circulatory shock and also because it is widely available 
and used in the ICU for diagnostic purposes (2, 29). However, images required to make COCCUS 
measurements are unobtainable in up to 20% of patients (30).
FloTracTM measurements of CO are still not recommended in critically ill patients (5, 6), and 
further clinical studies comparing minimally invasive techniques for CO estimation with a 
reference technique are needed for further validation of these techniques and also for extending 
applicability to other types of patients, who were initially not the target population.
Conclusions
In critically ill patients with circulatory shock, there was disagreement and clinically unacceptable 
trending ability between values of cardiac output obtained by uncalibrated arterial pressure 
waveform analysis and critical care ultrasonography.
Supplementary material
Supplements are available online: 
https://doi.org/10.1186/s40560-019-0373-5
 
Disagreement in CO measurements between FloTrac and CCUS in patients with circulatory shock
543244-L-bw-Kaufmann
Processed on: 14-5-2020 PDF page: 132
 132 
References
Sakr Y, Reinhart K, Vincent J-L, Sprung CL, Moreno R, Ranieri VM, et al. Does dopamine administration in 
shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care 
Med. 2006 Mar;34(3):589–97.
Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, et al. Consensus on circulatory shock and 
hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care 
Med. 2014 Dec 13;40(12):1795–815.
Clement RP, Vos JJ, Scheeren TWL. Minimally invasive cardiac output technologies in the ICU: Putting it 
all together. Curr Opin Crit Care. 2017;23(4):302–9.
Saugel B, Wagner JY, Scheeren TWL. Cardiac output monitoring: less invasiveness, less accuracy? J Clin 
Monit Comput. 2016;30(6):753–5.
De Backer D, Bakker J, Cecconi M, Hajjar L, Liu DW, Lobo S, et al. Alternatives to the Swan– Ganz catheter. 
Intensive Care Med. 2018 May 3;44(6):730–41.
Saugel B, Vincent J-L. Cardiac output monitoring: how to choose the optimal method for the individual 
patient. Curr Opin Crit Care. 2018;24(3):165–72.
Slagt C, Malagon I, Groeneveld ABJ. Systematic review of uncalibrated arterial pressure waveform analysis 
to determine cardiac output and stroke volume variation. Br J Anaesth. 2014 Apr;112(4):626–37.
Critchley LA, Lee A, Ho AMH. A critical review of the ability of continuous cardiac output monitors to 
measure trends in cardiac output. Anesth Analg. 2010;111(5):1180–92.
Koster G, Van Der Horst ICC. Critical care ultrasonography in circulatory shock. Curr Opin Crit Care. 2017 
Aug;23(4):326–33.
Montenij LJ, Buhre WF, Jansen JR, Kruitwagen CL, De Waal EE. Methodology of method comparison 
studies evaluating the validity of cardiac output monitors: A stepwise approach and checklist. Br J 
Anaesth. 2016;116(6):750–8.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the 
Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting 
observational studies. Lancet. 2007 Oct 20;370(9596):1453–7.
American College of Surgeons Committee on Trauma. Advanced Life Support Course for Physicians. 
Chicago, IL: American College of Surgeons; 1993.
Ait-Oufella H, Lemoinne S, Boelle PY, Galbois A, Baudel JL, Lemant J, et al. Mottling score predicts survival 
in septic shock. Intensive Care Med. 2011 May;37(5):801–7.
Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health Evaluation 
(APACHE) IV: Hospital mortality assessment for today’s critically ill patients. Crit Care Med. 2006 
May;34(5):1297–310.
Gall JR, Lemeshow S, Saulnier F, Le Gall JR, Lemeshow S, Saulnier F. A New Simplified Acute Physiology 
Score (SAPS II) Based on a European/North American Multicenter Study. JAMA J Am Med Assoc. 1993 
Aug 14;270(24):2957–63.
Hiemstra B, Eck RJ, Koster G, Wetterslev J, Perner A, PettilÃ¤ V, et al. Clinical examination, critical care 
ultrasonography and outcomes in the critically ill: cohort profile of the Simple Intensive Care Studies-I. 
BMJ Open. 2017 Sep;7(9):e017170.
Hiemstra B, Koster G, Wiersema R, Hummel YM, van der Harst P, Snieder H, et al. The diagnostic accuracy 
of clinical examination for estimating cardiac index in critically ill patients: the Simple Intensive Care 




















Processed on: 14-5-2020 PDF page: 133
133  
Lewis JF, Kuo LC, Nelson JG, Limacher MC, Quinones MA. Pulsed Doppler echocardiographic 
determination of stroke volume and cardiac output: clinical validation of two new methods using the 
apical window. Circulation. 1984 Sep;70(3):425–31.
Bland JM, Altman DG. Agreement between methods of measurement with multiple observations per 
individual. J Biopharm Stat. 2007;17(4):571–82.
Critchley LAH, Critchley JAJH. A meta-analysis of studies using bias and precision statistics to compare 
cardiac output measurement techniques. J Clin Monit Comput. 1999 Feb;15(2):85–91.
Saugel B, Grothe O, Wagner JY. Tracking changes in cardiac output: Statistical considerations on the 
4-quadrant plot and the polar plot methodology. Anesth Analg. 2015;121(2):514–24.
Monnet X, Vaquer S, Anguel N, Jozwiak M, Cipriani F, Richard C, et al. Comparison of pulse contour 
analysis by Pulsiofl ex and Vigileo to measure and track changes of cardiac output in critically ill patients. 
Br J Anaesth. 2015;114(2):235–43.
Suehiro K, Tanaka K, Mikawa M, Uchihara Y, Matsuyama T, Matsuura T, et al. Improved Performance of 
the Fourth-Generation FloTrac/Vigileo System for Tracking Cardiac Output Changes. J Cardiothorac Vasc 
Anesth. 2015;29(3):656–62.
Kusaka Y, Ohchi F, Minami T. Evaluation of the Fourth-Generation FloTrac/Vigileo System in Comparison 
With the Intermittent Bolus Thermodilution Method in Patients Undergoing Cardiac Surgery. J 
Cardiothorac Vasc Anesth. 2018 Jun;000:4–11.
Maeda T, Hattori K, Sumiyoshi M, Kanazawa H, Ohnishi Y. Accuracy and trending ability of the fourth-
generation FloTrac/Vigileo SystemTM in patients undergoing abdominal aortic aneurysm surgery. J 
Anesth. 2018 Jun 3;32(3):387–93.
Teboul JL, Saugel B, Cecconi M, De Backer D, Hofer CK, Monnet X, et al. Less invasive hemodynamic 
monitoring in critically ill patients. Intensive Care Med. 2016;42(9):1350–9.
Wetterslev M, Møller-Sørensen H, Johansen RR, Perner A. Systematic review of cardiac output 
measurements by echocardiography vs. thermodilution: the techniques are not interchangeable. 
Intensive Care Med. 2016;42(8):1223–33.
Hapfelmeier A, Cecconi M, Saugel B. Cardiac output method comparison studies: the relation of the 
precision of agreement and the precision of method. J Clin Monit Comput. 2016 Apr;30(2):149–55.
Saugel B, Reese PC, Wagner JY, Buerke M, Huber W, Kluge S, et al. Advanced hemodynamic monitoring 
in intensive care medicine. Medizinische Klin - Intensivmed und Notfallmedizin. 2017;113(3):192–201.
Jensen MB, Sloth E, Larsen KM, Schmidt MB. Transthoracic echocardiography for cardiopulmonary 














Disagreement in CO measurements between FloTrac and CCUS in patients with circulatory shock
543244-L-bw-Kaufmann




Processed on: 14-5-2020 PDF page: 135
135  
8
Mortality prediction models 
in the adult critically ill: 
A scoping review





Morten Hylander Møller 
Christian Fynbo Christiansen 
José Castela Forte 
Harold Snieder 
Frederik Keus 
Rick G. Pleijhuis 
Iwan C.C. van der Horst
Acta Anaesthesiologica Scandinavica
543244-L-bw-Kaufmann




Mortality prediction models are applied in the Intensive Care Unit (ICU) to stratify patients into 
different risk categories and to facilitate benchmarking. To ensure that the correct prediction 
models are applied for these purposes, the best performing models must be identified. As a 
first step, we aimed to establish a systematic review of mortality prediction models in critically 
ill patients.
Methods
Mortality prediction models were searched in four databases using the following criteria: 
developed for use in adult ICU patients in high-income countries, with mortality as primary or 
secondary outcome. Characteristics and performance measures of the models were summarized. 
Performance was presented in terms of discrimination, calibration and overall performance 
measures presented in the original publication.
Results
In total, 43 mortality prediction models were included in the final analysis. Fifteen models 
were only internally validated (35%), 13 externally (30%) and 10 (23%) were both internally and 
externally validated by the original researchers. Discrimination was assessed in 42 models (98%). 
Commonly used calibration measures were the Hosmer-Lemeshow test (60%) and the calibration 
plot (28%). Calibration was not assessed in 11 models (26%). Overall performance was assessed in 
the Brier score (19%) and the Nagelkerke’s R2 (4.7%).
Conclusions
Mortality prediction models have varying methodology, and validation and performance of 
individual models differ. External validation by the original researchers is often lacking and head-
to-head comparisons are urgently needed to identify the best performing mortality prediction 
models for guiding clinical care and research in different settings and populations.
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Introduction
Outcome prediction models, severity scales and risk scores are prognostic tools to estimate the 
probability for a pre-specifi ed outcome (1). These prognostic tools use variables (e.g., about the 
severity of illness) to predict outcome, often mortality, in a specifi c patient population such as the 
critically ill. In the ICU, mortality prediction models may be applied to stratify patients in diff erent 
risk categories and to facilitate benchmarking by using standardized mortality rates. An accurate 
mortality prediction model provides a stratifi cation of the risk of an outcome at a population 
level. These models generally provide a numerical estimate of that risk based on estimates from 
previous populations (2). Per defi nition, all mortality prediction models are best suited for use at 
a population level and not for individual prognostication, as uncertainty for individual patients 
remains high (3,4).
Several models are widely known and broadly applied such as the Acute Physiology, and Chronic 
Health Evaluation (APACHE) I-IV, the Mortality Prediction Model (MPM), and the Simplifi ed 
Acute Physiology Score (SAPS) I-III (5), whereas others like the Intensive Care National Audit & 
Research Centre (ICNARC) are used solely in one country (6). Previous literature has only reviewed 
commonly used models, models with diff erent outcome than mortality or disease- or organ 
specifi c prognostic models (3-5,7,8). To the best of our knowledge, no study has systematically 
assessed which mortality prediction models have been developed and validated for broad 
cohorts of adult critically ill patients.
Rationale and objective
The objective of this study was to provide an overview of available mortality prediction models 
in adult critically ill patients as a step-up towards future head-to-head comparison of model 
performance through systematic external validation.
Methods
Protocol and registration
This scoping review was performed following our protocol (Supplement 1) and was reported 
in accordance with the PRISMA-ScR checklist (9). Notably, we aimed to publish the protocol 
on PROSPERO, but during the process it showed that PROSPERO currently does not accept 
registrations for scoping reviews, literature reviews or mapping reviews.
Search strategy
We conducted a systematic search of MEDLINE, EMBASE, Web of Science and The Cochrane 
Central Register of Controlled Trials (CENTRAL) to identify relevant ICU mortality prediction 
models (Supplement 1). Mortality was chosen as the outcome of interest, as prediction models 
were originally developed to identify patients with high mortality risk. For all databases, except 
the CENTRAL database, the search period encompassed a period starting from the 1st of January 
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2008 to the 21st of April 2019. We used snowballing, that is, searching references and related 
articles, to identify additional prediction models that were published before 2008.
One author ran the search, after which the screening of records and data extraction was performed 
in duplicate. All records were screened based on title and/or abstract. Papers clearly irrelevant 
to the purpose were excluded. The remaining articles were screened for eligibility. Consulting 
a third opinion solved disagreements. More detailed information is presented in the protocol 
(Supplement 1).
Eligibility criteria
To be considered eligible, mortality prediction models had to meet the following criteria: 1) 
originally developed specifically for use in adult critically ill patients as defined by the included 
studies, 2) representing broad groups of ICU patients (with large diversity of admission diagnoses, 
e.g., non-diabetic patients, medical admissions, surgical admissions, etc.), 3) availability of the 
original article in English, and 4) mortality at any time as (primary or secondary) outcome of 
interest.
Prediction models were excluded 1) when developed for low or middle-income countries, as 
characteristics of ICU patients in these countries often substantially differ from those in high-
income countries and, epidemiological data from low-income countries has been frequently 
unavailable (10,11), 2) when developed as a digital model or derived from a machine-learning 
algorithm, since code and data availability is not a requirement in all journals. Since our utmost 
goal is to make a head-to-head comparison of available mortality prediction models using an 
independent external validation cohort, the code or data necessary to retrieve the underlying 
prediction model formula are required to reproduce the prediction models. 3) When the 
development of multiple customized prediction models was described in one article, but no final 
model was proposed, the prediction models were excluded. Finally, 4) we excluded prediction 
models specifically developed for subgroups of intensive care patients such as those with sepsis, 
trauma, cardiac and neurological patients. Studies not specifying inclusion of these subgroups 
within a wider, general ICU population were considered to be eligible. Prediction models 
developed in a medical or surgical ICU were included.
Data extraction
If multiple mortality outcomes (e.g., at different time points) were used, we used the primary 
outcome in the original publication (or the first mortality outcome if the primary outcome was 
not mortality) to describe the performance of the prediction model.
Details on the development process of the mortality prediction models included were shown, 
as well as the number of variables included in the prediction models, mortality rate in each 
development setting and method of handling of missing data. To give an overview of the 
performance of all mortality prediction models, e.g., values from discrimination, calibration and 
overall performances measures (12) for mortality were presented for development and internal 
or external validation cohorts in the original publication (if available).
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The discrimination measure presented was the C-statistic (area under the receiver operating 
characteristic curve (AUROC)), calibration measures presented were goodness-of-fi t tests like the 
Hosmer-Lemeshow (HL) test, calibration plot and calibration slope, and the overall performance 
measures presented were the Nagelkerke’s R2 and the Brier score (12).
Preferable values from external validation were presented if both internal and external validation 
values were present in the original publication. If not available, values of internal validation 
cohorts were presented. External validation was defi ned as using a separate individual dataset for 
validation of the mortality prediction model (i.e., no split sampling of a dataset also used for the 
development of the model).
Citations of original publications were screened for internal and/or external validation articles and 
shown as being present (+) or absent (-). A list of variables sought for in the identifi ed articles can 
be found in Supplement 1.
Results
The selection of sources of evidence can be found in the fl owchart (Figure 1). Articles evidently 
developed for specifi c groups of patients (i.e., sepsis, trauma, cardiac, neurological patients) were 
excluded based on the title or abstract. Evaluating 99 full-text articles for eligibility resulted in 
exclusion of another 39 articles, leaving 60 articles that were screened for original publications. 
Eventually, 43 relevant mortality prediction models reported in 38 publications were extracted 
and included in the fi nal analysis.
Characteristics of the included mortality prediction models
Characteristics of the mortality prediction models and underlying derivation cohorts are presented 
in Table 1. Nineteen mortality prediction models (44%) were developed using prospectively 
collected data specifi cally gathered for the development of the prediction model (6,13–27), 
whereas 24 (56%) were developed using either retrospective data (28-44) or prospective data 
previously collected for other purposes (45-49). The start of data collection for the development 
cohorts spanned 36 years (1979-2015), and the duration of the cohort studies varying from 
two months up to 10 years for each cohort. Two mortality prediction models (4.7%) did not 
report the timespan during which their development cohort was assembled (22,33). Thirty-one 
mortality prediction models (74%) were developed in a single country (14,18–26,27,29,31,33–
44,47,49,50), six (14%) in neighboring countries (two or more) (6,13,28,30,32,46), and fi ve (12%) 
were developed in multiple countries worldwide (15–17,48). The number of patients included 
in the development databases ranged from 232 to 731,611 patients with a median of 4,895 (IQR 
528 – 35,878). The minimum age at which patients were included was 15 years (2.3%) (35). Eleven 
mortality prediction models (26%) did not specify age (6,13,23,25,29,31,36,38,42,46). The number 
of variables included in the mortality prediction models varied from 5 up to 5,695, with a median 
of 16 (IQR 9 – 24).
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Outcome measures
The timing of mortality outcome varied between the studies. Hospital mortality was the 
most frequently used primary outcome in 29 (67%) mortality prediction models (6,13-
19,21,22,24,27,28,30-33,35,36,38,41-43,45,46). Other primary outcome variables were ICU 
mortality (7%) (23,26,34) 28-day mortality (4.7%) (39,44), 90-day mortality (4.7%) (48,49), 3 to 28-
day mortality (4.7%) (40), 30-day mortality (2.3%) (47), 180-day mortality (2.3%) (20), 6-month 
mortality (2.3%) (25), 15-year mortality (2.3%) (37), and 6 and 12-month mortality (2.3%) (29).
Secondary outcomes were 1-month mortality after ICU admission (4.7%),(24,31) hospital mortality 
(4.7%),(29,34) ICU mortality (2.3%),(50) 3-month mortality after ICU admission (2.3%),(31) 6-month 
mortality after ICU admission (2.3%),(31) 9-month mortality (2.3%),(47) 1-year mortality (2.3%),(50) 
and length of stay (2.3%).(24) Of the 43, thirty-seven mortality prediction models (86%) did not 
prognosticate any secondary outcome (6,13-23,25-28,30,32,33,35-44,46,48,49).
Hospital mortality rates of the development cohorts varied from 6.9% to 48% and were not 
reported for nine mortality prediction models (21%) (6,15,18,29,33,40,42).
For 21 mortality prediction models (49% of 43), data were collected within the fi rst 24 hours after 
patient admission to the ICU (6,13,14,17-19,24,26,27,30,31,34,38,39,42,44,47-49). For 11 prediction 
models (26%) data on ICU admission were collected (16,23,25,28,32,35,36,41,43,45,46) whereas 
for the remaining prediction models data timing varied from 24 days before admission up to fi ve 
days after patient admission to the ICU.
Handling of missing data was not reported in 11 mortality prediction models (26%) (23,25,26,
31,33,38,39,41,45,46,49), 20 prediction models (47% of 43) excluded records with missing data 
(6,14,16,19,21,24,27,28,30,32,34,40,42-44), six prediction models (14%) imputed values with 
normal or mean values (15,17,18,20,22,29), and four prediction models (9.3%) reported no missing 
data (13,35–37). The remaining two prediction models (4.7%) excluded patients when more than 
a certain percentage of the data was missing (>5% or >25%) (47,48).
Discrimination, calibration and overall performance measures
Discrimination, calibration and overall performance measures are presented in Table 2. Of the 
43 mortality prediction models, 15 (35%) were only internally validated (23,26,28-31,33,38-
41,44,46,48), 13 (30%) only externally (16,19-21,25,35,36,42,43,47), 10 (23%) were both internally 
and externally validated (6,13-15,17,18,22,32,34,37), and 5 prediction models (12%) were not 
validated at all (24,27,45,49). Fifteen prediction models (35%) included a description of an external 
validation in their original publication (13,16,20-22,25,34-36,42,43,47).
Discrimination was expressed as the area under the receiver operating characteristics curve 
(AUROC) in 42 of the 43 mortality prediction models original publications (98%). Only the APACHE 
II model didn’t report an AUROC value in the original publication (19). In the development cohorts, 
the lowest discrimination was AUROC 0.72 (95% CI 0.71-0.74) (48), and the highest AUROC 0.91 
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(95% CI not specified) (30). In the validation cohorts, the lowest AUROC was 0.58 (95% CI not 
specified) (44), and the highest AUROC 0.95 (0.91-0.99) (23).
Calibration measures were expressed by various statistical measures. The Hosmer-Lemeshow 
goodness-of-fit test was used in 26 mortality prediction models (60%) (14-17,21,22,24-26,28,30,32-
36,38-41,43,46,48). Calibration plot was expressed for 12 prediction models (28%) (13,15,20,24,2
8,30,31,33,35,37,43,48), and two prediction models (4.7%) presented the calibration slope value 
(30,48). Finally, one prediction model (2.3%) used the likelihood ratio test chi-squared value (23), 
and one prediction model (2.3%) used the Quasi likelihood under the Independence Criterion (QIC) 
(45). In eleven prediction models (26%), calibration was not assessed (6,18,19,27,29,42,44,47,49).
Overall performance was expressed as the Brier score in eight mortality prediction models (19%) 
6,13,28-31,34,41), and as Nagelkerke’s R2 in two prediction models (4.7%) (37,48).
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In this scoping review, we presented a contemporary overview of 43 mortality prediction models 
used in adult ICU patients in high-income countries. We found varying methodology, and the 
validation and performance of individual prediction models differ. Only 23 mortality prediction 
models of the 43 (53%) were externally validated. This overview provides a basis for head-to-head 
comparison of existing mortality prediction models through systematic external validation, with 
the ultimate goal to identify the most suitable prediction model for a certain cohort of patients.
Summary of evidence
In previous literature, the maximum number of ICU mortality prediction models reviewed was 12 
(7), which is considerably less than the 43 prediction models identified by this review. Where we 
included all developed prediction models specifically designed to assess mortality, other reviews 
regarding ICU mortality prediction models focused mainly on commonly used models like the 
APACHE, SAPS and MPM (3–5), or identified models with different outcome than mortality (e.g., 
organ dysfunction) or disease- or organ specific prognostic models (4,5,7,8). Additionally, only 
Siontis et al. and Strand et al. applied a systematic search to identify the models and discussed 
the validation of the models (5,8). Where we included all developed mortality prediction models, 
Strand et al. did only include prediction models when the search for the specific scoring system 
yielded more than 50 citations (5). Siontis et al. conducted an evaluation of validated tools for 
hospitalized patients to predict all-cause mortality. However, their analysis included specific 
patient groups (e.g., heart or liver patients) rather than general ICU patients as included in the 
current review (8).
Model performance is affected by the choice of outcome (31,51). Most mortality prediction 
models used hospital mortality as outcome measure (6,13-19,21,22,24,27,28,30-33,35,36,38,41-
43,45,46). In general, longer fixed-time outcome measures used in some models 
(20,24,25,29,31,37,39,40,44,45,47-49) are currently recommended (51). To elaborate, hospital 
mortality is dependent on discharge practices and availability of post-ICU care, and is therefore a 
subjective measure. Furthermore, critical illness affects patients after hospital discharge.
The time span during which the mortality prediction models gathered their data varied from 
short (e.g., upon ICU admission or during the first initial hour of admission to the ICU) to long (e.g., 
during the first 24 hours of admission). Concerning complexity (time consumption) and missing 
data problems, it may be better in some situations to use a simpler model with less missing 
data than a more complex model built from a dataset with more missing data which achieves 
a slightly better performance (52). Longer collection periods may lead to more complete data, 
as incompleteness is often substantial for biochemical variables for patients with short-duration 
admissions (i.e., less than 24 hours). However, sampling rate affects predictions (53). This limitation 
is considered less important in models with shorter data collection. Similarly, the treatments 
administered during the first 24 hours in the ICU obviously also affect predictions.
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Comparison of performance
We reported the performance of mortality prediction models in terms of discrimination, 
calibration and overall performance values. Direct comparison of prediction models predictive 
performances is not possible, as the development cohorts diff ered substantially from one another. 
As a consequence, prediction models cannot be considered interchangeable. Comparisons that 
are not done head-to-head in external samples independent of all models developed are at high 
risk of being misleading and may lead to inappropriate conclusions and resource use (12).
Of 43, 26 (60%) mortality prediction models used the HL goodness-of-fi t test for calibration (14-
17,21,22,24-26,28,30,32-36,38-41,43,46,48). The HL test is commonly used, despite being frequently 
non-signifi cant for small data cohorts and nearly always signifi cant for large data cohorts (54–57). 
When only the HL test is reported without any calibration plot or table comparing predicted and 
observed outcome frequencies, inadequate information regarding calibration is provided (1).
Many ICU mortality prediction models are available and comparatively assessing their performance 
is a crucial task (4). Twenty-fi ve articles compared the performance of the new model with existing 
models but used the same cohort of patients that was used in the development of the “novel” 
model (6,13,14,16-18,20,22,24,26-30,32,34,40-47,49). This methodology is inherently biased in 
favor of the “novel” model (54,57). Comparisons between prediction models should therefore only 
be executed in independent external validation samples not used to develop any of the models.
Machine-learning algorithms
Mortality prediction models developed as an electronic model or derived from a machine-
learning algorithm such as AutoTriage (58) were excluded in our manuscript since code and data 
availability is not a requirement in all journals and this is necessary to reproduce the specifi c 
prediction model. However, code availability appears to be a rising trend (59). Machine learning-
based prediction models seem to achieve increasingly higher accuracies and are becoming more 
dynamic (60), although they still have to include a suffi  ciently large development and validation 
cohort to adequately assess performance and the risk of overfi tting. However, a recent systematic 
review concluded that machine learning did not have superior performance over logistic 
regression for clinical prediction models (61).
The association between mortality and variables may have changed since the original mortality 
prediction models were developed, e.g., as a result of advancements in diagnostics and 
therapeutics (62). Mortality alone however is rarely the only outcome measure for interventional 
studies in ICU patients, and many trials, especially in sepsis, include an organ dysfunction score as 
part of on-going patient assessment so that eff ects on morbidity can also be evaluated (3).
Misuse of mortality prediction models can lead to inappropriate use of resources and potentially 
even mismanagement of patient care due to incorrect stratifi cation (57). Awareness of the 
diff erences in model design, the variance of predictions across diff erent ICU settings, and the 
eff ect of heterogeneity in populations are of utmost importance.
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Limitations
Some limitations of this study need to be addressed. First, having restricted our search to the 
period from 2008, relevant mortality prediction models might have been overlooked. Even 
though some of the most widely used mortality prediction models precede the screening period 
we identified 16 prediction models that were published before 2008, but optimally searches have 
no time limit (63). Second, we only included mortality prediction models originally developed 
for use in the ICU. Mortality prediction models not originally developed for mortality prediction 
in the ICU could still be valuable clinically. Third, in some original publications, it was unclear 
whether the presented discrimination, calibration and/or overall performance values were 
derived from the development cohort or from the validation dataset. We aimed to clarify these, 
but certain values might reflect another dataset from the original publication. Fourth, we only 
provided a systematic overview of all developed mortality prediction models in the adult critically 
ill patients. We did not perform a systematic review of every retrieved model complete with all 
consecutive internal and external validations, as results from different external validations in 
different cohorts are not directly comparable due to differences in populations, case-mix and 
settings. We restricted the scope of this review to only identify whether internal or external 
validation had been performed as a measure of thoroughness of development of the identified 
models. For this reason, only screening of citations of the original articles was done to identify 
internal and/or external validation articles. Therefore, we should address that our assessment on 
mortality prediction models not being internally and/or externally validated might be incomplete 
if validation in different publications was missed. A systematic search specifically designed for 
retrieving validation papers is advised when systematically reviewing the internal and external 
validations of mortality prediction models (64).
Unanswered research questions
Although we retrieved many developed mortality prediction models that can be used as a 
step towards future head-to-head comparison, with the results of this scoping review it is not 
possible to make a recommendation on what mortality prediction models to use and it was 
not our intention to do so. External validation involving direct head-to-head comparisons in 
independent cohorts is needed to unravel the comparable performance of individual models. 
Although we provide a systematic overview of mortality prediction models and describe whether 
these were internally and/or externally validated, it was not desirable to give an overview of all 
external validations of the prediction models since this would require a specific search strategy 
for each model. Moreover, we would have liked to assess risk of bias using the recently developed 
PROBAST score (1). However, this was not feasible because of the amount of prediction models.
Future perspectives
To identify the most suitable mortality prediction model for a certain patient cohort, ideally a 
head-to-head comparison of available models should be performed through systematic external 
validation using prospectively obtained datasets and appropriate statistical methods. The 
eventual aim will be to use this review to identify, update, and implement the best performing 
mortality prediction models in daily practice. We are in the process of validating the found 
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prediction models in independent contemporary cohorts to provide external validation of these 
models. Second, the process should be performed in diff erent cohorts as heterogeneity of ICU 
patients exists on multiple levels, i.e., patient level, hospital level, region and country level (65). The 
best mortality prediction model in one setting is not necessarily the best performing prediction 
model in another setting. Third, it is worth mentioning that ICU patients have reduced long-term 
survival and impaired quality of life after ICU discharge compared to the general population (66). 
Future research should also look at determinants of poor outcomes in ICU survivors to help guide 
long-term follow-up (67).
Conclusions
In this review, 43 mortality prediction models have been studied. The validation and performance 
of individual prediction models diff er and the best prediction models for guiding clinical care and 
research is still to be established.
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Foresight over hindsight: Mandatory publication of clinical research protocols prior to conduct
Introduction
Recently, the Extracorporeal membrane Oxygenation (ECMO) to res cue Lung Injury in severe 
Acute respiratory distress syndrome (ARDS) (EOLIA) trial was published (1). This randomized 
controlled trial (RCT) evaluated early initiation of ECMO compared with standard care in patients 
with severe ARDS. At a planned interim analysis after the enrolment of 240 (73%) of the targeted 
331 patients, the trial was stopped prematurely, according to prespecifi ed stopping rules, as 
continuation of the trial would likely not lead to a statistically signifi cant diff erence in the primary 
outcome (60-day mortality). The sample size estimation was based on an unlikely eff ect size of 
20% absolute risk reduction (2). In the fi nal analysis performed after the interim analysis, the 60-
day mortality was 35% in the ECMO group and 46% in the standard care group (relative risk 0.76; 
95% CI: 0.55-1.04, P = 0.09). The true eff ect may thus vary from a 45% relative risk reduction to a 4% 
relative risk increase, but the trial provides no fi rm evidence in favor or against the intervention. 
Comments emerged in medical journals and on social media about the decision to stop the 
trial. One of the accompanying editorials stated: “We are disappointed that the Data and Safety 
Monitoring Board (DSMB) acted so quickly to stop the trial, but others may have reached the 
same decision as the DSMB” (3). Also, on social media many suggested that stopping the trial early 
for futility was unethical, while others supported the investigators for following the predefi ned 
criteria (4).
The EOLIA trial renewed the discussion of hindsight on any study, especially since the trial had 
a protocol and followed it. The debate about this RCT after publication in a peer-reviewed high 
impact journal and the ensuing social media discussion highlight the need to consider key 
aspects of trial methodology. First, trial planning must include both realistic and biologically 
plausible hypothesized eff ect sizes, assumed event rates, and sample size estimations. In critical 
care research, eff ect sizes are invariably infl ated and implausible — for example, an absolute 
reduction in mortality >10% is frequently reported (5,6) that is not considered plausible by trialists 
and clinicians (2). Second, interim analyses and stopping criteria must be clearly specifi ed before 
trial onset, and should consider diff erent scenarios including possible harms, likely benefi ts and 
in some cases futility. Currently, research is usually registered in a registry (e.g., ClinicalTrials.gov 
or PROSPERO) prior to initiation; however, these registrations are often not detailed, not peer-
reviewed and they may go unnoticed by other experts in the fi eld. This is sometimes followed 
by publication of a full protocol in a peer-reviewed journal, often while the research is being 
performed and changes in study design may be diffi  cult to implement. We propose that full 
protocols of trials and other clinical studies are published in peer-reviewed journals prior to the 
commencement of patient recruitment (for prospective studies), data access (for retrospective 
studies), or search conduction (systematic reviews), so methodology may be optimized.
Current initiatives for improved conduct of research
The International Committee of Medical Journal Editors (ICMJE) has developed recommendations 
regarding planning and reporting of medical studies (7). The Enhancing the QUAlity and 
Transparency Of health Research (EQUATOR) network hosts an increasing number of checklists 
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that may guide researchers (8), including guidelines for reporting systematic reviews and meta-
analyses (9), randomised trials (10), and observational studies (11). In addition, extensions of 
guidelines have addressed the planning and conduct of randomized trials (12,13) and systematic 
reviews with meta-analyses (14). These initiatives add to achieving results that are reproducible, 
transparent and have rigor, so that clinicians, patients, and society may trust them (15). Even 
though these initiatives are in place, many trials still have avoidable methodological flaws and 
inconsistencies (16).
Perceived advantages of prepublication of study protocols
Publishing study protocols will likely improve the quality of planning and conduct of studies. 
Protocols can be checked according to the checklist fitting the study design, that is, Standard 
Protocol Items: Recommendations for Interventional Trials (SPIRIT) for RCTs, and Preferred 
reporting items for systematic review and meta-analysis protocols (PRISMA-P) for systematic 
reviews and meta-analyses (12,14). Modifications can be made based on established indices 
of high internal validity. Qualified expert readers assessing study protocols by means of peer 
review may identify important flaws or omissions, allowing corrections in a timely manner, 
that is, before the study is commenced.
Hypothesized effect size and sample size estimation are open to discussion, which may 
allow alterations of implausible effect sizes and increase study robustness and the chance of 
obtaining useful evidence.
A mandatory published study protocol adds transparency as it allows methods to become 
publicly available.
If other researchers or research groups aim to study a similar research question, these studies 
could serve as validation and confirmation. This may provide opportunities for trial protocol 
harmonization of definitions (population, intervention, comparator and outcomes), that may 
reduce clinical heterogeneity and strengthen the interpretation of results of subsequent trial- 
or patient-level systematic reviews and meta-analyses.
Accepting publication of a study before completion based on a published, peer-reviewed 
protocol may reduce time between completion and publishing due to rejections, revisions, 
and repetitive submissions. Reviewers and editors will only have to focus on protocol 
adherence, clarity of presentation of the results and discussion, as the methods will have 
already been reviewed.
Publishing protocols may facilitate the peer review process.
Knowledge on upcoming multicenter trials may facilitate the recruitment of centers.
Perceived disadvantages of prepublication of study protocols
Potential delay in time between getting the idea for a research project and publishing the 
manuscript, and in the time between finishing the protocol and beginning the research 
project/study.
Funding agencies require a near-final version of a protocol for their funding applications. 
Funding becomes more difficult to obtain if protocol amendments must be implemented. 
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Innovative ideas, included in the protocols, are open and could lead to incorporation in 
studies of other researchers or research groups.
Suggestions for improved implementation in dissemination of study protocols
Publication in dedicated protocol journals or as a section in existing journals, either online or 
in print.
Create an electronic platform to facilitate suggestions and comments potentially amending 
the study protocol.
Set reasonable time limits for suggestions and comments to be considered for the fi nal 
protocol.
Replace the initial protocol by the amended protocol once the defi nite publication emerges 
and add the initial protocol as a supplementary fi le, publish the amendments as a second 
supplementary fi le and cite the authors of the suggestions and comments that were the 
reason for the amendment to acknowledge their intellectual contribution.
Publish the amended protocol on a dedicated database, such as PROSPERO or ClinicalTrials.
gov.
Opportunities for journals to commit themselves to publishing the outcomes of amended 
study protocols if conducted accordingly.
Conclusions
We recommend peer-review of study protocols by way of prepublication prior to study 
commencement as it may improve study design, increase transparency of study conduct and 
reporting, and increase trust in the results. Several obstacles need to be considered, but the 
benefi ts are likely to outweigh the perceived disadvantages.
Foresight over hindsight: Mandatory publication of clinical research protocols prior to conduct
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Summary
This thesis aimed to extend the evidence on the applicability of hemodynamic monitoring to 
prevent and treat hemodynamic instability during the perioperative period and admission to 
the ICU. Second, we aimed to gain knowledge on how to improve the conduct of studies in 
perioperative and critical care medicine.
Hemodynamic monitoring used in perioperative goal-directed therapy
Perioperative goal-directed therapy is more than a single intervention
The perioperative goal-directed therapy (PGDT) intervention using hemodynamic monitoring 
has been evaluated in many diff erent randomized controlled trials (RCTs). In our systematic 
review, however, a meta-analysis of data obtained from these trials was considered inappropriate 
due to clinical heterogeneity (chapter 2). The use of diff erent hemodynamic variables as a target 
for intervention and diff erent hemodynamic monitors were only some of the aspects of extensive 
heterogeneity observed in the complex PGDT intervention. Given the existing standards requested 
for high-quality evidence, it was unjustifi ed to draw a uniform conclusion on the eff ect of PGDT 
on patient-centered outcomes. We demonstrated the need for universal and uniform defi nitions 
of the PGDT intervention to make a comparison between diff erent trials possible. In addition, 
whenever results of individual RCTs are pooled in a meta-analysis, this inherent heterogeneity 
needs to be considered by readers before conclusions are drawn.
Even though we showed that high-quality evidence was not available for the PGDT intervention, 
i.e., a meta-analysis pooling data from trials with low risk of bias, a combination of several 
aspects needs to be considered to make sure that the right patients will benefi t from the PGDT 
intervention. First, the PGDT intervention needs to be applied in high-risk patients undergoing 
high-risk surgery. Second, the initiation of the PGDT intervention needs to be started early during 
the perioperative period. Third, the PGDT algorithm needs to combine fl ow optimization, i.e., 
cardiac output (CO) or stroke volume (SV), with dynamic preload variables, e.g., stroke volume 
variation (SVV), to assess fl uid responsiveness (chapter 3).
Hemodynamic monitoring in the intensive care unit
Data obtained as part of the prospective observational Simple Intensive Care Studies-I (SICS-I) 
were used to expand the available evidence regarding hemodynamic monitoring in the ICU. 
The primary hemodynamic assessment when a circulatory shock is suspected can be described 
as a step-by-step approach where initially clinical examination is performed, followed by a CO 
measurement using critical care ultrasonography (CCUS), and concluded by more advanced 
hemodynamic monitoring if a complex shock state requires so. In this thesis, we expanded the 
evidence for each of these steps.
Clinical examination is the fi rst step but needs to be improved
We assessed the current practice of clinical examination in critically ill patients and mapped 
a Bayesian network, which showed that physicians regard the presence of a high-dose 
norepinephrine infusion and a prolonged capillary refi ll time or mottling of the knee as being 
Summary, discussion, and future perspectives
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conditional dependencies of a low cardiac pump function (chapter 4). The methodology employed 
to construct the Bayesian network was used for the first time in this setting so that rigorous testing 
and validation were necessary. Our findings give an insight into the possible thought process of 
physicians when performing a clinical examination and show that improvements regarding the 
diagnostic accuracy of the clinical examination for hemodynamic assessment are needed.
Blood pressure measurement methods are not interchangeable
Blood pressure measurements obtained with a non-invasive oscillometric upper-arm cuff showed 
significant limits of agreement compared to invasive arterial pressure measurement, and error-
grid analysis showed that one in four patients on norepinephrine would potentially have had 
at least a low-risk treatment decision (chapter 5). Blood pressure measurements obtained with 
an invasive arterial catheter are at the moment the clinical standard in patients with circulatory 
shock, and our findings do not support replacing this method with a non-invasive alternative. 
We believe that in clinical practice, it is essential to remain critical on the interchangeability of 
methods of blood pressure measurement. The analyses that were used to compare the two blood 
pressure measurement methods provide limited data on measurement differences between 
different methods in individual patients. For clinical practice, this means that in every individual 
patient, the optimal applicable method of measurement needs to be determined based on the 
benefits and disadvantages.
Experts remain essential for the interpretation of images obtained with critical care 
ultrasonography
Medical students are capable of obtaining critical care ultrasonography (CCUS) images of 
sufficient quality in critically ill patients admitted to the ICU, but experts are still required for proper 
interpretation of these images (chapter 6). The quality of the images obtained by the medical 
students was of sufficient quality, but the measurements of CO that were made by the medical 
students based on these images showed significant limits of agreement, i.e., unacceptable 
accuracy of the measurement differences, compared to measurements made by experts from 
the same images. Being able to acquire the required CCUS images and perform the calculation 
of CO is essential as the utility of CCUS in the ICU increases. Our findings were of interest as being 
able to calculate CO using CCUS is considered an advanced skill, and the medical students had no 
prior experience in using CCUS. For future research and clinical application of CCUS, it is feasible 
to have non-experts acquire the images which can then be interpreted by experts, thus saving 
time and resources.
Uncalibrated pulse wave analysis to measure cardiac output is not indicated in patients with 
circulatory shock
CO measurements obtained with an uncalibrated pulse wave analysis device showed significant 
limits of agreement and clinically unacceptable trending ability compared to CCUS performed in 
patients with circulatory shock (chapter 7). At the moment, the uncalibrated pulse wave analysis 
method of measuring CO is not recommended in patients with circulatory shock, and our 
findings support this. Due to the chosen methods, it was not possible to prove direct superiority 
Chapter 10
543244-L-bw-Kaufmann
Processed on: 14-5-2020 PDF page: 175
175  
or non-inferiority of one method over the other, as CCUS is not a gold standard reference 
technique required for formal method comparison. Comparison in prospective observational 
studies, however, may refl ect clinical practice better and allows for validation of these methods in 
populations of patients who were initially not the target population.
Initiatives to improve methodology and conduct of studies
External validation of research fi ndings in independent cohorts are needed
We presented an overview of 43 identifi ed mortality prediction models for estimating mortality 
in unselected critically ill patients with varying quality of methodology, and the validation of the 
individual models diff ered and was most often incomplete (chapter 8). External validation of 
the mortality prediction models is often lacking, and head-to-head comparisons are needed to 
identify the best performing model out of the available mortality prediction models for guiding 
clinical care and research in diff erent settings and populations.
Mandatory publication and peer-review of research protocols
Peer-review of study protocols by way of prepublication before initiation of a study may increase 
the transparency of study conduct and reporting (chapter 9). We believe that a structured 
discussion of aspects of study design in advance may limit the discussion in hindsight regarding 
the conduct and interpretation of the study results. Protocols can be reviewed according to the 
checklist fi tting the study design, and modifi cations can be made based on established indices of 
high internal validity. Notable fl aws and omissions can be identifi ed, which allows corrections on 
time. Potential delays in study commencement need to be considered, and innovative ideas are 
in the open and could be adopted by other researchers. Transparency and optimization of study 
design and conduct benefi t not only researchers but also patients, which is the ultimate goal of 
all conducted research.
Summary, discussion, and future perspectives
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Discussion and future perspectives
The chapters of this thesis combine to show that it is hard to obtain high-quality evidence needed 
to demonstrate the benefi t of the application of hemodynamic monitors in perioperative goal-
directed therapy (PGDT) in the operating room (OR) or patients treated in the intensive care unit 
(ICU). Even though several national and international guidelines support the use of the PGDT 
intervention in major surgery (1,2), the benefi cial eff ect of PGDT is not based on high-quality 
evidence yet. The same principle goes for the application of hemodynamic monitors in patients 
in the ICU as there is no high-quality evidence on the interchangeability of diff erent monitors that 
measure cardiac output (CO) or blood pressure. The ultimate goal in this research fi eld is to fi nd 
the best applicable methods to measure hemodynamic variables reliably and that these variables 
are valuable to guide treatments that benefi t individual patients. Here, we address the possible 
reasons for the fi ndings of this thesis and elaborate on the future of hemodynamic monitoring.
Considerations for hemodynamic monitoring in the operating room
Hemodynamic monitors are applied in the context of the PGDT intervention, and this 
intervention consists of composite components, which makes a direct comparison between 
studies problematic. Whenever a systematic review with meta-analysis of individual PGDT trials 
is completed, the limitation section of these articles contains the following standard phrases: 
presence of clinical and statistical heterogeneity, limited comparability between diff erent 
hemodynamic monitors, and high risk of bias among included studies. While some parts of 
these limitations are inherent to the PGDT intervention, other parts may be preventable if more 
attention is paid to them. One should be aware that the fact that limitations may be inherent 
does not mean that they should be neglected when accumulating and assessing the quality of 
evidence, and consideration of these limitations when designing the study is crucial.
Heterogeneity
Studies brought together in a systematic review will diff er because of the varying characteristics 
of the individual trials. The Cochrane Handbook for Systematic Reviews of Interventions describes 
variability in the participants, interventions, comparisons, and outcomes studied as clinical 
heterogeneity and variability in the intervention eff ects being evaluated as statistical heterogeneity 
(3). Statistical heterogeneity can be quantifi ed using various statistical tests, but the interpretation 
of clinical heterogeneity is left to the reader. As the PGDT intervention studies often use diff erent 
types of monitoring devices, hemodynamic variables, target values, types of fl uids, and types of 
vasoactive medication, and are performed in diff erent patient groups undergoing diff erent types 
of surgery, heterogeneity is inevitable. For example, there is still a research debate regarding the 
benefi cial eff ect of using certain types of fl uids (i.e., crystalloids versus colloids) on postoperative 
outcomes of patients undergoing surgery (4). The possible implications regarding the type of 
fl uid to use underline the rationale to standardize these components of the PGDT intervention 
when performing a meta-analysis. Because of clinical heterogeneity alone, we decided that 
pooling data from the individual PGDT trials in one meta-analysis was not appropriate.
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Research in other areas of critical care has shown that clinical heterogeneity may influence the 
results of systematic reviews with meta-analyses (5,6). Overall, heterogeneity limits the external 
validity of research findings. The consequence for PGDT is that it is sometimes considered to be 
a poorly defined term with impaired implementation in clinical practice as a result (7). Novel 
trials on the benefit of the PGDT intervention need to report all individual components of PGDT 
to allow for a more uniform comparison. In addition, the first trial on the PGDT intervention was 
published over thirty years ago (8), and this trial is still included in present-day systematic reviews 
with meta-analyses (9). Mortality in perioperative medicine has decreased substantially over the 
past fifty years (10), and thus with the general advancements in medicine over time, it seems 
inappropriate to merge data from these early PGDT trials with contemporary trials to estimate a 
single pooled intervention effect.
Furthermore, research on PGDT will benefit from trials with a sufficiently large sample size as most 
of the trials published at the moment only report on small patient groups, which increases the 
risk of heterogeneity (9). Although, if large groups of patients are needed to show a statistically 
significant benefit, it might not be a clinically relevant effect. On the other hand, statistical 
techniques such as heterogeneity treatment effect analysis using Bayesian hierarchical models 
included in protocols of extensive trials may be one way to limit the clinical heterogeneity (11).
Comparability of hemodynamic monitors
Various hemodynamic monitors are used to determine the target hemodynamic variables used 
in the PGDT intervention. Hemodynamic variables in PGDT algorithms pooled in systematic 
reviews are handled on the assumption that measurements produce the same value regardless 
of the type of hemodynamic monitor used. However, each of these monitors performs the 
measurements of these variables via different methods, and they do not naturally agree on 
values. Method comparison studies are used to determine the validity and interchangeability 
of hemodynamic monitors measuring hemodynamic variables (12). These studies consist of 
assessments of precision, accuracy, and trending ability of a test method against an established 
reference method (i.e., gold standard). The established gold standard produces the measurement 
value that is considered to be the correct one, and the agreement of the test value is compared to 
the correct value. High precision means that the values of the two methods will have little spread, 
and high accuracy means that the values on average will be close to the correct value (figure 1).
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Figure 1. Accurate measurements are close to the correct value, irrespective of the spread of the measurements; 
precise measurements are close to each other, regardless of the deviation from the correct value. Valid hemodynamic 
monitors should be both accurate and precise
There are several concerns regarding the assumption that measurements of hemodynamic 
variables using diff erent hemodynamic monitors are interchangeable. First, not all monitors 
show the acceptable agreement of measurements of hemodynamic variables (13). Second, 
most method comparison studies were performed in patients undergoing cardiac surgery (13). 
One of the reasons is that this patient group is routinely monitored using the gold standard 
pulmonary artery catheter, which facilitates performing method comparison studies. However, 
results of agreement of hemodynamic monitors obtained in cardiac surgery patients cannot be 
directly transferred to other patient populations as physiology varies in diff erent populations. 
For example, patients undergoing liver surgery may experience changes in arterial resistance, 
which makes the uncalibrated pulse wave analysis method to measure CO less reliable (14). Third, 
studies assessing interchangeability often fail to report all necessary assessments of agreement: 
precision, accuracy, and trending ability (15,16). Incomplete reporting of items in publications is 
a general problem, as intervention studies in anesthesiology often lack in full reporting of items 
necessary for a comprehensive evaluation of an intervention (17). A checklist was developed to 
assist with providing a complete method comparison, but many studies were performed before 
this quality check was available (12). We found a total of 18 diff erent hemodynamic monitors used 
in the PGDT trials in one of our studies. In another study, we applied the checklist to compare 
CO measurements made using the uncalibrated pulse wave analysis method with critical care 
ultrasonography (CCUS) in critically ill patients. As more hemodynamic monitors are still being 
developed, method comparison studies need to optimize their application and reporting of 
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the methodology to allow for proper validation and implementation of the novel monitoring 
technique (18,19).
Risk of bias
A bias is a systematic error influencing the results of a study. This type of error implies that 
multiple replications of the same study would reach the wrong answer on average (3). Bias can 
be interpreted as a target in figure 1 with low accuracy; high bias means that there is a low 
accuracy for the test results as there is a systematic deviation from the correct value. A risk of 
bias assessment is an essential component of performing a systematic review with meta-analysis. 
There are several forms of bias that are considered in a formal risk of bias assessment, such as 
selection bias, detection bias, attrition bias, and reporting bias. These different biases are known 
to contribute to an overestimation or underestimation of the true intervention effect (20).
Sometimes, a particular risk of bias is inherent to a field of research. For example, in the PGDT 
intervention, it is impossible to blind participants and study personnel to invasive hemodynamic 
monitoring devices. Some of these devices are connected to indwelling catheters in large arteries 
or veins, or a probe is placed in the esophagus of the patient (21). That an intervention cannot be 
blinded should not mean that a lack of blinding is not considered a risk of bias, although there is 
no evidence that a lack of blinding in itself influences intervention effects on mortality (22). We 
found only one trial on the PGDT intervention with an overall low risk of bias. The most common 
cause for the risk of bias of the PGDT intervention was lack of blinding or collaboration with the 
industry by at least one of the authors. Even if blinding in itself is not considered as an additional 
risk, most studies that we identified had a high risk of bias.
Collaboration with the industry is a specific bias of interest for the PGDT intervention. As clinical 
research is widely sponsored by companies, there may be a financial incentive to publish positive 
results. It has been shown that drug and device studies sponsored by companies have a more 
favorable intervention effect and more often have a positive conclusion (23). In PGDT research, 
there exists a significant impact of authors’ collaboration with the industry on publishing a positive 
conclusion to a trial regarding the PGDT intervention (24). Research on the benefit of PGDT will be 
helped by trials with an as low as possible risk of bias as it is an intervention prone to biases that 
influence the overall assessment of the intervention effect.
Hemodynamic monitoring in the ICU – improving on the current application
Improving on the contemporary clinical examination for hemodynamic assessment
Clinical examination of critically ill patients comes first in the hemodynamic assessment of 
suspected circulatory shock (25). Based on available evidence, the clinical examination should be 
used as a trigger for additional measures in patients with circulatory shock, such as a measurement 
of CO using CCUS or additional hemodynamic monitoring (26). Even though several clinical 
examination findings are independently associated with CO, multivariable analyses of these 
findings showed that clinical examination alone was insufficient to estimate CO (27). It is vital to 
improve the hemodynamic assessment made with clinical examination. Although technological 
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aids are becoming more widely available, further research into the value of clinical examination 
may potentially limit inappropriate overuse of technological aids (28).
Clinical examination by physicians can be improved by identifying some of the cognitive biases 
physicians may be subjected to and negating them (29). Physicians may be prone to premature 
closure in which the physician fails to consider reasonable alternatives after an initial diagnosis 
is made (30). In addition, a physician may be prone to confi rmation bias in which the physician 
is prevented from considering other information having already reached a conclusion, and 
involuntarily dismisses information which does not support their decision. For example, a 
physician may examine a critically ill patient who is receiving a high dose of norepinephrine 
infusion and may believe that the presence of this value must imply that CO is low. From earlier 
studies, we know that CO does not necessarily decrease with norepinephrine infusion, and CO 
response to norepinephrine infusion varies with underlying disease and comorbidities (31,32). 
These cognitive biases and how they limit diagnostic accuracy can be identifi ed by analyzing 
clinical examination data using machine learning methods.
We demonstrated that a crude insight into the thought process regarding the estimation of 
cardiac function by physicians using clinical examination is possible with Bayesian networks. 
This method has been developed and tested in an article describing the evolution of human 
orthodontic features (33). While we demonstrated that this method was feasible to give an insight 
into the overall thought process of multiple physicians and researchers, a similar approach could 
also be applicable for individual physicians. The physician can then be made aware of their 
thinking process and can be trained to use or leave out specifi c values obtained with the clinical 
examination, or the physician can be trained to reconsider their conclusion when new information 
is presented. Individual physicians can be trained using this method built into a game, and if 
multiple physicians are trained, the overall diagnostic accuracy of clinical examination can be 
improved. Using games for these types of educational purposes has been shown to enhance 
knowledge gain in various settings (34,35).
Clinical trials are needed to fi nd the optimal method of blood pressure measurement in every 
individual patient
Reliable blood pressure measurements are of vital importance for the care of the critically 
ill patient in the OR and the ICU. A mean arterial pressure (MAP) of 65 mmHg is the lower 
limit of blood pressure to target (25), and this is chosen because research in the OR (36) and 
the ICU (37,38) has shown that a MAP below this value is associated with complications and 
increased mortality. An invasive arterial catheter is the clinical gold standard for blood pressure 
measurements in critically ill patients and blood pressure monitoring during high-risk surgery. 
Placing an arterial catheter has other benefi ts besides continuous blood pressure monitoring, 
such as facilitating the regular drawing of blood samples and blood gas analyses. Risks such as 
thrombosis and catheter infections should be considered when placing an arterial catheter (39). 
Various alternatives have been developed to try and reduce the invasiveness of hemodynamic 
monitoring. These alternatives, such as the non-invasive oscillometric upper-arm cuff , are also 
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regularly used in critically ill patients (40). Because it is essential to target a specific value of blood 
pressure in critically ill patients, it is also vital that the values of the different methods used agree.
Most studies that assessed the agreement between the non-invasive oscillometric upper-arm cuff 
and the invasive arterial catheter are retrospective analyses (41,42). These studies were limited by 
the inability to correct potential issues that influence measurements, such as ensuring that the 
correct size upper-arm cuff was used for each patient or leveling and zeroing the arterial system 
to prevent under- or overdamping. We performed a prospective observational study where we 
considered these potential issues. Besides the statistical agreement, it is also beneficial to look at 
the clinical significance of measurement differences. Error grid-analysis was developed for this 
purpose (43), and we applied this method in our study.
The methods used in method comparison studies give overall conclusions on the interchangeability 
of different methods of measurement. Bland-Altman analysis and error-grid analysis both provide 
an answer to questions regarding interchangeability based on measurements of an entire 
group of patients. For individual patients, one method may be preferred over the other, but at 
the moment, there is no evidence to support the preferred use of one method over another. 
Ultimately, clinical trials are needed to ensure a potential improvement of patient safety and cost-
effectiveness, and the appropriate method to measure blood pressure can be designated for 
specific subgroups of critically ill patients (44).
Critical care ultrasonography will become standard of care in the intensive care unit
After clinical examination, including blood pressure monitoring, performing a CO measurement 
is the next step of hemodynamic assessment in critically ill patients suspected of circulatory 
shock (25,26). The routine use of CCUS for this purpose is becoming more widespread, and 
ultrasonography machines are increasingly available at the bedside in the ICU (45). It is now 
expected that every new ICU physician is familiar with basic assessments performed with CCUS 
(45). These basic assessments are designed to answer a simple binary question, such as whether 
a patient is fluid responsive or whether there is pericardial effusion (46). Measurement of CO is 
considered to be an advanced assessment, but the ability to perform this measurement could be 
of significant interest in the daily hemodynamic assessment of critically ill patients (47).
Our finding that, after a short training, even novices in CCUS can obtain the necessary images 
but are unable to produce a correct CO in those images supports the fact that measuring CO 
is considered an advanced assessment. This finding, however, also supports the use of CCUS 
novices to acquire the necessary images to measure CO. The actual CO measurement is reserved 
for experts. We used medical students as novices, and even though they did not follow a formal 
training program, the training they received was similar to the national requirements for CCUS 
of many countries (48). The full implementation of CCUS in the ICU requires clearly defined 
competencies (48). Once these have been agreed upon, a supporting training infrastructure 
can be set up. Eventually, a clinical trial has to be performed, demonstrating improved patient 
outcomes when CCUS is used for the daily hemodynamic assessment of critically ill patients. 
Recently, such a trial was conducted to determine the benefit of hemodynamic monitoring using 
transesophageal echocardiography in critically ill patients with circulatory shock (49).
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Prepublication of research protocols will improve the conduct and reporting of studies
Published studies can contain misleading results and waste valuable resources as a consequence of 
weaknesses in the design and conduct of the study (50). Waste of research can prevent physicians 
from making well-informed decisions, with severe consequences if harmful or ineff ective 
treatments are promoted (51). This waste may be in part due to the reasons mentioned in this 
discussion, which infl uence study results. As said before, some of these reasons are inherent to 
study design. However, there are also correctable fl aws in study methodology and conduct (52).
We looked at mortality prediction models and observed an example of studies with potential 
fl aws in methodology. We provided an overview of all available mortality prediction models in 
adult critically ill patients and demonstrated that a large number of these models lack complete 
development. A critical aspect of the development of a prediction model is to test the model in 
external cohorts, i.e., external validation (53). External validation was one of the factors lacking in 
the majority of the mortality prediction models we identifi ed. Validation of a prediction model 
in the same cohort as it was developed in is considered to be methodologically fl awed as 
the developed model will perform better (53,54). The eventual aim is to identify the mortality 
prediction model that is the most suitable score for a specifi c patient cohort in clinical practice. 
The next step to achieve this is to perform a head-to-head comparison in a single external 
validation cohort.
It would be benefi cial to make it mandatory to draft and make a protocol available before the 
conduct of a study to help achieve the complete development of prediction models. In this 
protocol, the comprehensive development of the model could be described, and any fl aws 
in methodology could be addressed beforehand. We even believe that research waste can be 
decreased for most studies by allowing peer-review of these study protocols before the initiation 
of a study. The same principle applies to method comparison studies that are needed to help 
validate hemodynamic monitors and for trials on the PGDT intervention or the implementation 
of monitors in clinical practice. Ultimately, this allows researchers to increase the transparency 
of study conduct and reporting and may help improve the quality of evidence for interventions 
performed in patients.
To conclude, future studies on the comparison of hemodynamic monitors or the application of 
hemodynamic monitors in the PGDT intervention need to properly plan and report on all aspects 
of study design and conduct. For the PGDT intervention, this means that a protocol is drafted 
using the proper checklists (55,56), this protocol is peer-reviewed by experts to ensure an as low 
as possible risk of bias, a feasible theorized intervention eff ect on relevant outcomes (57,58), and 
transparency regarding the individual components of the PGDT intervention to limit heterogeneity 
(7). For method comparison studies of hemodynamic monitors, this also means that a protocol 
is drafted and peer-reviewed in advance with consideration of the applicable checklists (12,59) 
to ensure that all components of validation of a novel monitor; precision, accuracy, and trending 
ability, are addressed according to statistically robust methodology (60,61).
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Dit proefschrift had als eerste doel om het bewijsmateriaal over de toepasbaarheid van 
hemodynamische monitoring uit te breiden, die gebruikt wordt om hemodynamische instabiliteit 
tijdens de perioperatieve periode en de opname op de IC te voorkomen en te behandelen. Ten 
tweede streefden we ernaar de kennis uit te bereiden over het verbeteren van de uitvoering van 
studies in de perioperatieve en intensive care geneeskunde.
Hemodynamische monitoring gebruikt in perioperatieve goal-directed therapy
Perioperatieve goal-directed therapy is meer dan een enkele interventie
Met behulp van hemodynamische monitoring kan de perioperatieve goal-directed therapy 
(PGDT) interventie uitgevoerd worden. Deze PGDT-interventie is reeds geëvalueerd in 
verschillende gerandomiseerde gecontroleerde studies (RCT’s). In onze systematische review 
vonden wij het vanwege klinische heterogeniteit ongepast om een meta-analyse uit te voeren op 
basis van gegevens verkregen uit deze onderzoeken (hoofdstuk 2). Er waren meerdere aspecten 
van deze uitgebreide heterogeniteit waargenomen in de complexe PGDT-interventie, zoals het 
gebruik van verschillende hemodynamische variabelen als doel voor interventie en het gebruik 
van verschillende hemodynamische monitors. Gezien de bestaande normen voor kwalitatief 
hoogstaand bewijs was het niet gerechtvaardigd om een uniforme conclusie te trekken over 
het eff ect van PGDT op patiëntgerichte uitkomsten. We hebben de behoefte aangetoond 
naar universele en uniforme defi nities van de PGDT-interventie om een vergelijking tussen 
verschillende onderzoeken mogelijk te maken. Wanneer de resultaten van individuele RCT’s wel 
worden samengevoegd in een meta-analyse, moet deze inherente heterogeniteit door de lezer 
worden overwogen voordat conclusies kunnen worden getrokken.
Hoewel we hebben aangetoond dat er geen kwalitatief hoogstaand bewijs beschikbaar was voor 
de PGDT-interventie, oftewel een meta-analyse die gegevens uit onderzoeken combineert met 
een laag risico op bias, moet een combinatie van verschillende aspecten worden overwogen 
om ervoor te zorgen dat de juiste patiënten profi teren van de PGDT-interventie. Ten eerste moet 
de PGDT-interventie worden toegepast bij hoog risicopatiënten die een hoog risico operatie 
ondergaan. Ten tweede moet de initiatie van de PGDT-interventie vroeg in de perioperatieve 
periode worden gestart. Ten derde moet het PGDT-algoritme fl ow optimalisatie, oftewel 
cardiac output of slagvolume, combineren met dynamische preloadvariabelen, bijvoorbeeld 
slagvolumevariatie (SVV), om de vloeistofrespons te beoordelen (hoofdstuk 3).
Hemodynamische monitoring in de intensive care
Gegevens verkregen uit de prospectieve observationele Simple Intensive Care Studies-I (SICS-I) 
werden gebruikt om het beschikbare bewijs met betrekking tot hemodynamische monitoring 
in de intensive care te vergroten. De primaire hemodynamische beoordeling wanneer een 
circulatoire shock wordt vermoed, kan worden beschreven als een stapsgewijze benadering 
waarbij aanvankelijk klinisch onderzoek wordt uitgevoerd, gevolgd door een meting van cardiac 
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output met behulp van echocardiografie, en afgesloten met geavanceerdere hemodynamische 
monitoring wanneer een complexe circulatoire shocktoestand dit vereist. In dit proefschrift 
hebben we het bewijsmateriaal voor elk van deze stappen uitgebreid.
Lichamelijk onderzoek is de eerste stap maar dient verbeterd te worden
We beoordeelden de huidige standaard van lichamelijk onderzoek bij kritisch zieke patiënten en 
brachten een Bayesiaans netwerk in kaart. Uit dit netwerk bleek dat artsen de aanwezigheid van 
een hoge dosis noradrenaline infusie en een verlengde capillaire refill tijd of mottling van de knie 
beschouwen als voorwaardelijke afhankelijkheden van een lage hartpompfunctie (hoofdstuk 4). 
Dit was de eerste keer dat een dergelijk Bayesiaans netwerk gebouwd werd voor dit doeleinde en 
daarom waren rigoureuze methoden en validatie noodzakelijk. Onze bevindingen geven inzicht 
in het mogelijke denkproces van artsen bij het uitvoeren van het lichamelijk onderzoek en tonen 
aan dat verbeteringen met betrekking tot de diagnostische nauwkeurigheid van het lichamelijk 
onderzoek voor hemodynamische beoordeling nodig zijn.
Verschillende methoden om bloeddruk te meten zijn niet uitwisselbaar
Bloeddrukmetingen verkregen met een non-invasieve oscillometrische bovenarm manchet 
vertoonden een te brede grens van overeenstemming in vergelijking met invasieve arteriële 
bloeddrukmeting. Error grid analyse toonde aan dat bij één op de vier patiënten die behandeld 
werd met noradrenaline er minstens een laag risico bestaat op nadelige veranderde behandeling 
indien gebruik gemaakt zou zijn van de niet-invasieve methode (hoofdstuk 5). Bloeddrukmetingen 
verkregen met een invasieve arteriële katheter zijn momenteel de klinische standaard bij patiënten 
met circulatoire shock, en onze bevindingen ondersteunen niet dat een non-invasieve meting als 
vervanging van deze klinische standaardmethode gebruikt kan worden. Wij zijn van mening dat 
het in de klinische praktijk essentieel is om kritisch te blijven op de uitwisselbaarheid van methoden 
voor bloeddrukmeting. De analyses die werden gebruikt om de twee bloeddrukmeetmethoden 
te vergelijken bieden beperkte gegevens over meetverschillen tussen verschillende methoden 
bij individuele patiënten. Voor de klinische praktijk betekent dit dat bij elke individuele patiënt 
de optimale toepasbare meetmethode moet worden bepaald op basis van de voor- en nadelen.
Experts blijven noodzakelijk om de beelden verkregen met echocardiografie juist te 
interpreteren
Geneeskundestudenten zijn in staat om echocardiografie beelden van voldoende kwaliteit te 
verkrijgen bij kritisch zieke patiënten in de intensive care, maar experts blijven noodzakelijk 
voor een juiste interpretatie van deze beelden (hoofdstuk 6). De kwaliteit van de beelden 
verkregen door de geneeskundestudenten was van voldoende kwaliteit, maar de metingen 
van cardiac output die door de geneeskundestudenten werden gemaakt op basis van deze 
beelden toonden te brede grenzen van overeenstemming. Dat wil zeggen dat er sprake was van 
onaanvaardbare nauwkeurigheid van de meetverschillen. De metingen werden gemaakt door 
de geneeskundestudenten en deze werden vergeleken met metingen door experts die gebruik 
maakten van dezelfde afbeeldingen. Het kunnen verkrijgen van de benodigde afbeeldingen en 
het kunnen uitvoeren van de cardiac output berekening is van essentieel belang, omdat het 
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gebruik van echocardiografi e in de intensive care zal blijven toenemen. Onze bevindingen zijn 
interessant omdat het kunnen berekenen van cardiac output met behulp van echocardiografi e 
beschouwd wordt als een geavanceerde vaardigheid en de geneeskundestudenten geen eerdere 
ervaring hadden met het gebruik van echocardiografi e. Voor toekomstig onderzoek en klinische 
toepassing van echocardiografi e is het mogelijk om beginners de beelden te laten verkrijgen die 
vervolgens door experts kunnen worden geïnterpreteerd, waardoor tijd en middelen worden 
bespaard.
Ongekalibreerde polsgolfanalyse om cardiac output te meten is niet geïndiceerd bij patiënten 
met circulatoire shock
Cardiac outputmetingen verkregen met een apparaat dat gebruik maakt van ongekalibreerde 
polsgolfanalyse toonden een te brede grens van overeenstemming en klinisch onaanvaardbaar 
trending vergeleken met echocardiografi e bij patiënten met circulatoire shock (hoofdstuk 7). Op dit 
moment wordt de ongekalibreerde polsgolfanalysemethode voor het meten van cardiac output 
niet aanbevolen bij patiënten met circulatoire shock en onze bevindingen ondersteunen dit. 
Vanwege de gekozen methoden was het niet mogelijk om directe superioriteit of non-inferioriteit 
van de ene methode ten opzichte van de andere te bewijzen, omdat echocardiografi e geen 
gouden standaard referentietechniek, en die is vereist voor een formele methodevergelijking. 
Vergelijkingen die gedaan worden in prospectieve observationele studies kunnen mogelijk 
de klinische praktijk beter weerspiegelen en maken validatie van deze methoden mogelijk in 
populaties van patiënten die aanvankelijk niet de doelpopulatie waren.
Initiatieven om methodologie en uitvoer van studies te verbeteren
Externe validatie van onderzoeksbevindingen in onafhankelijke cohorten is nodig
We presenteerden een overzicht van 43 geïdentifi ceerde mortaliteit predictiemodellen voor het 
voorspellen van sterfte bij willekeurige populaties van kritisch zieke patiënten. Deze modellen 
hadden een variërende kwaliteit van methodologie, en de validatie van
de individuele modellen verschilde onderling en was meestal onvolledig (hoofdstuk 8). Externe 
validatie van de mortaliteit predictiemodellen ontbreekt vaak, en een-op-een-vergelijkingen 
zijn nodig om uit de beschikbare mortaliteit predictiemodellen het best presterende model 
te identifi ceren voor het begeleiden van klinische zorg en onderzoek onder verschillende 
omstandigheden en in verschillende populaties.
Verplichte publicatie en peer-review van onderzoeksprotocollen
Peer-review van onderzoeksprotocollen door middel van publicatie voorafgaand aan de start van 
een studie kan de transparantie van uitvoer en verslaglegging van onderzoek vergroten (hoofdstuk 
9). Wij zijn van mening dat een gestructureerde bespreking van de essentiële onderdelen voor 
start van een onderzoek, de discussie achteraf over de opzet van het onderzoek en de interpretatie 
van de onderzoeksresultaten kan beperken. Protocollen kunnen worden beoordeeld aan de hand 
van de checklist die bij het onderzoek ontwerp past, en wijzigingen kunnen worden aangebracht 
op basis van vastgestelde regels met een hoge validiteit. Opmerkelijke gebreken en weglatingen 
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kunnen worden geïdentificeerd, waardoor correcties op tijd mogelijk zijn. Er moet rekening 
worden gehouden met mogelijke vertragingen bij het begin van de studie en innovatieve 
ideeën staan open en kunnen door andere onderzoekers worden overgenomen. Transparantie 
en optimalisatie van onderzoeksopzet en uitvoer van studies komen niet alleen de onderzoekers, 
maar met name de patiënten ten goede, en dit is het uiteindelijke doel van al het uitgevoerde 
onderzoek.
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operatie uit liep en wij nog drie uur lang testjes en bloedafnames moesten doen.
Mijn bestuursgenoten van Bestuur 2011 der Stichting Sociëteit Volonté en tevens goede vrienden 
wil ik graag bedanken. Jefta van Dijk, Jorn Kalsbeek, Pieter Steinkamp, Marieke van der Velde, en 
Laura van Wijk. In onze studententijd heb ik met jullie een fantastisch bestuursjaar gehad waarin 
we niet altijd even serieus hoefden te zijn en alles skitterend of juist heel aal was. Gezien het 
feit dat we allemaal nog niet zo veel konden toen is het best bijzonder dat we allemaal met 
onderzoek bezig zijn gegaan. En over een paar jaar kunnen we zelfs met drie anesthesiologen en 
drie chirurgen mooi onze eigen kliniek openen.
Mijn ploeggenoten van Altijd Hard, de beste competitieroeiploeg die A.G.S.R Gyas ooit gekend 
heeft, wil ik graag bedanken. Henk Aarnink, Freek Apperloo, Mark Kloosterhuis, Harmen Gietema, 
Jeroen de Groot, Reitse Nijland, Jelle Vos, en Harmen Sjoerd Westra. Nu moet ik natuurlijk wel 
eerlijk noemen dat ik zelf niet heel veel geroeid heb, maar de borrels en feesten waren altijd 
fantastisch. Sinds 2009 hebben we trouw nog steeds iedere donderdag ploegavond met een 
standaard ongezonde maaltijd. Nu we burgers en arbeiders zijn hebben we onze smaak wat 
verfijnd en in dat kader wil ik ook de Happy Italy bedanken voor de vele vierkante meters pizza.
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Mijn paranimfen heb ik te danken aan bovengenoemde vriendengroepen en graag zou ik ze nog 
in het bijzonder willen noemen. Pieter, direct vanaf het begin waren we dikke vrienden (toen ook 
letterlijk). Al snel kwamen we erachter dat we ook maar bestuursgenoten en huisgenoten moesten 
worden, en uiteindelijk hebben we dan ook in drie verschillende huizen samengewoond. Dank je 
voor je heerlijke humor. Mark, ik ben dankbaar voor onze vriendschap. Afspreken voor een borrel 
of een hapje eten is altijd heel ontspannend voor mij geweest. Jouw ontspannen kijk op allerlei 
dingen is altijd heerlijk relativerend. Fantastisch dat jullie straks aan mijn zijde zullen staan bij de 
verdediging van dit proefschrift.
Ik wil graag mijn ouders bedanken. Dankzij jullie heb ik alle kansen en volledige vrijheid gekregen 
om te worden wie ik ben geworden. Jullie onvoorwaardelijke steun en vertrouwen is altijd een 
enorme hulp geweest. Mijn broer, Jelle, wil ik graag bedanken voor de gezelligheid hier in het 
hoge noorden. Ik vind het ongeloofl ijk dapper dat je de stap hebt gezet om hier te komen 
studeren en ik ben heel erg trots op jou. Opa en oma, Wim en Jeanne, het is heel fi jn om een 
hechte familie te hebben.
Nadine, jij bent het beste wat me ooit overkomen is. Ik hou van jou.
Dankwoord
